var title_f18_2_18464="Leukoplakia - buccal";
var content_f18_2_18464=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F81049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F81049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Leukoplakia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A white plaque is present on the buccal mucosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18464=[""].join("\n");
var outline_f18_2_18464=null;
var title_f18_2_18465="Contents: Critical care obstetrics";
var content_f18_2_18465=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?8/24/8590\">",
"       Pulmonary, Critical Care, and Sleep Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Critical care obstetrics",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Critical care obstetrics",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Cardiology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/33/13850\">",
"           Advanced cardiac life support (ACLS) in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/28/28101\">",
"           Biomarkers of cardiac injury other than troponins and creatine kinase",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/60/16329\">",
"           Clinical manifestations and diagnosis of cardiogenic shock in acute myocardial infarction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/36/36424\">",
"           Clinical significance and treatment of ventricular premature beats",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/10/22689\">",
"           Differential diagnosis of basic electrocardiographic abnormalities",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/24/11658\">",
"           Electrocardiogram in the diagnosis of myocardial ischemia and infarction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/22/20840\">",
"           Management of cardiopulmonary arrest in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/2/2086\">",
"           Normal sinus rhythm and sinus arrhythmia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/41/31384\">",
"           Paroxysmal atrial fibrillation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/50/3878\">",
"           Sinus bradycardia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/25/14742\">",
"           Sinus tachycardia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/27/441\">",
"           Supraventricular premature beats",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/56/34698\">",
"           Treatment of acute decompensated heart failure: Components of therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/7/41079\">",
"           Treatment of acute decompensated heart failure: General considerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/32/8711\">",
"           Treatment with digoxin: initial dosing, monitoring, and dose modification",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/38/39530\">",
"           Troponins and creatine kinase as biomarkers of cardiac injury",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/35/40505\">",
"           Use of vasopressors and inotropes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Catheters and monitoring",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/33/15894\">",
"           Arterial blood gases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/51/26424\">",
"           Arterial catheterization techniques for invasive monitoring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/1/29\">",
"           Complications of central venous catheters and their prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/40/25221\">",
"           Insertion of pulmonary artery catheters",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/31/27128\">",
"           Pulmonary artery catheterization: Indications and complications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/10/44199\">",
"           Pulmonary artery catheterization: Interpretation of tracings",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/32/9736\">",
"           Pulse oximetry",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/35/13877\">",
"           Venous blood gases and other alternatives to arterial blood gases",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Endocrine and metabolism",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/17/275\">",
"           Beta blockers in the treatment of hyperthyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/55/4986\">",
"           Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/61/31703\">",
"           Determinants of glucocorticoid dosing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/46/44777\">",
"           Diagnosis of adrenal insufficiency in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/38/10852\">",
"           Iodine in the treatment of hyperthyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/55/33655\">",
"           Thyroid storm",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/48/15114\">",
"           Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Fluid and electrolytes",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/44/31432\">",
"           Approach to the adult with metabolic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/5/33882\">",
"           Causes and evaluation of hyperkalemia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/58/13220\">",
"           Causes and treatment of hypermagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/17/5402\">",
"           Causes of hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/30/3562\">",
"           Causes of hyponatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/55/4986\">",
"           Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/35/39479\">",
"           Clinical manifestations and evaluation of metabolic alkalosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/2/9258\">",
"           Clinical manifestations and treatment of hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/2/44069\">",
"           Clinical manifestations of hyperkalemia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/16/44295\">",
"           Epidemiology and pathogenesis of diabetic ketoacidosis and hyperosmolar hyperglycemic state",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/63/36857\">",
"           Etiology and evaluation of hypernatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/48/40710\">",
"           Loop diuretics: Maximum effective dose and major side effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/7/34935\">",
"           Maintenance and replacement fluid therapy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/58/23464\">",
"           Manifestations of hyponatremia and hypernatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/34/18986\">",
"           Overview of the treatment of hyponatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/10/42154\">",
"           Possible prevention and therapy of postischemic (ischemic) acute tubular necrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/29/41430\">",
"           Serum osmolal gap",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/41/27288\">",
"           Simple and mixed acid-base disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/9/32914\">",
"           Symptoms of hypermagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/1/21526\">",
"           The ������anion gap/������HCO3 ratio in patients with a high anion gap metabolic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/54/17258\">",
"           Treatment and prevention of hyperkalemia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/48/15114\">",
"           Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/52/24393\">",
"           Treatment of hypernatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/14/14568\">",
"           Treatment of metabolic alkalosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/20/13639\">",
"           Treatment of severe hypovolemia or hypovolemic shock in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/18/11558\">",
"           Urine anion and osmolal gaps in metabolic acidosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hematology and transfusion",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/4/24650\">",
"           Acquired inhibitors of coagulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/46/18153\">",
"           Anticoagulation during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/3/5178\">",
"           Approach to the adult patient with a bleeding diathesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/19/15674\">",
"           Approach to the adult patient with thrombocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/61/36826\">",
"           Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/20/25929\">",
"           Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/36/4682\">",
"           Clinical use of coagulation tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/1/29721\">",
"           Diagnosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/31/11769\">",
"           Immunologic blood transfusion reactions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/21/10582\">",
"           Intraoperative and postoperative blood salvage",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/25/38294\">",
"           Massive blood transfusion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/56/8073\">",
"           Pathogenesis and etiology of disseminated intravascular coagulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/31/42490\">",
"           Treatment and prognosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndromes in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/49/793\">",
"           Use of blood products in the critically ill",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/37/21081\">",
"           Use of red blood cells for transfusion",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypertension",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/4/43080\">",
"           Blood pressure measurement in the diagnosis and management of hypertension in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/29/36314\">",
"           Choice of therapy in primary (essential) hypertension: Recommendations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/26/18853\">",
"           Drug treatment of hypertensive emergencies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/55/39801\">",
"           Eclampsia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/26/422\">",
"           Initial evaluation of the hypertensive adult",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/27/41398\">",
"           Malignant hypertension and hypertensive encephalopathy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/37/28246\">",
"           Management of severe asymptomatic hypertension (hypertensive urgencies)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/30/8679\">",
"           Consolidated aminoglycoside dosing with gentamicin and tobramycin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/23/375\">",
"           Diagnosis of intravascular catheter-related infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/29/6616\">",
"           Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/37/37464\">",
"           Epidemiology, pathogenesis, and microbiology of intravascular catheter infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/57/12183\">",
"           Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/51/21306\">",
"           Evaluation and management of severe sepsis and septic shock in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/47/20215\">",
"           Manifestations of and risk factors for aminoglycoside nephrotoxicity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/41/18072\">",
"           Pathogenesis and prevention of aminoglycoside nephrotoxicity and ototoxicity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/20/5449\">",
"           Pathophysiology of sepsis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/53/31578\">",
"           Prevention of intravascular catheter-related infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/10/24744\">",
"           Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/20/7498\">",
"           Treatment of intravascular catheter-related infections",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Intoxicants",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/58/16297\">",
"           Gastrointestinal decontamination of poisoned adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/6/1129\">",
"           General approach to drug poisoning in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/61/20441\">",
"           Management of moderate and severe alcohol withdrawal syndromes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Liver disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/38/24166\">",
"           Acute fatty liver of pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/17/2330\">",
"           Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/40/38538\">",
"           Acute liver failure in adults: Management and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/37/26198\">",
"           Approach to liver disease occurring during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/18/34090\">",
"           Approach to the patient with abnormal liver biochemical and function tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/30/17897\">",
"           HELLP syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neurology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/56/19337\">",
"           Hypoxic-ischemic brain injury: Evaluation and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/11/19642\">",
"           Status epilepticus in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Nutrition",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/32/13831\">",
"           Nutrition support in critically ill patients: An overview",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/51/26424\">",
"           Arterial catheterization techniques for invasive monitoring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/1/29\">",
"           Complications of central venous catheters and their prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/55/34681\">",
"           Critical illness during pregnancy and the peripartum period",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/40/25221\">",
"           Insertion of pulmonary artery catheters",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/21/10582\">",
"           Intraoperative and postoperative blood salvage",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/7/15482\">",
"           Management of pregnant women undergoing nonobstetric surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/25/38294\">",
"           Massive blood transfusion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/57/1944\">",
"           Noncardiogenic pulmonary edema",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/31/27128\">",
"           Pulmonary artery catheterization: Indications and complications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/10/44199\">",
"           Pulmonary artery catheterization: Interpretation of tracings",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/62/6120\">",
"           Shock in adults: Types, presentation, and diagnostic approach",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/37/21081\">",
"           Use of red blood cells for transfusion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/35/40505\">",
"           Use of vasopressors and inotropes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonary",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/16/10505\">",
"           Acute respiratory distress syndrome: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/15/29945\">",
"           Acute respiratory distress syndrome: Epidemiology; pathophysiology; pathology; and etiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/48/4871\">",
"           Acute respiratory distress syndrome: Prognosis and outcomes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/48/38664\">",
"           Air embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/42/15016\">",
"           Amniotic fluid embolism syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/33/15894\">",
"           Arterial blood gases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/57/12183\">",
"           Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/42/2730\">",
"           Mechanical ventilation in acute respiratory distress syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/57/1944\">",
"           Noncardiogenic pulmonary edema",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/1/13336\">",
"           Overview of mechanical ventilation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/44/31430\">",
"           Oxygen delivery and consumption",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/8/33925\">",
"           Oxygenation and mechanisms of hypoxemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/32/9736\">",
"           Pulse oximetry",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/54/9065\">",
"           Supportive care and oxygenation in acute respiratory distress syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/35/13877\">",
"           Venous blood gases and other alternatives to arterial blood gases",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Renal",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/44/33479\">",
"           Acute kidney injury (acute renal failure) in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/45/36570\">",
"           Assessment of kidney function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/54/12138\">",
"           Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury (acute renal failure)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/1/34839\">",
"           Investigational biomarkers and the evaluation of acute tubular necrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/28/2501\">",
"           Nonoliguric versus oliguric acute tubular necrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/4/4170\">",
"           Pathogenesis and etiology of postischemic (ischemic) acute tubular necrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/10/42154\">",
"           Possible prevention and therapy of postischemic (ischemic) acute tubular necrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/28/4553\">",
"           Renal and patient outcomes after acute tubular necrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/49/12050\">",
"           Urine output in urinary tract obstruction and postobstructive diuresis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Thrombosis and embolism",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/48/38664\">",
"           Air embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/42/15016\">",
"           Amniotic fluid embolism syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/26/27050\">",
"           Catheter-induced upper extremity venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/57/6042\">",
"           Diagnosis of acute pulmonary embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/12/33994\">",
"           Diagnosis of suspected deep vein thrombosis of the lower extremity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/41/11930\">",
"           Evaluation of the patient with established venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/59/40890\">",
"           Heparin-induced thrombocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/50/35626\">",
"           Management of anticoagulation before and after elective surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/48/43786\">",
"           Overview of the causes of venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/8/33930\">",
"           Therapeutic use of heparin and low molecular weight heparin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/17/42266\">",
"           Therapeutic use of warfarin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/32/42503\">",
"           Treatment of acute pulmonary embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/4/43082\">",
"           Treatment of lower extremity deep vein thrombosis",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-4500F2B982-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f18_2_18465=[""].join("\n");
var outline_f18_2_18465=null;
var title_f18_2_18466="Calculator: MELD score for end-stage liver disease (not appropriate for patients under the age of 12) (SI units)";
var content_f18_2_18466=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"MELD_SI_form\" name=\"MELD_SI_form\" onkeydown=\"clrResults();\" onkeyup=\"MELD_SI_fx();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: MELD score for end-stage liver disease (not appropriate for patients under the age of 12) (SI units)",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <center>",
"     <div id=\"calc_equation\">",
"      <table cellpadding=\"10\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"       <tr>",
"        <td align=\"left\" bgcolor=\"#6c9a9c\">",
"         <span class=\"medCalcFontFormuli\">",
"          MELDScore = 10 * ((0.957 * ln(Creatinine/88.4)) + (0.378 * ln(Bilirubin/17.1)) + (1.12 * ln(INR))) + 6.43",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"     </div>",
"    </center>",
"    <div id=\"calc_main\">",
"     <center>",
"      <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"       <tr>",
"        <td align=\"right\" width=\"50%\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Input:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Age",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Age_param\" onblur=\"MELD_SI_fx(); minMaxCheck();\" onchange=\"MELD_SI_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Age_unit\" onchange=\"MELD_SI_fx();\" style=\"width:105px;\">",
"              <option value=\"0.0833333333333333|0|mo\">",
"               mo",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|yr\">",
"               yr",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Creatinine",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Creatinine_param\" onblur=\"MELD_SI_fx(); minMaxCheck();\" onchange=\"MELD_SI_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Creatinine_unit\" onchange=\"MELD_SI_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|mcmol/L\">",
"               mcmol/L",
"              </option>",
"              <option value=\"1000|0|mmol/L\">",
"               mmol/L",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Bilirubin",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Bilirubin_param\" onblur=\"MELD_SI_fx(); minMaxCheck();\" onchange=\"MELD_SI_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Bilirubin_unit\" onchange=\"MELD_SI_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|mcmol/L\">",
"               mcmol/L",
"              </option>",
"              <option value=\"1000|0|mmol/L\">",
"               mmol/L",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              INR",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"INR_param\" onblur=\"MELD_SI_fx(); minMaxCheck();\" onchange=\"MELD_SI_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\">",
"             &nbsp;",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Hemodialysis twice in week prior",
"             </span>",
"            </td>",
"            <td align=\"left\" colspan=\"3\">",
"             <span class=\"medCalcFontOne\">",
"              <input name=\"Hemodialysis_twice_in_week_prior_radio\" onclick=\"Creatinine_param.value = '353.6'; Creatinine = 353.6; MELD_SI_fx();\" type=\"radio\" value=\"Yes\"/>",
"              Yes",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"left\">",
"             <br/>",
"            </td>",
"            <td align=\"left\" colspan=\"3\">",
"             <span class=\"medCalcFontOne\">",
"              <input checked=\"checked\" name=\"Hemodialysis_twice_in_week_prior_radio\" onclick=\"Creatinine_param.value = ''; MELD_Score_param.value = '';\" type=\"radio\" value=\"No\"/>",
"              No",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" valign=\"top\">",
"             <span class=\"medCalcFontOneBold\">",
"              Exception Diagnoses Age 12 to 17 Years",
"             </span>",
"            </td>",
"            <td align=\"left\" colspan=\"2\">",
"             <span class=\"medCalcFontOne\">",
"              <input checked=\"checked\" name=\"Exception_Diagnoses_Age_12_to_17_Years_radio\" onclick=\"MELD_SI_fx();\" type=\"radio\" value=\"Non contributory|0\"/>",
"              Non contributory (0)",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"left\">",
"             <br/>",
"            </td>",
"            <td align=\"left\" colspan=\"2\">",
"             <span class=\"medCalcFontOne\">",
"              <input name=\"Exception_Diagnoses_Age_12_to_17_Years_radio\" onclick=\"MELD_SI_fx();\" type=\"radio\" value=\"Urea cycle disorder|1\"/>",
"              Urea cycle disorder (1)",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"left\">",
"             <br/>",
"            </td>",
"            <td align=\"left\" colspan=\"2\">",
"             <span class=\"medCalcFontOne\">",
"              <input name=\"Exception_Diagnoses_Age_12_to_17_Years_radio\" onclick=\"MELD_SI_fx();\" type=\"radio\" value=\"Organic acidemia|1\"/>",
"              Organic acidemia (1)",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"left\">",
"             <br/>",
"            </td>",
"            <td align=\"left\" colspan=\"2\">",
"             <span class=\"medCalcFontOne\">",
"              <input name=\"Exception_Diagnoses_Age_12_to_17_Years_radio\" onclick=\"MELD_SI_fx();\" type=\"radio\" value=\"Hepatoblastoma|1\"/>",
"              Hepatoblastoma (1)",
"             </span>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Results:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              MELD Score",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"MELD_Score_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"3\">",
"             &nbsp;",
"             <br/>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <center>",
"          <span class=\"medCalcFontOne\">",
"           <input name=\"reset\" type=\"reset\" value=\"Reset form\"/>",
"          </span>",
"         </center>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOne\">",
"     </span>",
"    </div>",
"    <div id=\"calc_notes\">",
"     <span class=\"medCalcFontOneBold\">",
"      Notes",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       The Model of End-stage Liver Disease, or",
"       <b>",
"        MELD Score",
"       </b>",
"       is used to estimate relative disease severity and likely survival of patients awaiting liver transplantation.",
"      </li>",
"      <li>",
"       Children under the age of 12 should be assessed by the",
"       <b>",
"        PELD Score",
"       </b>",
"       .",
"      </li>",
"      <li>",
"       If a patient has had 2 or more hemodialysis treatments or 24 hours of CVVHD in the week prior to the time of the scoring,",
"       <b>",
"        Creatinine",
"       </b>",
"       will be set to 353.6 mcmol/L, the maximum creatinine level allowed in the model.",
"      </li>",
"      <li>",
"       If the patient is between 12 and 17 years old, and has either a urea cycle disorder, organic acidemia or hepatoblastoma, the",
"       <b>",
"        MELD Score",
"       </b>",
"       is set at 30.",
"      </li>",
"      <li>",
"       For patients with hepatocellular carcinoma, the PELD/MELD score is increased according to an algorithm established by UNOS (United Network for Organ Sharing.)",
"      </li>",
"      <li>",
"       Additional information about the",
"       <b>",
"        MELD",
"       </b>",
"       and",
"       <b>",
"        PELD",
"       </b>",
"       scores is at the UNOS website,  file://optn.transplant.hrsa.gov/resources/",
"       <wbr>",
"       </wbr>",
"       professionalResources.asp?index=8",
"      </li>",
"      <li>",
"       Please see appropriate UpToDate topic reviews for further information.",
"      </li>",
"     </ul>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <span class=\"medCalcFontOne\">",
"     Equation parameters such as",
"     <b>",
"      Exception Diagnoses Age 12 to 17 Years",
"     </b>",
"     have two or more discrete values that may be used in the calculation. The numbers in the parentheses, e.g.  (0), represent the values that will be used.",
"    </span>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"   </form>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18466=[" ",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"var currenttimeout;",
"",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function MELD_SI_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 3000);",
"",
"with(document.MELD_SI_form){",
"",
"",
"doCalc = true;",
"if (Age_param.value.indexOf(',') >= 0){ Age_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Age_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Age_unit.options[Age_unit.selectedIndex].value.split('|');",
"Age = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Creatinine_param.value.indexOf(',') >= 0){ Creatinine_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Creatinine_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Creatinine_unit.options[Creatinine_unit.selectedIndex].value.split('|');",
"Creatinine = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Bilirubin_param.value.indexOf(',') >= 0){ Bilirubin_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Bilirubin_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Bilirubin_unit.options[Bilirubin_unit.selectedIndex].value.split('|');",
"Bilirubin = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (INR_param.value.indexOf(',') >= 0){ INR_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(INR_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"INR = param_value;",
"if (Exception_Diagnoses_Age_12_to_17_Years_radio[0].checked){ Exception_Diagnoses_Age_12_to_17_Years = 0; }",
"if (Exception_Diagnoses_Age_12_to_17_Years_radio[1].checked){ Exception_Diagnoses_Age_12_to_17_Years = 1; }",
"if (Exception_Diagnoses_Age_12_to_17_Years_radio[2].checked){ Exception_Diagnoses_Age_12_to_17_Years = 1; }",
"if (Exception_Diagnoses_Age_12_to_17_Years_radio[3].checked){ Exception_Diagnoses_Age_12_to_17_Years = 1; }",
"dp = 0;",
"if (Hemodialysis_twice_in_week_prior_radio[0].checked){",
"Creatinine_param.value = '353.6'; Creatinine = 353.6;",
"for(i = 0; i < Creatinine_unit.options.length; i++){",
"if (Creatinine_unit.options[i].value == '1|0|mcmol/L') Creatinine_unit.selectedIndex = i;",
"}}",
"MELD_Score =  10 * ((0.957 * ln(Creatinine/88.4)) + (0.378 * ln(Bilirubin/17.1)) + (1.12 * ln(INR))) + 6.43;",
"",
"if (doCalc) MELD_Score_param.value = fixDP(MELD_Score, dp);",
"",
"",
"",
"if (Exception_Diagnoses_Age_12_to_17_Years && (Age >= 12) && (Age <= 17)){",
"alert('Beacuse of this specific disease, the MELD Score is set at 30');",
"MELD_Score_param.value = '30';",
"}",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.MELD_SI_form){",
"",
"if (Age_param.value && Age < 12) {",
"Age = 0;",
"Age_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Age is 12 yr.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Creatinine_param.value && Creatinine < 88.4) {",
"Creatinine = 0;",
"Creatinine_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Creatinine is 88.4 mcmol/L.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Creatinine_param.value && Creatinine > 353.6) {",
"Creatinine_param.value = \"\";",
"clrResults();",
"Creatinine = 0;",
"doCalc = false;",
"alert(\"The maximum value for Creatinine is 353.6 mcmol/L.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Bilirubin_param.value && Bilirubin < 17) {",
"Bilirubin = 0;",
"Bilirubin_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Bilirubin is 17 mcmol/L.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (INR_param.value && INR < 1) {",
"INR = 0;",
"INR_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for INR is 1 .\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (INR_param.value && INR > 100) {",
"INR_param.value = \"\";",
"clrResults();",
"INR = 0;",
"doCalc = false;",
"alert(\"The maximum value for INR is 100 .\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.MELD_SI_form){",
"",
"MELD_Score_param.value = '';",
"",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
""].join("\n");
var outline_f18_2_18466=null;
var title_f18_2_18467="Patient information: Dialysis and diet (The Basics)";
var content_f18_2_18467=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16439\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/49/28439\">",
"         Food labels can be tricky",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_table\" href=\"UTD.htm?1/41/1691\">",
"          What do labels about sodium mean?",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?25/30/26092\">",
"           Some foods that are low in potassium",
"          </a>",
"          <li>",
"           <a class=\"graphic graphic_table\" href=\"UTD.htm?28/3/28732\">",
"            Some foods that are high in potassium",
"           </a>",
"          </li>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?18/42/19107\">",
"         Patient information: Choosing between dialysis and kidney transplant (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?25/1/25619\">",
"         Patient information: Hemodialysis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/46/25315\">",
"         Patient information: Kidney transplant (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?8/33/8722\">",
"         Patient information: Low-potassium diet (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/19/41266\">",
"         Patient information: Low-sodium diet (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?15/43/16051\">",
"         Patient information: Peritoneal dialysis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?12/15/12531\">",
"         Patient information: Planning for a kidney transplant (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/22/11619\">",
"         Patient information: Preparing for hemodialysis (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?9/26/9635\">",
"         Patient information: Dialysis or kidney transplantation &mdash; which is right for me? (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/57/40852\">",
"         Patient information: Hemodialysis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?41/41/42640\">",
"         Patient information: Low potassium diet (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?38/61/39890\">",
"         Patient information: Low sodium diet (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?14/10/14501\">",
"         Patient information: Peritoneal dialysis (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Dialysis and diet (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/dialysis-and-diet-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H20736855\">",
"      <span class=\"h1\">",
"       Do people on dialysis need to watch their diet?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Most people on dialysis need to watch what they eat and drink. Your doctor, nurse, or dietitian (food expert) will tell you if there are foods or drinks that you should limit or avoid. The diet that is right for you will depend on:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        The type of dialysis you have &ndash; There are 2 types of dialysis, called hemodialysis and peritoneal dialysis. People who get hemodialysis at a dialysis center (in a hospital or clinic) need to watch their diet the most. They need to limit or avoid more foods than those who do peritoneal dialysis, or hemodialysis at home.",
"       </li>",
"       <li>",
"        How often you have dialysis",
"       </li>",
"       <li>",
"        Your health and other medical conditions",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20736870\">",
"      <span class=\"h1\">",
"       Why do people on dialysis need to watch their diet?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People need to watch their diet because their kidneys aren&rsquo;t working. Normally, the kidneys work to filter the blood and remove waste and excess salt and water.",
"     </p>",
"     <p>",
"      Dialysis is a treatment that takes over the job of the kidneys. But dialysis doesn&rsquo;t remove all of the waste that the kidneys normally remove. Plus, normal kidneys work all day, every day. People usually have hemodialysis at a center only 3 times a week. In between treatments, waste and excess water build up in the body. This can make people feel sick and cause problems.",
"     </p>",
"     <p>",
"      When you watch your diet, you can help make sure that:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Too much fluid doesn&rsquo;t build up in your body between treatments &ndash; Having too much fluid can raise your blood pressure, which makes the heart work harder. Extra fluid can also cause weight gain, swelling, or trouble breathing.",
"       </li>",
"       <li>",
"        Your body has the right amount of nutrients &ndash; Some foods have high levels of certain nutrients. Eating those foods can raise the level of certain nutrients in your body between treatments. This can lead to problems.",
"       </li>",
"       <li>",
"        You stay as healthy as possible and don&rsquo;t gain too much weight",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20736885\">",
"      <span class=\"h1\">",
"       What do I need to watch in my diet?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You will probably need to watch:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Fluids &ndash; Most people on dialysis need to limit the fluids they eat and drink. Any food that is a liquid at room temperature (such as ice cream) is a fluid. Some fruits and vegetables have a lot of fluid in them, including melons, grapes, apples, and lettuce.",
"       </li>",
"       <li>",
"        Sodium &ndash; This is the main ingredient in table salt. Most people on dialysis need to limit the amount of sodium they eat. That&rsquo;s because eating a lot of sodium can raise your blood pressure. It can also make you thirsty and cause you to drink more than you should. To know how much sodium is in a food, you need to look at the food&rsquo;s label (",
"        <a class=\"graphic graphic_figure graphicRef53229 \" href=\"UTD.htm?27/49/28439\">",
"         figure 1",
"        </a>",
"        ). Try to eat foods that are normally low in sodium or foods that say &ldquo;sodium-free&rdquo; or &ldquo;very low in sodium&rdquo; (",
"        <a class=\"graphic graphic_table graphicRef61514 \" href=\"UTD.htm?1/41/1691\">",
"         table 1",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Potassium &ndash; This is a nutrient that affects your heartbeat. Most people on dialysis need to limit the potassium they eat. If too much potassium builds up in your body, it can cause problems with your heart rhythm. Foods that are normally low in potassium are listed here: (",
"        <a class=\"graphic graphic_table graphicRef81516 \" href=\"UTD.htm?25/30/26092\">",
"         table 2",
"        </a>",
"        ). Foods that are high in potassium that you should avoid are listed here: (",
"        <a class=\"graphic graphic_table graphicRef58250 \" href=\"UTD.htm?28/3/28732\">",
"         table 3",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Phosphorus &ndash; This is a nutrient found in many foods. Foods such as milk, other dairy foods, nuts, beans, liver, and chocolate have high levels of phosphorus. Most people on dialysis need to avoid foods with high levels of phosphorus. That&rsquo;s because if phosphorus builds up in your body, it can cause weak bones and other problems. Your doctor might also prescribe a medicine for you to take with your meals and snacks. This medicine can help keep your phosphorus level low.",
"       </li>",
"       <li>",
"        Protein &ndash; Protein helps your muscles stay strong. Foods with a lot of protein include meat, chicken, fish, and eggs. People who do peritoneal dialysis might need extra protein, because the body loses protein with each peritoneal dialysis treatment.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Your doctor will probably prescribe a vitamin for you to take every day. That way, your body can get the vitamins and minerals that might be missing in your diet.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20736899\">",
"      <span class=\"h1\">",
"       What if I get thirsty?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you get thirsty but need to limit your fluids, try these tips:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Suck on ice instead of having a drink, because ice lasts longer. (But remember that ice is also a fluid.)",
"       </li>",
"       <li>",
"        Chew gum or suck on hard candy.",
"       </li>",
"       <li>",
"        Eat low potassium fruit that is very cold, such as frozen grapes.",
"       </li>",
"       <li>",
"        Rinse your mouth out with water or mouthwash, but don&rsquo;t swallow.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20737134\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/1/25619?source=see_link\">",
"       Patient information: Hemodialysis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?15/43/16051?source=see_link\">",
"       Patient information: Peritoneal dialysis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/22/11619?source=see_link\">",
"       Patient information: Preparing for hemodialysis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/19/41266?source=see_link\">",
"       Patient information: Low-sodium diet (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/42/19107?source=see_link\">",
"       Patient information: Choosing between dialysis and kidney transplant (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/46/25315?source=see_link\">",
"       Patient information: Kidney transplant (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?12/15/12531?source=see_link\">",
"       Patient information: Planning for a kidney transplant (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/33/8722?source=see_link\">",
"       Patient information: Low-potassium diet (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/10/14501?source=see_link\">",
"       Patient information: Peritoneal dialysis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/57/40852?source=see_link\">",
"       Patient information: Hemodialysis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?9/26/9635?source=see_link\">",
"       Patient information: Dialysis or kidney transplantation &mdash; which is right for me? (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/61/39890?source=see_link\">",
"       Patient information: Low sodium diet (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?41/41/42640?source=see_link\">",
"       Patient information: Low potassium diet (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?18/2/18467?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16439 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-CCD5015BA2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18467=[""].join("\n");
var outline_f18_2_18467=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20736855\">",
"      Do people on dialysis need to watch their diet?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20736870\">",
"      Why do people on dialysis need to watch their diet?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20736885\">",
"      What do I need to watch in my diet?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20736899\">",
"      What if I get thirsty?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20737134\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16439\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/49/28439\">",
"      Food labels can be tricky",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_table\" href=\"UTD.htm?1/41/1691\">",
"       What do labels about sodium mean?",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_table\" href=\"UTD.htm?25/30/26092\">",
"        Some foods that are low in potassium",
"       </a>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"UTD.htm?28/3/28732\">",
"         Some foods that are high in potassium",
"        </a>",
"       </li>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/42/19107?source=related_link\">",
"      Patient information: Choosing between dialysis and kidney transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/26/9635?source=related_link\">",
"      Patient information: Dialysis or kidney transplantation &mdash; which is right for me? (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/57/40852?source=related_link\">",
"      Patient information: Hemodialysis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/1/25619?source=related_link\">",
"      Patient information: Hemodialysis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/46/25315?source=related_link\">",
"      Patient information: Kidney transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/41/42640?source=related_link\">",
"      Patient information: Low potassium diet (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/61/39890?source=related_link\">",
"      Patient information: Low sodium diet (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/33/8722?source=related_link\">",
"      Patient information: Low-potassium diet (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/19/41266?source=related_link\">",
"      Patient information: Low-sodium diet (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/10/14501?source=related_link\">",
"      Patient information: Peritoneal dialysis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/43/16051?source=related_link\">",
"      Patient information: Peritoneal dialysis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/15/12531?source=related_link\">",
"      Patient information: Planning for a kidney transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/22/11619?source=related_link\">",
"      Patient information: Preparing for hemodialysis (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_2_18468="Acute osteomyelitis light microscopy";
var content_f18_2_18468=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F72714&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F72714&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute osteomyelitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 306px; height: 214px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADWATIDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDa1fxhN4f0C1j01lF1MTv387Me3WuNufGmu6lOJJtQkAj+YIrbQcMMY9ecVGIZ/GGvShWS1t4YHl2IMnCjoBn7xPeuf1fTm0+7kktXu3gUrG2YwSjZ+YgD6H8q9OMZc10v8z9dp0aFC/NC8lq3p+vlpodtZeK7+XS7q3vpkeMlZFhlRz5jlwA3y4O0HHTuea67wv4lvnMDanLZ2NraxSLNEzMrSKqgxuikn5dp5zzxXm97E76lJZxTK68FJEiVcHIbZuU4xkDj16VqabdPdXDRXVncPfwxC1jZl/ctkbcvng5UAZ7EZrolSi4nHicHGo27JJ/1+R1V896zjxENTzZwxzbFngyQGbG3AGePlIz1wDWHeeJ9S00LdXDRt9ujIV4oyj7BlkYH7ucEcHB+X1remZh4S1GOe0kUPbPdFfOV0jO0AKvfnGeMjr7Vw8tw32O2utQi+0QrbhUtpTgR9kIxjqMc9eTniimlLdGeGj7VuLitPQ6+Kzi0yeK9udTuJY9SMSC4hVHLErwWOMYxwGrE1PTdTlu742puLqG2mMsW1laQs6Eo4bA4BUZUcdsVQg1iC60O0gluZrRrSAgwACYqy5KFcnGQCV/L0rr/AA9qdtLp+nJFKVmliZh5o2PMyk8ttzx268ChuUNSpxqQV5Lddui/4BHFqUt1cK+oXMxMIS2a3h3hFG0uXUqM7spyuQB681OmivJcm+W8hntLhg7wTQ4J28R4DHJZc4J6nv1rG8ZXaWf9nXVm0ULki5k+z/NDKWGMBxww4I6d/c1gaj4rupIVaGWWE7g+Ff5EIGMAY6EjPNZydo8ydkXQwc6qUqWifex3V5/Z0dteXF0l6Z5UVboW7EMTkAyoAcqfpnjiqLalYXGoX1lmYxTmNIsK5fJUgnkFRg4xjrXmV54i1OWV3F1LkjB+bAI/Ck0rxJeWDB/LSaRTuV3bcysOhyQcj2rzo5phrtSkdbyuUNndnbatcR6T4omhQSwae9uGt3hXcVbbjcQeDgk5/CuJg1JbTRDBOA0zzBlugFDkdNoODWs3i1tSbffQWyOqOo/dqevHc8D6HrXNSWkMqrFmRI15QB92D69674YiE4pxkvvLhhqijdxu9t3+P+ZqrrLfbHaVFvARsRC5idcMCDkEdCDjI9q2tBvoY/E13dvJJdXFtb7oLd3ZppXIwFVhweucEemOa5BoIUuTLHLkOQDubay9fw/WruiySWeoR38ytHexuHTaN8cwA+6T29OPT8acKnO2rp+gVqF4tW1b/r7/AF9D0i/murfwxqLwrKpaMef9oLb4J1A3H5uGTOBleOvWszWLTV7nwnbmG/8Atu2XfFLan5VIJBDMOhzjHOOue1aWh+I21doEthp2ovq1uM2c64COMmTcAOhwOvXbTLvV00/TtU8NpaWti0SK0UkLSf65vmC4Yk9BnqRn8qpN7JHlQlO6hyp31+/S+v8ATMzXNWvm0Ka3v7COLUhd+cxT76BvveYBk5wgypwMEfh2Hh59V1DxaZGia00SGDnzI1C3XXcm3PA+bqPQfhgjdq+obo4rSaC5sIjcXskgEjlzzLsBHKhSoHB5BFb+l6xJq3h+6TRdtntk8q0luXI8zIBfceuPm6ryMClJ+7ZIwrwUqbUY279te3qUtL1a4u/EunX2tXsOn6RBdfY4tNhk2rHMhCqpOMyDlSSODu68V1fi3xzYaFrd7Yz6T5yW4g825VRiMyZwW4JGByCM5PHFcB/aFpHqTougvfT6WfMitJpdvmSgDc5IBDuNoILHJB74rE07VT4gfxK+t3cCtcQwNI91JtVNrBUO9FOSCRxj+I+mamVOLd5LQ5Z4BOSlOOiWvzelrdbfezuJddj0zWhayaS81jfGJre5lALDILFmC/dIz0OPxqnqnjPwvd6r9p1GC9ubmVAynyXh+7naqRjHGQSTz0/Crms6xZReING0jT47eW6LxM8jRfak2bfnRSTnPy4BPQZ71yPi3V9Kl8S2t1Z2Fs4SExZS3VViY9GEY6kAk4P3vaqhFNp2ZvDCqrJNw0S1e35fl6aHSa5rcWo+LIbTSPtdpcuiTvL5YYWikLkbOgO0n7w4OOlS+LL/AEq68K2V3p8Nxf2glmiM5LwyRSbDgvjA2cgcgjv1ri7fR76SeLU4tc8ie+E7mfY3MKfxEDJC4zgYzworq/EMlh4e8N3Gl211Hr1w8qyy20CBAEA3MAqYIJUdjk8dqHGMWl2FKjRi4Rttvp+vl6l3Qtd0vwjeRafdW15qlvJZR3huHi8yWJnAym3aMjJX3BJzit3xnqemTXX2BbWVbjTpElkQhYkeN1OXkA5MSg8k9DivP9O1K4vfG0KTaQ9st1mFopg8jxQIqmNACCAxABz0BB9asXtxqk/iW9uNQ0ya6m1a2Glosb+XgEEszHOBgY6Yzn2pOknJS6nO8FCUlVau0tb9/wArfgej+ENSj1lJb23tLY6a/IvHUFXYYBWIEZKg5BJxyOlS3c+karqHkpdWG2zcH7PGwV2nyQqyY/h4PydyPauJtb6+0jTYrG3azs9D0iJftMsDEq7nOEQcnDuRljnkMM5FVNLk0O0urnX9evJ4Zn2zxWtsHhFw4Jffg4L8tgE8HJ96ylTUbyehl9Qcm5pa9EtX/Vt+x6npFoFge61O3t1nb7w2LsRR6Z6A9aZe6xoNmoM0tgARndhccdecYrw/xV8TdW1lJLa0ZrGzY4CQsQ5HoX69u2K4+41W+uIwk11M6AYwZCRXlVMfQi3d39D1sPwtOs+fENRv0XQ+hbPx74PureKUSRQl1z5c1thk9jxTbrx/4Ntyf3tvNyeI7XP9K+cQ75++TTWZu5rmeZwtflPQ/wBU8Gtby/D/ACPoq2+JPgqYsNwiIx96yIz9OOa2LPxT4YuSBFc2DA4OfLACg9N2QMV8thiO9TQ3dxASYZnXIwwBOCPxq6eZ0H8aaMpcJ4e2jf4f5H19Dd2P7vyHtnVx8vlspGOxGO30qayu7TU7RZrSZJYGIKyxNjI4PX6EfnXydb+LNWtYhFHfXaMRtVkmO5ec8ZyBXq/ww+IdifsmiXEH2RVRI43f+I4C8n14HNd0Z0qivTldnhYzh2pQi5U/esevs17uO17Tbnjduzj3oqUOuBkKT/n2oo5vI8C/kfLui2AsWg1S+LRw7TjyZCS5K4xjjAzkdR9acmnJ4gvkg0ySTfJJLPcySdI9pwmATzwcHr37V6J4YstM/wCEQltpo/7Q+yoUfZFtcvtL4AHUkMOhIrlfCdtHp2u3up7f7MsN8kKW0x2yMd2RuB5Gc5H/AOqvXVS97dD7iOL9o5ct+Zd+vyF1PTdOtrayszO0Fy0P2q7MCsA4QkfQ5IH5VUW/v7/wxcwSxj+xba63eYr4uJVQ/KoPOOCOo6Dg5q9qMkreKGuoIra5tZLSTZNcJvgDdo2LNnJwBwcZPpmo7u4g1KHS7WFLePUbdpGZLWXy4omOcBRypyccHPX1prW1x3lU9xpvq/Lr8u1zQ1SZobWwuNwYSwBUdWZZAHY4VuxADf8AfQzWfrjj+ybC2sJJJBcSMkpc4AkUb+uMnO7HTtTrnTPM0+1tGUwtK3loisWjjZeTk9hn9CDWHquqG0tZtN1GM+dbfLG0TfI6juBjqQTzTil0OihTjpyy21Zu+HND1OTTrXVrZrO5IilLWsibfNYKcHdj1Hf2/CfVNavLe1s4ru2hsZJ7edJSoDGGTouxhkgYUE/Xpmqp1K4m2Npuo/Y7JbZDCChMbhVzIMhTjjHU9apaxcXqwadFqGpRzW920s+5kAWOHYATyORnvnPJFS03L3jmS5qnNVd1fbsc/rl8twdNkS4klMNskYOwKDjrxjHpzgViTyF5Gck8nLZrpjocc1l58TQ28CRM6ouZCxUcquOSepx1xVXStFF7JAm75p/M8vKsoyp/i/u5GeD7etceKw1Su3FP3T2qNalRioXs0cyMZHOfrQe+fStrVNDubJssBt37VZVJRvbJ4B9s1jSo0WPOUof9oV8tisurYd3auu6O2FeE1oyNx9OvWmsqYzj9Kf0prDPUdO1cKHJDdo+tSWt5NYsyRM3kyqVkj3cMuen50zjOf1pWI/iFaUqs6UlOD1M5QTXY9BNxo8uhaHqtijWr6c/kzRRIQ7Enhw+R/EMkd619R1BdQ1JLDVJJLm9sn3mdI1QurISVkXJByoIBByMj0rhPDs5gsbwrDdNOqb4mhIAG053MeoAzXb6Np9xp+oNa3NjELG8iG+Ub5PMwT8sjH5sZGeBxgV9vh6ntKUaj3aPCr0o0pW6/j8inrkiaKkdvcwQwzzSJcXZiUsrKpO1Bz1GF7Y6msc+KhK4zZQrY52eSy7ztOA4B7E54PrWreWjPFPbXWoxXemWFuw3tHlIJd4Hlls5PAU/gT7VyE7RwzbI4ZNyjcq4zn3zXRurmuGSnF8z/AOHO58SSaes9nbhri7F5b/u3vPupKI22sAm07920kngjHvVH4WadpdjrtppD2EV8mqp5im66YV3DblGQeF4B785FZ1nPDa2kTSW6XRktAImmJSSCQfxIcEsu7C98hiOKXUfDl7YW6STQx3V7EBIEs7wAwxIS7Er94k4I44wc9arlSTXU8qrSgr3euqV99fyOx1/SprK2u9T8OiKHSLBmESyEnysMc+WuMgNufdnriqekQC4u4WeC1S2eYXAliQ5DqAsbspI4Vx0Gc963/B8f9j+GLFtK0u9u5L6cPPAzea0KbGlBIwACd2ACO/NZWtaD4juG1DxLpWYcxxItnPFl1VHy21c49W/H1rFS3izOGJjZ05WstOl/631NFdTXT/EWqfY9PtEm0S3AWQKSzxsu4rknu27B9OK4rX71LsN4m0O2XSZIYwiWiBSdxfYW3DjkH1/hFL4h1mGX+0NX1B5rgTX/APo0tvK1vLaiNdg3RfMSDuxgDHc9a0ZrD7fqDyRSm5ljtJMW8koNx5i/OMD5QwwRxjHOferiktWb0VFXnJWaW/8AwL+trnN+HriG01G61K8u5yYX/wBJSMsPtCk4ZTz3XH5V1XiaOfw3ffvNWvRCIylsVO4sMbiCBgK24nDAHjrWTLoyWuuXf2O5toPssK3zx3TBlWJuQhbH31B5Ujj1NZ9xeStNPcao17dNdFI3ZHx5QXBDYJ4PbPpmqtdp9Dr5FXtOi9OqPSdJ8b2Y8LtrE1pHPJb5hnj8hEkkkUlkHHy7QrEjvwehNeTeIdcvfEF8bzUGDM2QiqAAi5JwMfX/AOvXUW1pp2p+FtYTTTPAbxYz9iKAyxuGOGVwfu4JGOoB7jpw1xDNbTG2nQrLHlWHoRwQfyrxM2U4wvTTt1OjJsNTpSlKUbPz37/qRrkDk578UEgEA8Z4owc9KXaRx3r5jVu8kfSbKyELDP1pM+gz60oUg9h+FGMDA6/ShRbQX7iBTzkH8D0oA5GKeAcd6ME8dqtU07JIBNpUEngCum+GOiQeJPFsdjcXHlLCfPZADmRQeQD2Nc7tIVSRlWB2k9wDg/rVjSdUk0LX9O1qDzA1q/7xY+rIRgg/nXqYSnGlJSkrNW/Hr+p52YOpKjL2MrP+vyPsSOQRxqiqAqgAD2oqnZ3QurSC4ijfy5kWRc46EZHeivUsflDp2ep4p431ie3uNMt9MvGhRVaKTymAikYAZ6d84A545rn3s55nivPKERd1SSRw0hLsceYMkAeuecVJE0seqTf2fa27WhfzYYRyjzHPznuF6HPT5ewrUlkfUoJG1xo9LvbaB4vMRXdJomYZXaoxsyyYOSepr1orkVkj7xfuYKCWv4/d1KSaDJe3dlayXHkWYgKpC6BxcHK/M4IGRnHQnpTZ3g0nWLaw1G3s5NjBIo9Otlh2r2eQ5yW4HtVzTls9IkEkU0100JMVyYHeQQRuowY1OPlGFB7j61ZdLS0vLa+sIf3s75aW6QxeYr56M3oRz+A71V3fyME1OfPJa62/r06Gh4mhuLjQr2xj8qxtHYK8sh2l0bcHIGAN3A5zzntXDTNZxRR6fFJHLHBAIUlaQbmb1OPp09/xrutVtrPVdOkV3DQibyVkjO7a+MdR7Hp71g6hoMdto7Ri187YwaOeOMuxbpkgcjHFTSaSNsGoUpcz+L7il4Taea9ltLaYWtxEhMLSH5DkbfmXuOR+Q9K3tShWbVok1W1mvrmxtVkaWBcQsSAMdORxnHH44rmvLghhX7QFUrG0TJMrEOc525HTrW5oniH/AFEW6GMRskQRsxiKMDBw3O7oMDiqmnfmRriaEuf2kNv66/5HEXdzJPPZW1tbSW8Iw0SNktLI33mLYGTwBxW3aXWrC3DRzhAnmRKrR4WJkwSW7nK7uv1xWxZTeRMsiSLeebcGUuYQ8yM7gH5Cd4+XbzjriptQvZfO3X9pB9nErPZqUaN2kHy5bPC5Hc9x0ptp6WIVVpclv6/r/gk2g3DvLq2n6vOiM0QO0Hyw+Q27B4OMAHPvWQI9F8W2aC1glsZo2KIzMNrZ6Bxk9STj6VDe6Jq1tF9ontri4aZYo47iQCSaIE5x5YPOASDnrntV+7S40O/nC6fNAz4SJokUhg6kbnIyGCnt2OD3rFxT1TI5ouXNTer6X/r8TzfVNPnsb65gmRVMJwMZ+b3wRVBXBOM5PXiu7162sLsRiCdjqsSqki3QCmUqMbkIOBnB49/z4rUYGtpsKvB6bvl7V85muAULVqasuvqezh6s3C8r/wBf15kLYBp0MKyOrycAcCoXViyuCQO4q5Bbm7jJRkV1xt3DgkHjP4152CoqtWjBm027OyvY7XwlBPe6dqQiLWlrYkSNMqckYGQScqwIGQCBiuz1a4/tHS5r60u9QW5l8qNXtZMGMLJztUZB+8SQeMVyVpcarqHh2G0Eylbe5xFPEpBkiI2sMgYGOgB/pWt4e1QadY/2TqcLtKwcvEp6IVJwSCeTz3719k46XtseFWpzq3clrr939f5D/EMb6bY6rYRafaCKT/TnuV3MLkdBlsAB846cdfpXH+HraTVLuNb25EBLAeZsBXJOAMMe/wDSt3Tbm+8RGys4ormO2aVmuwbhY4yX3EEAg9ANpGSDgcCuz8LWulXtk1jpGnL/AGeJGGorcAPlNm5QOectjp0welW5ciuzGOIlhKUk07/1q/0+48z0vXobDWNBGogwSxOoeS4j8sW+yQsEyDnONpO7HbOetek694ggs9Btta0XQ4I5DeCO3CQhvMyoy4249xwTkD8KzPi/pv8AwkXgyzeG0ube+ilkmgtFgJZl/iL4A2sQAea8P8K63ren31vbaLqElu0sq7VLgRhzxuIPA69a5qld8/vLQ+dr4+dLER9vC66W+63nqe56bretX+o3On3tosV5CUuld98SSqXI2PjkkjOFxg/rVHVRq2iw2tvp8N5pumXDLGlnIWlVWLNvCMyhgWHPfr9KPG3iO38QaDHpy3lyNWheN96w7leVGweeu043cdOK3dW15tVg1AXt5FL/AGS0NxGLP5ZGkbdhtx6DoMe2e9bJWs3HQ9iMakakZyhZP167W/D9OplX/h200k2s19dNPfXM7S6akbbWt3kZVYsDnfjAY8chTngmqkIhh1S8muftTxCBoJVeFYfPLrgksOQArKOD/Dn2qDxJNaTNptvfXOonU5BBbw3LMjcBs7yAcg87CR0PFXtW0d9VtreYXCxaxcRTRw3EMjbJigBVNp5B+ZsEDqBnOa0i9PeZUVGN5Vb67/n07WI9StRcXyaTc+VBcS2drLaTRsxE0sQIMZcnLZ6DAzWdb6ZPq+m6hLe20en6pt8xII42A2rjJIbnkEDpxwfatzS9Cg1TRFmju132sgljkuG82SHKjzEI4KNvU9eh6Cq17p+p6Vo+nW15e6i98Wll+1W8+DG25RGmDjepyxIJHQ0J9EwpVXTXLB6/09zibJHsr1ZopI3IfbsRie2cH368V3Fhpml+J7kJPbInnQeezidv3jNnK8555JwMVl3moaR9qtXhs5pb66vYZJAP3eyQADGFO3cMZOTgZPPFc3rMyw6mbfSBM9vEzTLLJIBuION2QBjAwefWrkubRaHp+0WIi9OVrrr19Buv6Dc6BdyWd6YSkeNkyE7Zc9ACQM8ED65rI9SA3HbpmuzvXM0En2yUiK7uIRGhRxJFknLjevCsQuQOOMU3XPCF7HqbxWNq0kfzFXQgjGTjPPU15WMwCnZ09+x24HGJQUa0te/f+tDjiABxg47Cg4BySPxrZ/4RzURO8c0SwMsRmPmMF+UHB56ZzgYr0n4K/D9rvxI2oarHC9jbxMfKzks7jaAR6YLH6ivKeBrpc1rHRjMzoYSjKtJ3S/Pojxwt93aR7+1OB+o5xz3rZ8U+GrrQNfvtOkjdlt5Sivjhh2P4jmslbebJCxuSBk4UnFQ6OJUtY6HXTq05wVSL0eoz+dIyh1KnOGGCBWjaaLfXDyKIXQRY3mQYC54APuSRx1rqvDvgK7ur63OpBba0Mi7/ADW8tnQ90B69h+NdtLB1XrJWXn/Vzlr42hTi3KS0M228b+K7e3ihg1WZYY0CINqnCgYHOPSivoOLSdNjiRI9LgCKAF/cZ47UV2Xj5nyjzfC3/gL7keFW9ixkgvY71vIt0eC1mj+Yuzbgm4A+rMM4HvWtf6jqdjpVvZiSyuyLdlltbohWdpGLBgxcds8DOMVl2EVvcXdvfWN/c2qQKyLYhzbrPJGPMGzIxt+b5mOenvWj4UWW41K+k1W2g+xi787zLxwfsxkUgssh+VwSAMD1BxXpO276G1WSab6L+tDYstGtNNu7XT7S+NvPNexyvLbKWdMjcIHIJO3GOpGa2fEN55F7Hp+qNHLAzoI/Nh3GQAZIwOvQnNUL26truQHQWS3vpZo3uFnjCGYpkqGJPI4xkdDx7VAuiXQ1S11zWYHguI52YzpdJJHCiYIRVOOZcbQAcj3rLd80n/mcbtFqc92vnfv5GaviUxiDTNF02JI7wSvcKreUUQnhgCByw59vSkeX+y7HNqLlrVJ1luw8pJUuQDtYAdGOTjOfaniaXVPE10be3guYZphPNdTp5Utsh27IwRy2MMM981p+IdO1I/Pp17a29nDbiNEjIaeRiwZ0DEZXdwcnuOlae6ml3Om6h7vLZv8A4H9eXc5fUJ7G+adYL8xtdB2tVaDAkAfPAIGSQCN2f8KW58ORQ2lmN77r1EQblzhznOAc7eV4z2PFQaTpl/eavLFLAtpIkqyo5IkS3I57klQQMkDjPWrev6mNP1pDbzSrqiW/lrfwSbo3wPmG3kLtwTg960V78sWdsak4yUYPXt+Wplw3ggvfI1K3xMsDIJyTFLtwV5Pb60uiXEJN3cyuXubeQLZ28srPkk4SUnPbBHOB9K259UScDUIp11aVwBLBcRpG0cBbBdQRk9DnBxjngVjahb21xfSXMVhstI1UuFk2RujqMlWzgOCxGOQSDVJ3D2saz5WrP+tDbklVbIySXAmumnETMFxHAzAHd8vDAHkZOOcdq6ZBMbmS1huJZYPIb/TpQGKuTwCpHIGSfwx3rNtPAKXukxXPh3U3ggZRtRSDjaDwQeQe5BPOOa0NR0nUbC2We+DkRgmTaAEdT2ZRxjFc03GTsmcjq06j5FPXt5/1/wAMcv8AEHwz5c66rbiSXEQbfFGCAyry2B1J9un41yfjKxaMwyurpLIu5lkHzLyR/ICuu17UpD4ajgERgsXuo7dVCYeIbsqVA42nHWk8THTLtfsd9PPBfIoNuGjO2XeQPvH/AGhzzx1rOtS9rSdOXXQ9HB13RtGo/wDPyv8A10PJiMqQRjParOlHy7wIGAWTueQDj0oubWS3nZGO4jqRjk1XyeMHBHIr4+PPg665lsz27J2l1PStMuriHwlZ2c0ax3bTv5EagRpdIhBYsvTjJ7jp3qLxGNZ1Dw7LqU1pDIY8OLu3KqFwSNu7JzyB+JrnPD2pCfUkk1O8l2pbPCsBwRISuABngc962rFNlhBo9mmow2Lybry0kAO0MyhWTI65we/OenNfYUKka0eemeFUpzou0fvfby/rfoZdvbu1j59sjOpRVulBJ2HqWb/dwefxrq/h7rVtbXLRBYra4lDN5SuWMpXGNx7jnpx0rP1uQ2+v3oS2Fv5Ex8qIIP8AVqApLHkHgsQPU81S8M2V1odxbXUcsSRsWmURqsTOq/fHIO04UjPGVJrqa5ojqt1YarRrv5Hps1imqX4ni1OYzOXUqJgwCuOgBPyhSMgdc98cVxfirwDomiadqaRwtLdzKJYVkBGw5IwrjA6kcE9uldBbaVZw69LeW+nXdlNdWLSwS/aCYGZdrbpDglScnqegHHNWDLZSa9aG5vpJbG1iaQSJcJtlcnoyAAEKAOfUj1Arm5dVfY8W1OcldXUejSf4677WPOtOurvw06Xt7bQ3TWjx4uo3+SYyIpRH29GADEkg59e53JZrjxDb38V9Yxw3mpzosDL8u/yo8ne+cYA6Ake2a3NJ1RrG2t49R0eGPQZ5I5bdjErwwq7lo93PU8NgA8/pDbeELj/hJtNV9QWSF598qO24ykJgAIc54yM4xx71omo6M3otRhLnle2z3du3y0/4JkeLI7Dw5FpP9lwKZoZI2uGnBkMTn5m4wMq3y57fKMEda3rvxTNregWLTW+mvrRkJSPaC0Lbwp78Zjwc8dvaucu9Jvbnxnf6JoiGwvmBWJLhmeHKNv5X/nmVGMDPJH0r0ddUvYNLvLjVdPhmu7PYJ47WPeAGOcoxxnC7SV5PT2FKTWnVmVeUITh1e+/fbv8A8Mcl4c8PfY/FBtl1W4g1OLFxNNt3m4ymE8znHdwMnnOfQ1R1C1tdXg+13VxMLwXCW88b7lVGC71kAOCGCHAOSOT3q3qUV1YyQIs4mW1Uy2VxLM32pPMjaSNNpCqwGG+U5+ori9Dkj1qRhqMzPIXDrPdbiqhBlwxU8MEORyQc1aTb5jak4SfO3ZeS3fy79tbss+J7gRx6jDZWweG3uFitbgtkupi2iMA9l9e5Y+tZ0Ef9i6jYlLmVFuWQzNgOuCRkYIODxx6YrrI4o/FF3p9ttv1aCNAyK+5UhVt2/I4yQwHHXI7Vp2FgdRtjqVxbwCxDupgFoMGHYWBYs3yNgkZyOcelaXUVr/X/AA51OrCnD2bev/D9u6Mvw7bWGl63baVqhWaQ285uLxGKrGzMGRZANw54Iywxu461V1jS/wCzLrThYSHVNav0mcyWxJNo3l5KKgLDOSeT6cDPNWZIvNuLPUjDbHT7u5WFWs5/MEbnCFZGI5BTYw9CNvHe14i0ebR9Uit9DksxbT2zrJOk4EhcBslye5GMEdDnpWW733MKSvKNpvXutNO/X+rlnwjpegvotpPq0lwHsw/2tZHYb2VQSrDGcAAHA969H+GvjnR5jLZ20SQyzvLKi7mzIETfxlemAeK8q029Q+D7S21Ezwn7YYVu7KRsx5UgyyN3A6EdK6Xw9p13a+NryWO0UMLC6Amt4GIlfY+GyTtyf9nru9OmNWHMnzM58wpU60KkKzfVrXt/SL3j6/gh8XWesnS45rSZyLj920jeaiARHGCe7D7vYVT0Wa/1rTtRv7jRINLbc0MELw4a5QqSCx+UgHIBBA69RWHpzaw13a6FO8lvNDaRTeZEWZkmHzDze5GWGVyen4VRsdR1e6K3ieJkLWcjtewud8u0AZ2x9DzkYHfH1qvZtK36ijhpRikp6JK2706f12Ogs9IhS5ZP7cWe5iZPMRnVY4HcbDlAwz93KqTxwPr0YsNNg1iytItMuLiK32+XLNvEEMit8pxtClhjg5rloJdBc6MY9HNyNSvBd3AlOHgZSQGY8bju5A7AfjSw6jNB4tGl70vIbuX7TNBcKXZpVYncgOdrDaTxwKHGUuv6GdSE22unnp5Pb/hvzPZDMAeZFH/ADRXDP4bNy7Tm+1yPzTv2LfbQuecAdh7UVy+zX8x5f1Wn/P8Agv8AM5Dw54fsNRs9Pg1F5lu/KR0gDFHQpvDHP91sgFeBx+NQ+ILKeVU0++vktY7J3nt7SCDe7Rq5VZAQSSxAJOBkdwKtalHO13pWo6s96jPdmCOKzXjaSvlrIMZZflJyOxPsKzvGbXtnrun3OnwGXUIldoo0ZmZVPdl7Ajdxx07mu6PM5bnuRTnU0lb8uu35bXOt1PRtK8QXksclxLYXNpAsccygAurDP8Q5IK8kHPzdqztQvI00mDS7J5NYGmzRq4U4YsHAG7gg89uen41qLommTWrXQaG5Nw/2kzPJ8okAwNpzgfh/hWVLo0jsgb7GmyZmaHBMU0RwQzAHlwQMMT+FZRa2b2M6ahbdu2yf59zL1jS7fVtZh0zQPMhhjiZYzan5TD2k6dN4ZOvUdqoal4Xm0qCa1kndJPIM4eOT95IRgFmAY5wTt6cH61Uj1q/tNYvLtb3T5bmEbH2b9oyRnBbGBjOR0z610827UfDEl7BDpi6vPGczRSZZFPdcZ+YkA4Hfk10c0oW7HdB1aXKrprbz9df6ucvY+GY4dPuX1K5eC/WFnESj960YI3EoCSRjsQelUry4uLm2t7HTbNUsYMMbkw7GlHIb5cLzuwOmeK1dKtNb1Dwq93LaAwNG6GVsxzKEwRECeodh15GAQajsbi+n+xWdm0lleTlUBumV408v5cLztJH3jgZOfwrS769ClVUqjnfbt/X/AATR0XWdCtrLT1QGOYx7Zd2+QOd21lVcfJuJwcew7VqeJH0y005Lezs7Nf7QX7U8M6FlYDHOCRzyMfoKwdY060sdUs7ISLfa+Lkfa5Y1kVd+FIIHQIAckd8fWs7xdrhGqxLbsPOtEWFmwD864LEA+jDA9hWFScYJVJPQnD4f61NOndLfW/y3Oq0i6Xwz4lsbvTp2XT7qBWurZ92DGf8Altg8hkJx0yRwa9fgktry2ElrLFPbyAgMhDK3JB6cH6d8V59p/hrQvE1lDd2Fx5TtGPPEDZZGZQdoOflw2SRzmoPCWqxeHdXl0+S9gfSJGCo6gqsM5AOMnjDA/n9awrKNTWO6PHxdCGIvKnf2i3TW/wDX4ifEDwgtlaQ6r4ehlSa3YZtkbKFSScgE9ie2enpWRYS6Tr9zAmoRQtqQRvlYnhc/l/Epx3r2EtGcAsuSMrk9f84//VXn/wARPC141k154Vjjiu85liX5S2AACPU8AYPY+1KlW5lyy37mmCzC8VRrNp9JfozzS38NRJdX0F5IzwwkqmosNpfCE7cZwwyMAL79a5q80mdkZlt5gVbYQUKndjIAz7V6NI1tf+ENLjNnLPHDeIHSzXBt2wzGQAA8LjOD1zyaz7COwhuDdapqbX7anaOLW7nt3H75GIwByVI2qcY5GOe1XXw9OvFqoj2qGOnQbpNXt06/8Oebx2jKTlDuUg/dweO9dx4Smk1G9iiub97e6gcyWzHDBnxwDngjrx3qmt5cyRwxRSObdFW4kmbbE87lipdWwTtG7ccjHy9K2rWbwzrmmW9teRXtncvMVF1crgMy/MAzx8Dg4xgdKyw+CWFfut6nXicVFwcHF2fUXWm1u3tDPDYolgxF3eTxMFFyzr8zYYnoRjAzg88VY8MwjUZG1a3ukOnm2ZbpLqdZhbgb1XdkjIYk9R3rT0OaDw9rn2Y2TS6bLILT7TI7SCAkAJgE/wCqJKgNwc5zWpPcaRqcGpaVZ/atEv1jV7qC3thHPNEATt8sYyCrMMjnn8K6W7aWPCrV3Beyiv8AhvTr/WyGy2yx6euknXcWVmR5riMgxwRonyE5+blhlu+cAVzXjiPTdK1FbbTrlbW3BEt0NmBgrhUUcBQcEnGc557VqtHcWF7b39ja31pHJEllHbCNXjihRwwy7NwCMnOM81geNPCsEEUd1pjRyaQ33p0fzUtHB4Y8nryDnsQacNGtf+HKw65JR5nt2tv/AF+RkaJte8e41gTvYWflTyFXkk5CEKikEgbSw6Dt2rf8G69Zan42S8vLt4ba0gygkcqc8/MDgdzjGDnFYGlafbRWayONSuGmeRHjt1aJYlVASSxOGIzkDHJU84p5eOz8PuZWt/IlYeQ1zCsTyR5beduCwYMCAScenJq5xUmdjcXKUE97r/hv+GNweM9dfVZbgm1bSA7xPeOwDSBQVLL8wYcc4Xr05qvpHiKcJJY29tFbaTfuII0ZwUk7yO5bnPIHzEcAYqtpdvPDqMUMJFrdQzCWaS92NFbxZztG/nlfmyBnHNa/hCPRdX8Q31neQ3Fle4WWG5vnVsttC5MZO08YA6jg5wRUuMYrb+v6/wCAYVadOi+dRvbXb9F2NbU7KI+JE0vVNQuUufKWVI7mVGQmQsm1QQCoPCjaw4bFZ50pLOZ7TwjpM3lrKbeecTExwqYxIWIIxk5C8noOOuK6KCfxI+pJcX2htc29xqK28F9dohlig3DJZUAZEyGKsc4PJ7U7XdY8M6F4nv8ASbaTUWv7yBPtMtiFkaDcNqsNxPzBSDgAnGODmslOSfLv6bHlxxbUlbddtVfS/wCWxX/txItKvNOv5LuO0kVFS+adoWZj/CuANu3ap9PbFUvB2g3P2/V9S1HUru68mUxQYukkguUYtyY1yBn5Tj0PtUus6fZTTNYeINWuJbPS545/MktyvnicZWMR/dOwoNx54ZgcVlT6LeWer39j4e1aO+g8t5otPinQDady8K3DBRgY4zuHPy00lZ26/wBaGi9lUXNG6+Wn+S03L2l3Gn6297aXkpgszCstnHB+7/eAHdCAByQVLdM89OM07QPCmm22nahf3i3FsIyxjWVWJCYyMgjJJzjp2PFUbXxrbWWnE3WmXWl3qQpbm8e33Rx3Cr90R5H3gDkcda6tbu4uNRs7XU/sI0yaz867uAHhCsQchSTyTyRzng+1KTnHa50OvWp6RbUf629fvOd0W6ht9autFu3GnwLbK8F88gRjvGSB0UYB6H0/Cm+G/E15Jq95pF0JpYrW1vGhBYxGYJbyr85AGQQOvGDgii80yznvrrW9M1K5k0eBV8+JogV2oMLEqk/Nzyd3Wt/WPEGjaGVvzeWGo6pPay28YY55MUmwbFzgFyFJ64Y9hSk0+l2/zFVndS5ottrbqn92hyt9cG4vrrU9WsvOhm+zzrLbyKht/mVWiZwCSOSecE44qWeW3t9RxNHIVjtHuBerG7MwJCsAcE85U5Bz/Ota4NtqGmXM2i2KNepaRXKWkbbY5BJnAVsck7G/ICoNQ1GK/wDBjz6nY65FNDdrHJaXCsjyqoBcL/fQAscDGdvUZqubokUq9ONoR69P8tbetir4I+2T3syf2fMZrSxZ7bfv8sOHK7ST8rElQdxOf51P4PstXGt2F/e2E8dz9ubz7a4IJSORDumjdxuVQQBtU4NUvAuspomrNaGc3WkGQ2lk8zlWjKrvOc/MQVPfI6AV1kGpa62rLNb3un3tvJIrGGaAxSxxs3KjAIJVc8k8ntSqcybSW5zYpVJSlZKz6/p/XqLe+MdXivJ418J6jIqSModVkwwB6j93RXaNd24YgSYHYeWD+tFcfPH/AJ9nmJv+X8zw/wC0TvfNo2q29093FKhsBajESDKkCTBAIBCnoeOnpW+2rySAW121lBPaNHbNebNpLbifL3H0XAxjqT9aijutOj1PUL/UraS2uHlcQ/Z1KvFHtVBKpOApxliccU3VnvZNE+0W5uNS03zs29zMiXDBuCD8ozlSCuCDk16Gja0Pf92VRNxtf5a+Xl/WpljSryS5bQVvBHp1u0duckLH5zMHwmF649uMj1zSeNvEM2gyWmk2F0wFpEouHA3CUhCNpJ5IHB4Aq94x1aI6Jbi8twt2s3ms9lui2JtAJk7bycjvjpmvKNRlE9xJJDnYzEpvO48k4ye/vXFmGKeHpc9tf61PSwGF+sNTqK1unp1LEGr3lvdNcQSCKZhsZo0AJX0+lPi1eZrmea4YSPMmxmfp1BBwOh461loG8td+N+BnHTNHtXzMMxxNKpzc9/yPfVGm1dRt8jvLPxBLGIbTV7ho4lt1lR4nYRyv8wD8nlckZBGCM5BxW7f6PFJp2l6wZ7aOaAfafOXCoBu3LsAXlmG3Pqag8BaNa6l8NLq61aOIQWUr3EEkZBf5R8yuMHg4HHvSf29a3VhFYG1im06VDF9kYfvGCtkuuOQOnHbHGK+yo1faxUor1+Z8sm6smqavyuzv1M+4vba5aKbSXupNSjJW8WVi/mKwZVfknoWwenbjiuPvhIL2fzhiTzDuH412tvANTnktvJuLTzSSkUMLBC4OI1kbk5B5z0+UZ6c0PFHh3UoYY5J7ONJFjILxMCXCcbmXHAwM7sfXnrjj6Htadluj1cJXjSqOm9L7f5ehY+FviB9L1+GzlnaK0vGETAf3+in8yB9DXc+NdAVUvJ7mSeeK5VI2DOX2HoDjHCjrn1+leHB2UAqSGHfvn8PwrtLHxlqmoWLWV1cxS3Ko3lC5T5Jickh23Ljg/Q4x1xny8FjFKfs29enmRmGBn7VYmn2s0d54N8Vyx3FvZ3zlxHArRyFcnHTg55zxXdweIbGczxxybJYgGwykDB6EHoa8tuPC4tdOtWuboLdyWqlDEhRUycjaOvGQKw3j8QRxiymDSxYJeVeSUJ5wTg564PtXruhCo7o8qrl+Gxj9rB2uX/C+sNouqTWF1MscUlwYn8sExxs/Kc9ucr/nNbN5bXieJYI71lfR7ePzUV5M/wCkZwilVPQ7u4wTivPUuobW6gjgecTvLG08zIWYbWyGwD35+ma6w2Usypq0V7G94LmOKa7fCbYehyvIYDOR/tfSt5Q1ubYihZ6bWV/0+fQm1O2sWP2+4sruS+utMWOXTHiYMm2QAMqjBGCpPDdzxziuYvL2/n8O3MV2v2aOJ0BSJDETKSTlxxkFSo59BXo2uXXn6h4f1vTb/UGSWUWypIjFAjdRIg7kAgHHXFS6je6F4qt9U01bu2a2kVBbvEmHWYDcTu6dNv055rNTaW3/AADjo13BK8b9Xvp/X5HK/Du81C0mhW9gWSznilaJ2jyvmqCQNx7H+dR3E9r4jnh1bUYrXSmwLN1JeGaQbg0iAKTgGPHOR1PNLeLrNrb2ElzczabpaQvFZJcODI8uMq0gUHCkKepPQHrS6neaZbaUs8zS32s8qYInlC7SG4VGxwQDkdzz6VbWvMbTUK9TnfXTTy6/5+Y21s7u6k0+2+12dnLIrJo7XJIdcv8APGGAIx5a4B/WtX7LJ4R8Ma1Zabbw2t5cOPKWSVJDcRBFEjYLEYXeeoHToe8dtoCQw6fa6A95pdpftKHOpOQZZdoYIi5Dr/HyhBBA7VoeJfERtNHiE2iTWl3MkoEmoOkn2cqUwzAcMCrNjv8ALjHNQ5OTSWxwuXPVUErpvbT8fuMyOO/utK8jTpLYTzujS6hYSosc6pGvDsDlehUABfy5qG2ttSzejXJFNnMq2tuk8gMoyylnUN/CC+Sefu9OK6b4fQaG1vJcyX7Ra1cDNzBbzBVi3jcqqgAAICjGBkZpuneHzJqt9q8Epvry2QCKK8jEvlnCn92xIBJAYY6AmpdRJvyBV+VSW1u6/Xt5/gVNe0+9RtHtHso7tLiIRX88iBjKq4zluAARuPGO1a2seHdGCsnh2ysruO9KKI/PDAhGG/b82TgHOBnn8qnvRpejWCReIL8TaUQQsV0reWJnYsu9hkjBO3PTAFZ2kysun6TrVnp1hYjTZJoUtY8lcyYzsfk/NjGcfeyOnNZ88mrr/gEe3m1H2ejXqk+qv1vpby7mv4Sn8L6VY3V9DeyWss5MU8N3O5UPuJClGJw5AyB1waTxDY6FDp0viaweys33R77sINwCNyQNp+bAwDjPTmrgn8NT6zqOqG3jiutMMb3U88OCr7eHyB8zKGIz749KrWeh+ENRvNPntbiTfJI94qfaW2S7NqFirHDAFUHHeoUrPmba/rY89zXP7VqWr16/L7v+GMOMahJ4Kv5NL1FLq6ERuIZFO9jGRkYyuRnnIwPwrKuor6G30zxHqEti93bxPaXT2amb95sBAIQEDBMjHoOB14FddFDa6bfas+seJtMudJuoGMdlBbIpUbwrOdpJbBITFUrHUtE8t9G0+HTrvRG3fa47GNopY3G0IT0OcgZJOffitFO92kd8a9SpJyhHq+lumq23M7QNS0rVPCsFl4sdNS1ZbuZYEn5YyIOFyMZ4Kj8cZp2uWGu/bdPsIdJ36PcSxsxfLyQNkhyWLEKNmBx36VZ1LS/DejX2n6k01vb2oFw5UvvT5m3llcj7249FPWpNI0vVdW028hu9Uuby4i8xIftsPkwXEbgBVO0gsAUJ3Dn5utS5JPmW35Ec6p2qLS93rsntp/XmYvjyPRorH+xrhj9j8mS2C25d5llVlkK9/QHJGcd60ll8J6rbJd29npv2mwto3glK7TAefL34PQHPBzyKnl8N3GpXyanqus5khYxvawIxiglVNrqGPIOD16+h6Y88vNIXTYpLPUJFvzNH5xhsQbePyQRjcCBu574PHetIRUlZPU66FKniElF3l8++u/5naeEdJtfsCwXVlfC8u2FzdzTj90wWU7VQqcDB+ZRjGDmumu/DvheZdPNzYNdwIwtxiSSdVZsDnDEZ6cmvKdJuTfxRPBDcwTTSfZEsmnEaRqqhQSoHzIQTn1IxxW94M1CLRNVa312OKxjty/2EQ7YYGUjY0jlTtbgIBuywyDSnTlrJMxxWHqK81Lvpqvu/r5CanpOmee+irePa6grCciNiRK/ljaN5U4OFbABHGa3PD1zrGpNA9zALIQX42NFKdk9sqMc/KzAnO3rjqKqSWjGZ4IdIvxNcXErzGVhEbsDIAbJOY8cDaeCw471va14Yih0AwaPazWV0kIMZs7raN+OUBPsOpFE5KyjJiqzjJRjKW/o/12L4uUwPNuYlk/iG4cHvRXGweHtceGNm07RtzKCfMmVmzjuc8n3orP2cP5vy/wAzX2ND/n4jnLCwDW0dpDBHcWkECQxzuoKKC2WlYHOFJB55zmp9Z1I2GknTwYXsGwka2j7SXGC+MAYDHnr3x7C1dwW48S6ZqukxXFtaXcCm8nZPNjLM27yzzk/3SOQDiotf+2nVI9J8N3ISO4Iu/s0uzEkpYszL/cUBehIPpXWpXaudkZ3abjol91v1/ruc74v1aLUTJFZQvkBC0pbJOByp9eTnqa49+CcnGeoI617BL4Zv9AsVit/sWsLKWNunSQPIMfMQvCgKpLZFcf4ksruCe1i1PRbKO7uZPLiht5mMpxgZGOGGT35rzsbgFi9acrP8D08JmdKCUEtP67nFc5yTwRjH49aQH5sVtp4d1GW4mjisJmdDnywDwM8Z44479OKpCxngu28y3cmKTZIM8J6g8cnOa8hZFiJNczVv68j03i4LRbnQeGILm08OXU4uZYbOYlJI1UnzskfKB0zj3zivQvBml2im21qzhNwqQbBbbP3m/ABB5IBGOme9eT6/pPiDToLKUGU6a8xdVMgaMM2MgemApFTaXrSx21yj3+omQZQw2kpRA4AxuJ68DtX0kI+zgqSe2nqeLWk60ZQhpfTya+/Xz6noHhiKSLxFqtrbMsc8sq3NtaySg5VeWxgttbaV44ODWh43sLy8t9Pvby4jto7ZZku1Vvm5yU4wpIwMEd/euR0zxldavpljpxVbS9EqrPdoNheMAAAMnO4qMf4dtHUok1bVIrXS7TUpbsRiGWSOXiTCYLuWPQZ79fers3JSZyqE3NVp6Le/4b6f1uefalYm2EckbNPbsPln2bRIcc8dj7VnPkodjbWx8rDsa7rWtC1LT7D/AEy6eSBTt2KiRxoBxyB/EDnoO9cXdx+XLtWvmM3wXsZ+2p7P8z6TC1fa0tfQ7Gw1VtauUnutSSC5Gn/ZWkmPIdWXawPuAcnj8a6F4Zn0+efVtStrGGKFzbSI/m+Yw5dgAB0Bxg+n415PaXPIkhYHt7e4Ndp4Q16ytIre0vpZIbaKZpWGA+/KgYPGSOpAz3PrXpYDM41YqnUdpL8TgxOEahzYd6f1sX9IUG7a7hMcYicqJgoCzgncuM44wGH88Va8c3un31qxsIZbC+QgOgXZFL0wcggZAPTHNV5J7K/0Fb2W4tJ75ZZo4recLGZIwCduFO1M9eRk1aub3T9ds7OK/wBE8qIsZhKt15ah1OCvToVySOpxxyQa9m6k0zhdVytU5W2r7ab+u/8AT0Ohs9Rg8O+GLRbZVkhmkllG1isdsoO5y2AeMg44ySQMVqSaPp1/4hTXba8tp9PvIjEunhQouXUMDjJAzgEYx0HPFcH9pHhtkcXMN1bXa5l0wAyRxxsOdrMOhxnIxz24zW9carocmiJdaClxb31k5ls1XLmFzwTtJ5U5OR/WspRd7x3Zw1cLUfv009b/AI9+3r+pYt9EZ/GMUl5Fa2loIHSG1luhI7c7lCpyBszjGcDtXMfEifVrma2uZbaOzRYjHI9tcCV5Cx2qcqAcDkcnucd63tQvrbxDYpqml2dvNqLwi7upWfY8SrlGCtja5wrD2GM1g+JLeC1urTTrC4TS7a5WTbc3EqEuQMgEqBhQVbg/3uvo0r/F/X4jwqXNFy0t07fe+v4mhcQ6nqE+nPpmt2r3qWi+TqBA3uFZ2xGCM52KQSMdMc0ngyDT9csbqTVLqK9ayuDcy/8ALRpB5ajnB5CgZ5J4B6VsWWiyQeDPD8mn6TJNJbok0v2V081B8zMEOCSrMT8voevWq1vDrfh3w5K9jpdudQnZgLcKJXIwAWwigO2M4B6D1qb6WjuR7RSi0rJ/5X7fjptsT+Kry0lJ1XQgIZ7uURJO8ADXkTRFmkUtz8uRnv8AKB7VmeCINcudGiuNOuhqf2O7WNpnQK8in5mJ3A4Cqxxk884xV3TWt9asrm3v9eji1Ga0VJFnVF+zMMjKdg2OCBjOTnnpNpeqaX4Ps9HsrbfqH2hpoHuEuVbJkZfvR7sNngZ4wF681L0jyrVhJTp0+SMbyX3Wt52/r1sbdpr2j6nr1rcXts9lK0EyyLIo8u5t2P7sMcgZx8wBBPPrWb8QF0zUvDukWvh+50+30W4maJ5UcBLdgcrIe4w2705YetNnt9W8WWkWl6Xp7GO1WGC7vJgqQTR4Jzbg7sEABcjJyAa53xD4auI72101fDZ0/wC0XMUNq7KZ40DBizs4BBZW2kcjjrmphBNrXbocUY0uZSUrNdLp/wBeXb8DtBff2/YXe/XobHR4bRYpIpec7XAaUE4ZkP3c9yp61u+JPCf9q6TZQx3rARMVd1Ut5sZJJUHcMc/yrGS307XPFkc+uJf6XeMUsYPPO1dRiIYN8pHyFjv4ByBtPGc1JK8trd6zcavrF4GsYd9vDbKY5WgKqHDK4CsN7Agg5B4z2qXdNcunyOWNeUZR9k7W1267ad/mZd5oUfh68t5rxbeeOxtZhEsPzS3AwRsKHnB753A8das+B7zT9X1lEGhG2urWAxSXIcKAXwCmwY3fcPJH0rSmuofC76fq1xb3Mlq9lHBHvthNfGTBO1n9MZXHTOTnmmW2mxRRS6t4ZiutOcW6SsuppvWQEknyyzcNjIznHzc9acptx977+h0TxPtYP2m72fnruvn5/cV9Y0CwsbS2sNF+yG50hluBFIMKVOSVBbOCw5zz92qenXniDUvC97D/AGsbm/maO9sUEapshDKfJZgMAnIHfoa0fD2pT32o215frp+o6Ukcl1LO80ZfT8gqAqrwY9oYbvXNZ0v9kJot6PA09vd3c00cu61m8toAW+V8nqoOPl9CaW+ktWTFc37up8Sa13W+uvQ6TwZeS2HhXUb+9tL24vLi8lmuLWEido3PBVcNgqCvbA56CvINR8SaoXmhNxc79oiMk/MoUHJXJyVBOMgHtXoWkWuo6PpMI8P2mn7bORftVvYQyBWbdmdomLDfnKgKcAYJ5xisKDUY/EeswpLptzJY3k0hlmvXWZoxt3IEYBTGp549gK5a+HrT5nSlZf19xrlsoUZylOF+u+3yf4fcc9o9vYfYEu9U0yee1t13PfKJPvbgRGSAFHPOd3T8q6Qawt5oklhrVk9jqLzmSKxaB5mvIAh4yUG1c5PGfu1Lqsl1ocE1ndy6dq+ltb21pa208i7WnLL87xheONxBz0QevE/iy41G21zThHbabcStLtj+VY5IzuGNrOSCMbuMDnFdUfaO15L+vn+h0VJ/WJpyvbff/gfeZGoX11p0U41eO4voFvBcxy3UEkaW8BdCybnTdwxB6Y44PIB6DXVXxHqiWobUrO9GntJbXQjmjy+4byqHbyBj5u+7A6Vcgns/GljdO9jJb2lhIXs5WkCrNMGKsNgIBO5cDd3PFZ2tBv8AinNXlttZ0cRMlrOszYmmA2sFYDO5Sd2Rxz2pR5nJX3V+n/BZyykqslTjpLXr5X/q3Xcq3XxE8GW9zLDdaPqLXEblJC0QBLA4Ofn9aK9Ch02G4hjmns4I5ZFDumFO1iMkUVHtKS01+85XVgns/wDwJnm0cFlrmq21jGHsdMjtpEFv5W6O0kDHcWOQpYnjGT+prOv4NGt9dgjt2eaPTEeIGzgbfJM6nbwp67iTySKXw/dNa6hc6VcQtBHab7/Zcz5iLKCSXZRnbnGOD9aNC8T6nBrE8Fn9lm/ta4Ywi0UtHEwYKAGIG7IVuM5z1ru95NpHtum4Plj276a9b9zC0PwlqOk2MFxc/a1WaeKSCOzkLfaSv3kK7128BuoxXY6/pY1dLOz8l7bVZLceQLk4MK5BJJBOG4PTJ9TWb4v8TP8A8JXqFjHqm5bdWthEkh2TSAKhJ2gENxnP9724pmn/ANuyQ20k95dW0Owl5ZuBHDnChC33ixB5z0x1zSTcrS0KpUppKq2lfb1eq+7qbthYzC8VrnbHdvabJZQ+UkXIUEv/AHsDkY79TWFc6Vb2+uSt9p2QTK8OIlL/AL0qTuJz6dM+vasTUYdYjstSm0iznntnkLw3BQqnlgHadp6DBwT+dHhjRtdk003l1fLpMLF5ZZVYfMSMAgDlsAeuOaautbnRFKC+K/8AWnfXy7HRaP4esxpFloet2RlN0RPBPDOZBKSCdxCtlRjjJ4rF8YeBl0sLNZeQnDrbwM5EuQOWUEnIAHXNdzoVvp+jaTBfT6ni+uYSI55UAmVGXeIwoyFx1x3/AErlvGM0mpXNt5Ml9NPGnlx3F0AsTK5G5+ACcAEAccdjUxblPTY56FWo6t4r3eun5X/zPLzPLFkTOj3CfM20hV5OS3Ye1angrxcdA8VxXSx3VzGF2zxo4AAb6nBxx0qe9srm8Wxtra3sHlZm4DESlMDLMGPTvzg8Guc1C3k0zUbmCaUzJGuZEhIUQcZByOp59eORUVYNeh14iXMvZt6bP0/rd6+i3Xo3jvxXFr99BJpBlht4iWmEpAJIHBHXua4S7bey7jjPfrio9KulliRW3qsUYEkj85BGcjjnJpVLTRCXCHDY+Q8Y49cV5GaxcqSUNUerl0qcaKhAjx8xyeevXNIPQkE04ruRsKVA64OD7801SOWYEn2OMV85KKeu1z0E2tCSGaSGRXTawU5CuiuPxBBBr0e48cWGqaSXk09k1eFHhVkOR5L53AKABzn0/GvNGBGRjB+lVrVJrdg7Ts2ehavRwGPq0Xyz1S6a3+X/AATgxWGp1Jxk43t17Hr+nWcGpaSsV9Fi4WxS2eIIA0DGQqLljkDbwepyM+9ZN3pl34YtXsLu6jF3E6XVpLGfvAH51U++R+Iq9aazrWoaDFHLbXM0Syi0IcKVuflypbI+ZVKgcHuc9K059V0zWtDbTr61ewvwC9nLKpZJCCSQpXp7ivr7tavY8X95Rm3LWN7aPbz/AMyO1vrJL5NW0+SO3JKxzPIQqAFC0hQcjk7ScAfXk1j+J7S5n8I6kIUsbiKGeOd7xJRK6KNoxnaWHAbgkDn3qroVxDC9/bzfPDOhJ8skiRgdyqSeADk5HBwetaVr4o1TTYZdPgXTnN5I0K2cClTcb1VdyPyPlJGQeTim4tbCxVJU3tfbV9vXujsNI8ULeeG1ttAhkge0gimPlLv+0xbCNqgA8bjjNUPCWmjRtCMF1Yz22vwy+ZG0krKkxc4VFbOM/KM5Ax+tebaFrU/h/wAU28uiPJD9pQ27tIB5SsGwSQMYAbBz7Yr0+bxsH1+1XUkZ7K1YTC8gfa6S8/fUEhk2nnmsHBq6ijlqYWpByVFXW7tv/wAFP1Lfg7wSNHur+58THTJ4rt/3SNh9shYk4LAZJzjAqt8TfD8cMlutjp9vaRKhle42LGikEAKVXJJJbPAPGc9DVPxPJoxP2/xfqV9K7zzPpf8AZ6svkxHpnaMZLdC2O1dbokV1daPfafHdamm5Qbe51LbIQx3DrnDYPODjqKhynF87f+Ryxr1KNVV3LVbrp8vTroY3wo8QBtE1UG3Iv9PtliFzMQocDcUUHBO0ZznBFbjx6rY28Nxrmpyg3GoRzkpIojtoY0wwc7lGwlcnAIBIyKt2ng7TNQ067j1prW81C4jFpd3cDbW4PCDk4OCBz17+lN8TeDtOsfBM1tpVn517aQS/YmeFbibex3FVVuCSRjH5Vm503PTr5XPOxGIo1Krkt29dP17ddite6m2p3t4miyQXep6aYJo5PlAntW2tLEsrDapbA5zxjqK6a80y31SF9OvUju7O4Jaa3dtyqmANvXuee3P0zXmd9ptlZ+Ek07XWsdB0jMT3MsLsWaX5d8MsXXay88HAwPQCuq8Iabpdvp+o6Np17q8gu8hrloyrRKyYyjhdqjKtj/az+KnFRV4vYzrU4xUmtl5aevbz/wCAL4geLxDoerDTIXkvLWRUht5osSxTK2wvsOTjBPzYIIPWue8M30eoaG9tqVvLD59xIsttcB/n2xhiiqwAAUjOBgccV0Gu+EFkksZrbWFXVLaDbvuZDGbmNAo+eSMhwB1IBxuOTjNa2oy2ms3VpNEl5FObQSxalCu1GXcrfZyWBbDEAkBc4HBFCmkrLX9CoYpUkox1W/W66ad9r/8ABPJPDV94kt9Gk0ux+ypfSW89vER5WSFbcAQVz90OAD3YdOzhrUg0qeOPTptN1zUYir3EdszyIEQszMmwYB3OAR3z6Ct3xF4em095NZXTNOFwQsjm1umjLuQRIrBwMRn5sHIOccVRg0tJNGtftNpJp1zDJmHS081nuI1TkFt3zhRkgDjcoPeum8Ja2/r8T1nOlUXtILfy1v1bt/wCjdam/huXTI9PhkFvaWktpcyQy4FwyqxK7D/GruxHdhzmrdgG8U6W+rQWsN5NYLJ5hMmAszR8SHIGSDk7MHqPWt7xPBpFr4JeKQrHPahY45tod/PCgqpBBy/A4PNang+ZbKzn0zUEt703ECag9xbWKxW7K/G0jPzN8pOSBxiodRcvNFanLPESUbwWt/1u/wA/IwbnSY7+7j0ucQx6laQ288sqR/NjgHO0D/axzxngCsS3it/EGpLKUZJbFobhhdoZGntkL8xY3EsWKkdDxyRmug03X4YNS13UppJo71I1Ta7ssYVywjJVgMMcfQDvVnXra88MaZaudSe8nlkSRp12RMmCp2ALwVPzDJ67sU1KSfK9/wCrnQ6lSSVFddvXRsn1nUPDnh2ODT9SgGWiS7ig8ppFTZJkMMZ5BOc49+a4W81HUZze61qmoXFpAl7FctDcKSogBkOIj0YgyLyAOg55AqW01O61bVoLeby1zM0iywKI3iTdwhB3H5jwR+HSn6l4oXUNVht9P09NUeX5JYthGwbgyrlxt5KkEckcGrjTcd1dmqwXsZKUl72/9fqX9LvZI9MtEW6edVhQCVkmBcbR8x+Q9evU0VppqXg28RbmXWFtJJh5jW5uoP3JPJT73bOPwoqLrs/xMfbYV7xZxFnLcReJrm508xTWkhMZluCShUoSxY8Z6/d9a9f8AeHtJ8Q6JaXoIivdOvXYSWiqiGUDryCSMOO/YV8qza5cwwRtaZuY53aRl3EgnaRuA7EevtXsHwp8c3OlfDvWYLCL/idTzqlpGo37WaMlnI/2QvQ9TgetTVqKouWm/eOjNKcq1LloN86tb09dtnfsNvPB2m6P4j1KwGpRzRxIsb3MsOH3+qN03bgQR1znvnGEbjUbP7dYfanvNPMhSG5kjkxCefvAnoMdRgdKk1jWJZLf7Jfi4e1k23GFOxo26Zdc5wzZ9Mdh2rAWdwHu7LDRwRMtwgB3KjOVHB5O4FeR09R1rrir6Sdz0qVJ04L2s72+Se2v9bGpNod1L4QnltpY5HMhmlnjbAVSAduevbp2PrTLe51CDR9Jiktkni87bE6/8tWwBg89Rx9QRS2K3iaZHCqXNhOm9RGqKqy5YffJ43A5GDnrWlovii30i7uUvHvhdx2vk7vNXaDnJbGNuewx6Y5zTatqaJyUeeKu+mv9epU1FL6XUI9TSFkluhFPHFbqR5cYYYc8/wCztzxwT0rptYmnubbQ73UIL6I2qs6vEoaJjt2hpjnheM569eKwP+Elk0y3uJpRmGffsN1++81Dg4G7IB9u9Vl1q88UaeY5rdUsbMGSGXDIiYI4ZBhcDGB6UnF3WhlUpSk4qy083ex0OqaDcMI7Nby1tWmD3KeaSGxx5gjx/AAM+5J9K4LxFoV5YhbqEx31jI7wSSW6ksxAOevI/iHIOce4z6Fb6xdajoV7C00URSUsl4MFHUnJUenYYHTArldVstQZG2u1zDcKFZlOQcHgrkkj8KlJvc0oQrSTjKSWp5vAbe3tpEjWeHzNiRuR2x/FwMd6msYpNPeWCOVGVuC0h2sTtyOelSXb6jpWrm3+wliEL7WHGw4AOSMsfpU9juuDeLJFukliysDcBscZ9hkfnXA4c7UWv6/4JhQUVNKPxRdtmu9/8u5bS3MkEDyDaZTsXI+8cZOD34I5qWTR7gKSkU0mAMiMbsDJ54H15qzomtCHUY0u7FLp1tWwjHCRtjAIXpwc9PrXVadpltBZwppN8bu+lnWKdYpGG9OW2lhjAOByehHHsll+Hldpb6HpvGe7qtuv9f8ADHEHRLiCeSOWCdWUgYEZ5z0/Ous8EaBFJrEUs8RvLEwvLutwrgupwIwD3PJ+ldNd6/q2lNFqPFxHcAL9jlG9IwD1jbALnryOlUdd/tS1eK90+JXvbmQA6k0gma3QDaeTgIuM5OCefwq6OBo0HzQjZ973OWpia048qSSfmdZoCRam2nyrYTto1y9zLvnkjYKS2MFRnIYZAwOmc+lYFtpmg36W2kWF/qcZikeeC5e2YGNiozGjbRgHbntyx6540rjXb6LT4Ra2djaJNNFag2LCQ7X5DDA74JzTppv+EPiuNNW31S58+5ieNnUu9w+ASscpODgBRhsYycV0JyW3y/r5njyjOMryer2V/wAevc4a2gW8s7eK1MUaSTspi8wZkcnPmBOCF54JGTiro8P6lo1sbZJHIldpkdHJ2qiZdzjoAMe57Vq6TFH4w8WNa3Nzb2LrKI7kpKBPJMvL7OD6RjAOBkjHWup1yNdJ8T2ltNLd3iwQLaw+SyJJHLcGQM8mFG0bcYOewxzWsqlnbqbzzJ01GlG3Mrv+meJ6to0lhe5kVd8xM5WY8sJFB+UY5BGCM1Z0yZWUPNFIsb/K6NwyjPUVo+KLe5Mtpc6m9w8jOyW0shDvMsaAbmwcY6Y6ZyevWqqaJc20b313vzKDGgjw6LjH3z1XPb1xQ027ntYWpFJafE7O3f8AroewaNfxXPhsnWrqy0u9vnNrZ+bGcZHIbkjPHcED3rWj8NXfh+ykuV1lby8uLiMAzxP5XIChVUFiMnGTkivNvC6XWvQx2uoSJLb2io1tHdQtLFkHknkdAMY967PUdX16+1y2itLhf7MgiNxJeW67bdiM5Rix56dB681zTg76M+axuEqU6zippLr28ktCfVPEGn+Fri9sL3R/t9xd3328pZQqVViQybs8l/kBJx1K/WtqG/sDq2naPc3F3caletLfW/nJlrUIoj5zkrnkjpnca4KLVdOfxppep+IxrWmapcW8cyWquhjjjUn5HI5IOc/NzzXfaPe6FLKo0CX7fJIT5kwPmNEB/fY/MF4x+NZTjZLQ86thlGCtF36vp+dl38zmL/S7nQbi+1S5WXX7dpls71dT/dsVyhV4mfIdd2Me+cetdTY/EfRZ44lkju7SdpvIW1lhPm84O5VXOV+bqOnNS6/Fb674aNiNQl0+5ugssavbIZSiHcY/Kf1AI7EZBrC8JvoGt6Jp2qaVZBbDRbl2tzJiJY3b7/yKCGHzBvr05ptxqRvNPQxbVaH72N5LRO9vJabP+tzdu7JNenvLLXrfTZUgSXbJbSKxWF/uq6sCQSBn+7kcZrlrbzvEfiaSTStZu30eawe2Se3lbOnzB1cK6HBjbYNo6fxCq15qNpq3hTUp/Dl0+qQfu/NiuLR/MuUeZlCmTG5hnIGB8oA7V0mjvbajr0dtosUE+hzWjXFxfWk+/Zdbl/dk9Cdpz607OC/rT7ybqkr38ttuvX16aGf4v8MyS6ZdXSRvqU4uUuPL4LN8uxlBPUbcnHX69KxvCFjeRaVGtxYXFwum3S3kMcdxvuEkK+X5TKyABAuc4PUV2NrrOkyzXdveX19p09vefY1F1IYmlbICsg7qcgA4wciqXi0w+Fiw0ltLsdQvgxlmuk2hwoOAzZB4LE5Pqacart7N7nQq8qq9ja73X3LtvoY1rpuuW+t2N1F9ltYnuZZL63aYnzC8w52gDcdgBBPA3YOa2fE3iDUNDS3/ALP0lrm0jZBIQ+1gC20EBQfl9eO4rH0/R9StfCeq3kxaFrq1F6s0kxe8gmAUhCpBUjO/5h2wOetXoIvEOk30er3srX+k3kQT7JGvzQ+YwIJJxjAOO9OVpPWzNIRpzbkmn0Sel3vp9/U5m98S2XiDWYoLpo7W0mUi7hfeszSYwg2ldrY57n2pPF2k6Np503Rvtk7tLAjxPJtAkAYBAOuWDKPl/wBvIxjm7P4aju7621OztrK7gt5nW+jSMySj94MRxhSRuVc5yeo6CtK21WDW9TGreGEvpF0zNncW8kG3IJwNm77vrleTtAPFacyjbk2OuVeEJRjQvZbrS3kcV4btf7Hu7rVdbdIb7zEnFoAZZNhcqDgc7ckkn1qHX7lIfGf2y3nt7bZqbLIfnUONzk8Bck469vrXZxyXFrqup20UcsEirJHZXYjM7M23eypk8sPm4zj2rBSO28UtbRvbNF5IjieCR1E8oZhvZjldjAKQQCcguOwrRSu+aWx0PEPn5pbW6dn3/rdkcyzCaQDQFkG4/OsGQ3uDjmilnubCymktZfFXiCOSBjEyQwz7FKnBC4U8ccUVXNLovzF9coL+X8TxW1sxEwJkJY5JAHX6Vp214bVo3j+WdGGyQj7o7gjp6c1V3A8frmgsNu0E/jXxVPFTw0nKmz6+NCmocqR0ES2t4JwbmTdJHtGVBI5B4xwfp8vTrWtxpEVtJb3cLXUaRbS0ZAL/AHkQ8lQ2MZ5xnA4riVZgcqSO+RVm11Ga3kYqxLEAHJPI969nD59CStWjb0MamETldPy1O1vr2W30Frq5tRcvqhN68Qfy0tWVgo+YZ3bvlJ54OBxzVfSdJ07VTb3EYie8d9klv5kmFLJuABAwWyD3Ax+mB/wkF2ZYWeV9keSsahQvOM9vYcVu2njmVIUSW1MgTJHzhRnGM8D0GM13xzXC292f5/5HD9QrRjZa/d/l/kdLrNtI+l6FbTwEXjNJ/ok58t5224GCOAOT35IxWW1unhqE2+oWzw3d47SJCz/u0ByBl+p6ngcjjJqnp3iWBNWgkjjtjaoWYG4BNwMnO0PnAycHIwK1/wDhL4L/AFGKO70u1MG8p5sk6sUUkjO4njqDXTTrxn8Ek16/8E5o06tJ804u2rITaQ3l8ZUuraWyS2MUi7jszx0brywHf1xjpWz4e0e0NnewRqsqShSEjmBAKkuEBznOSTzn0rKmFhLHqMd1He2zRqIYQIN0TYOQ20HDY4AOfQ1W0eWyt3ntdMYPqjiN3ku/3aqoyfkQHG456Z6flWzu1oXNOUNPL9CXW9Eht9B+xyFUu3uENuLibDlMZIwFAGDjrnPPPSvOdUsv7JuBPEXmaJv9aSDGoYAHkAZ/xr1F2uNSt4oLqSKyZWDlrpCZAd3BB27cEegzzj3rH8UeE75rCWXSoobi3RS222T+LB7AnP8AkVlUjzKz3EuVRtPfo338v69DhrW4e2gnvJh5UsgAjDdGPsemCRXX/C5sa5dSeIoZbKK+hMO2RwioBgcnGcnPHNcDFc3c5SZTmCLC+U0Y4UDGctx1xUniS+uL5W+1xO3kxhiHl2BAW4zg9c8isVO0L2f9dTKrNTpN3dknbzfe6v8A107ev65d28ly9vexQvp2jgGyla4wXQIV6DBJzgcnGPQ1z2j+MRHcPcrBZBJY/JeJXdowc5DZBLex+tc7oNhNrN0sU0kJV4mbZLJwyAcdM7skjgc1u+FNI02e1mk1GI2xXIjiCMiOeOSSM5ycADk/hW8Vpdm8YU6at0+f32H2Vzothosl1aG/m1K1ddpwCpcD5RgL/vYB54q2up6hHZ2UUCsztMXm3gMJMA7eVAIxzwBzkVuRT2+gwwR3uhJBp+3zHkEgkxO3C5AzznPPNUo7690zSruC5t7C5iJ+0RXruViRsqFA5BwGQ5Hv17U09dvyMXJLXlvbbX9fLsaum65o4vbafxDH9nn094NRgMbMXmeRVU4i+8QNynoOAfpXX+M7z7N4p8NSOZITc3XkyugBRwEbahJGB95jxg/WuF02eRJ/OvdZkFxNFHfbrq18yaJtx3Nu24G3hRhsYGeM1F4kit7W5s7+zu9SheeXCICyvJIoH70I33toCjp2681DgnJNnlywHtaim9G+ln8zK+Lk9ouv6XZ2EieXYBlOWJKyFidi8fMcY+lReFxqeqR6je2Nuty10pjuViOCyqhACg8gjg++Kd8TtWm/sWSOxtrddPgJlurkRqksl3uCPkN15Vfu5yM+lcvo+tLBf2720htFlGy5kgDFSm7qSfmX049KcWo+p34Wr7ns3ZNa6/dfp2/4J6J4et49IhsJL64ANzP51urAjbOhwFOB1zwR0/nXZ2cf/CU6Dqun28FxbNIjQ3G0Aqu5eNpJJzjFZOiatPcWbyajc2csljcCEPIoKnP3CG425BHJ9u9O8Pw3ESPDpa6rZRtKJ5JUUgSHAXGWA7KOg/Gomr+pji+ao5Slbm79Pu06WGp4S0218Z2ME5vRYfZo4ogsLMN6gjmTGB0zzUHiGwsrfxldXWlXN5Pc+TEYTbBZFDjJETnacB9uN3bNdbpN5ZtNeq+t3E8ttCYpNKu1XzUYHJflQ5yMY7Yrkpbq31bUY/K0+4EBjKXUcEpt7mND90uARlNwyMnIycdamMpSevRHFCvUq3522oq3l6nWRJols9xrl25m1kSHMcs6xrHdNEoNsCMLkjaOc9RzTotTlj8PQ3EnhO+s9NmEq3sE0hM6HG1AqAktvJAzkYyScYzWLDeaVdWljqWtafPp0CzyJBaTzrKJiVzl1OckbSRzwFyK3/7caCJn06K8vFnITes0YCD2DEA85/Os3F7Hnzws21Jemuny3srfMIo7H4f+HLW0tYbiM38wWG0nlUGN36oXwR8vPJ9Opralk1LS9raVa/2lYyxgRxRMkbROMnczs2CpG0cDgj344G71zTbTxGLPVdYvntWjfKSFTabdpJVgRhnOCAoP865hPF+r+E/Fq6fq1wuqW8++O0YTGAQRgkYI2iMDhBg52564odGUtd3+YVMG5bu779+3odj400h57661OKdb/WLVUk0a3t4y00SRyRtLlMgSYbYcdeOvaofEVpP8Qilrf6DqdneWcMxjkmHkwtMFACBj6kn5sEY5qaGLV77xVNcedMdOst8yxxah5XkcDCOmwZVghPU4OT0xTNW1rU9Rgn0vTrO507Ug/m2sl1GxS4iwwG2XOFcEA/MMEVUXJWtuvwHTpzUvdsmuttrrt6b6eZF4pi1iS3uZrjw8ftsNnb7bqC+RIiiSB2jG/jahLFnPOBx613tpazSKLK4t4msZrbDTRyM3PG0LgcjqckjoOuTjG0OJ9C8KG58SPJeStGsTxJD5hLMceWqgYOWwPQ/Sty61eO1nsI44ridp/wB2IIVAESnHLjtjp171jOTfuxWxhU5ub2dLW3Vd9zldJt5/D3i+XRtGtJLO0knfUp52PmJdRlCDGrN91w+MgHgDPSt251OJbRhBCyTT3Ajke3dZhGxIzkk43ewyfas3VNbmvbzU7HGjXenAGKVlvVE0QZW3qQOQwXHp35rP0/QJx4WjEVlNaapbIhtIt0SfaZECneyjKknHLfewSARVWUrSl5fMu137Sol067v7/S/byRnah4rfTdcmjgktcWFlLK7ysVtw7Oip5jkZHOV47t0rOtfCE2oXg1aS0ttL8UTyxzlDcmRUjDFzMiZ+YlmZdpOMdORy24ure70kaHrejq2p/LLPb2rYia7Db44S5OdxG0kcrhiMk10ssmmeKLbTmudGtX8228uK6ljKvbsyggA4B2jjIyOo461s24axX9febz96XNSWnf062/TsbE1hqDSubfxBaxwliUQ2ykqvYZ3c8UV47L8CNWuZXnbxBpQMrFyBG+OeeMUUezp/8/F9xwt2e5m2HgDUr21ika3a3Zj8xfHQ9CF+9j68HtWbrXhG80u9gt9stwZQdrRxMRkdRn19q+gbrUdK1Tw1PcpNLFDHlXmVfLdipwdpIPB6ZHb0rgdO8iO6uU0Wy1fzr/ekU8krGN2VkbPyDcF9XPbPWudYTD1m5TpL8j6yhmmIlTcno13X5u/Y8pl0i9iLBradCBnDxlMj2z1qnJbyRMRJGwbGcEYODX0KNNs4o9I+0MLnUzPKQlrPgxswYuyF+WCg4wK5mfwlp2oalqcl9cXuPOkaJdweUkfeZgoPAJAx+dctTJ8LUT5Lxf3ndRztP41/VzxgFJgQrZAODgng1NGFVeuAMjk9a63xFo2k2eoS21pcXKlAMSTlZPNbuAEAIA9SKxZNFvVtkuI4HeCQsEYL97acHjrXl1cpxNH4VzR/roetQxNOolN6N99DNOSTjAxzxgGkEjDoxx780+SKRCQyspHao2Z94XYSuPvZ6V5zVSm9bxf3HU2mtdTQGtaiCN107+znd7d/oKbHqUy6it43E6gDKgAHHQ4AwelUj0x2pK2hmWJhqpu5m8PTbvyo9F03xnBqEItNbtbOSNvlMqJ5Uyj/AH1PPf0/Gum8OtdadaSfYby21O2lcIykk+UM8nOTnq36CvFMCnQX89nODbTTQyY4ZCR+tejRzyVuWpG/p/kefWyynyvldk3s9V/wPkdL4z0X+yhPcXFobS1uZJPsojZNjhcHPGMA9gQe/NcGksV7NdxTSy+fdIse2bouOcZHHPr712+h6/EYr228QW0mrW12QzebIWMOM/6tTkAnJ6YzXRQ6Hofivw9cxaQZ7RoJB5i3aDzSuMrkjpluB7ivbpVo4mPtIS09PzPKr06kLRqrb7mtvlo7dd3oeZ6bqN3YXEUMyva3CKEtmiHmH5TnLEHOOBwcV2Gm60ttdKwmGoRRSxSPbyx7MEttBH+zyCQc8jOOK5e58OTaddwCWR3ZmCMiSfNCAPmQkHnnvVWziddQeCyvpGtthDgoHCnAPUd+4qoyqQfLJX/roVCNRRSqLd2W1/Lsn8loul9vX7aO/wDEHh2dvsz3Q+0b4zbsJz8u4sMAgN1wo9e9Zt5b2elquixS3Or3MsZlVdQkKKeT+7RAfvcbsE854rovBmtxR+DdllBawzRIIg8YJaW4OQB5a5PQA/nVvSZJp9BvotU0FLHWtPniNmUPlvM7ZKn+8AMkYOQcfhW6l1OepXnGpZq1na3r1flsMfw23iSJ7m3t76CaO1kiSFl+z+bhRtAP9wknOep6YFT3nhgXx06y1UagJLGOS4j1KCRdqMWBaInkcqB1z17VjR6tqlromuXt9qX2uG1dsz8l4WZgjr5fAYAMGBJx3HrU3gLTbBtG0+Wa/u4LKO8khSIzgQ3ckiY2lTnn/Ck3Lvsc9aM1GUpSTSfTden9d+xwGvtdS2OoabJCgSLzpjHeb2kbDlmlbB5GM4zweoFc5pNtPNppfzbRWMyxRqq7mlU5yOg6H+de1Wvg022qRzQai8+oWET/AGZ79WxMjoECluwGCMDOd1cZoyCxubyXUdO+w3trG06THBT7oHGOGI64x3Na3UtTooSUpOd9klbVb/1t+Jq6foyTapHaf2reDNxDJepCgNuyBQWZssNuxhjIz1wBXb+HNWutW0O6sdMv7UXBkH2TUDDlHI2syBRzkfN+nFeR2HiK7h1BkmmjmN9bLHNO8o8kBgcbo1U5JON2fU103geOaTRJ4WvBZvFDNdo0TeShcPGGcumR8qADHX5sdKiUebUzxlPmTb12+T7+f/Dl3WNN17UfE8WoRy2djctcR2sy26N5rcHJmK8EdPm/DNdJ4DtrHVjr6Q3Ej3BMcMp8vyp4lKAqVbcxZcnqe4IxxV+5Fo2tSC+hD3OuxsI5IVDRi1jj/wBaWIUqcHlQSQSMe3J+DorPw1eWtzDqrx6XbytHJcBgy3SygLHkjO4iQuB0xsNQ3eDtoee68qlPlg7WV/8Agffsba6CU0/UdPIudV+x3YRhM3myoskYQPEflVGGWJ5YAZ9ataFpVrYPP4ei1Oec2w8yS4l3+bAz42Yz8rA/N19sVHqPiCbwayaLFb3OtXvNxqN0pIMYL43MFBAxkfKSMfQ1y0N3M19eahqdrc38Xl5aG6kFk0m3bsZymSyA7xnsf1SUpJ9vz/r5Dp06tVScXo9VtdvT7r/LTudZqHha1aOytbm0i12NWAnC7YJ0bJDyl8rlApPGck1BqMenPdND4n0rSG1N4ZZNNMMbukqkdHk6FiQOAcd6537PLDew65b22nxWdwm0w2jPOJDjaqJnIHU7ieTnnFdQI4k09tOuLctDdW5eCxgBiljHy4RCOg6LkEDj0ofN3/r8geHn8c5Xvq+9/wAjc8DXlrq/hqS+1eBbDVSiw6nEm6NQ5GQD7FXHI9aj0nSNTl8Ui8F5cT2SSvD5N1YiNIYxuI8skksOQAfQV5bf3p0Txpp+kaiuo3lnPMJpIHYxF5nxtYujZk2YI5wBtzXrEnjW7TxNZ6cui3P2WcPI9w7LhEX/AJaLtyCOmQcHkY71jOnKLbhrc46tKpRk3SfMnfts12/roZGjeKZ9dkn0SCaFrwzvLbXMlsBEGjkB8nY/zFwo37sdCCKuWdt4nTxA8awQxQiGUl7pS6vIc7GVw24AMoJXA4PHPRnxC0+Eyw69pn2e11svHbpfAtuRTuDHoVJ255YYxx6VDbeKr+Dwzp2pzRJLb3LKstwkn2dIpGVSodXJO05OSDgccd6fLeN4Lfv3JScofu0lzb97+v5FLQYtL0jStSh1iOzn8WMZor2GB2UzNtLGRAx5/dkH5e3HXiqvw98QzXkN9q2orr99LpAVILFR99XIUyquRvwM53HAAyBmqfh6K8j1qGfWzf22tI6tY/bZAzmMBt0fmLgvGd+eVyveu1uvFEUd2kEVulpcSmOKS9u1HklSxyo5BZmwQB/tA+1XNNXW9/6+43qUpqlKCjfm1v29PL01MPW9KtRqmv6+Lv7HpYtBv1HeJBBexuFY+U3Ak2hRuHFWLS6e08MPdamy2ukyWKeRdW8CSPbuy/fIjJDHBQ5AA+U+orIsdd1K/wBP8T+HtSso2L+YLa2WLEiwSSOm9gSPMUEZJBzzVH4bQ32kanNol3o6W959oJNzFcsojg2snmKr5EnzDp3yCRxRyy5XzdPy/r1MOSST5nottv6X9aMEvPFOxfsHiyzls8fuZH06MMyfwk/P1IxRS3ejeEPtc3majcQyb23RDUnQIc8rtHAx0wOBRWvLDt+B0+yp/wAr/r5Honhiy8zwnbrqVjarvLGUIi+UY8na2OnIwePU09r3QNGWGeKWzMAkdGkiCMtsdvzA7eVHy4PucVzms6NrD6DpunzJBqdwLxvIZWMIdQhODhl2cBhxkf7IzVOysbiSBm1LSNNafTdQjDRWibHSMQ4J8zcNzqGyxOdwyAO9c6hfVs5nBSu3LRt6L+v8jX8Z6bLLpNneaFbvPOj74brT9okRW+8UU/K2Rnr26VqeGNI0xrCCfbKmrGBkna7dt/mPguWTO3JYDOB7DFTR69Zpp2heTG1zp+rzC2hmyUKoyEqSOuTtx2q9cyabZmexDIs0SeaqSK7DDHgk8n73oahzly8pjKcpLks7912v1ONj8JwQQx3fii00ua73BGe1RgpHZtpwef8AOapeOND02PSIJrB2t/swEvlW5OTGx5+QnHJ7n3p8z6z4msLz7EbWKGEKgaMmMmdNrFskEhc9Bg5BwcVY8Ix6lfWt7Y6lDDHeQr9lN4djs+eV6DkDI4OPzrovJe9J7dD2ITq0rVJzu4vVX6egzWPh/p2qW9jMlvDArbXbyYirTDbyCQflz644rkNW8Aac9/LaWMdyLiNctGkm4gdjuPGe2K9V0VNft3jtdWezeBFYNJGCGbBATjnHAyccUzWdRttJSe+1h0gsYiFLxqzswbgA4HUn8qxcuZ2mlL8TOjmFenLl5ubtZ+f4nhkngDUJ7h0062um2x72E8flEewycE/TNcxqmk3em3MkF1E8ciHDKwwRXv8Ap2owz+Hr3V5G1I2vmhrbc0e4RnCZUDHBOSQxz19q4rUPDxvrzUNRjimawlI2PLNuYMy72O3PBzxjp6HFc9XK8PXv7vK/I+gwOcVJzcK2y0+Z5LSEA9RnFb2v6FJYzK0bpJDKglidOMq3IyD04rEZSuM18visHVwsrTWnfufQ06kaseaLuiJHIc7CQR6VqaTq93ZCdILmSNbjaJNvBbacrz7Gs1N2Pm6Hp70tTQxNTDy5oMTpqatLU6DUYRcFNTt7m5kgjjUXcjhRtkLEF9oHOc+3NYf9lXGkQPJbyGVZCcvIqL5h24AH908Ec5z2qa1vJY1kgLt9nlAWRQeuCCPyIFUbmB11rzLOVY1CrvaTLtntx0I7V9VQx9PEw5orXr0fr2PKxGGdO0ld2emuqutf6/Hc1vh/LqNjO8MuoDZKxZi239ywBYkE8buCoI6Z4617FoV5qOs2N3rL6XOzeZE0H74M9wqbgwG4/eU55IGcgdq+e7No5pHsp71XiWZE/wBWcGQuTg5GSK91tU8RnR4ZbG/SO+hZ1Ns6grMPY9Bwx7+tddFp09Oh484RdNOm0raau763Wl9NN7/cT6vZaZY32o6GksaLqjLcOskiuxH/AC0Qo3C8YHrnGO1bHgyDTp9Etbc6dPGYZ2liguINm2Ych+c9jwQa881WwtradYtfgiF8pjhuZ7PO9yyfKzM3XGNpA9c5OK2dB1ixRtKe0S4l8uZwlxeOZJEjI/eAcj1GOvet3CXKRPDTnRstW9fXTQ7bWLyO11Nri5lwlwwSCIxbGiG0ELgZLncpbPHFeP8Aj9bq3164SW9R7u3tj/opcRxXKMvJIXIGB3PpXZ654uSztb6S3jklu7N9o3gKHyAAu4ZOOQOnrXld1qt++lXTXD/NeR7HlkYyyRhTwqk9jUX9mtTTC4aVOO2y/X7vv366XKXhE22paiPtVw0FkGWGF/Kysjtj5ST1HYenWvYPhTpQvBdWmp217a2UBVoDPH5cjhmBeN85V0YqAVGeB2rzLw9cW+oab5bq9yz7pIFZzFtJwqjKg8Agn8hXpHh7T38P2KWutE3On2RF2qxSEMXEisrA8YYN+BBIOKqP8OyZFejOpR5Yu91o++vTV9LI6TxNqdpeXEdgLWSyvIHNpZSK+0RrIgDBih/dqegDHsCPUUPCeh6Trvg1/D+ovZW98s2+L+z7wzvGFJdJDhmHDM3ByOlGpNe2OoLNYpp6C4ghMV2bVd0jMCS7rySygBQDx83U9qXhi5OpqbS90SzjuM+eLm3CwEupG1cJ0GBy3Wo5Zcumxw/VJSotRXu7t9fx6dWu4vijTNQ0e7uX1zWrRIrtFNxdbJftFzHkCQ4XhOAvAOM84zTdRk0nTdX0+GSUX2g3lrJFDeG4d5FJfDrIGGCM9CeRzjpVzU/FR1HU7W31WASWEduZ96EHEvOQMjJA5XJHPWuN8QeJdDn8w2WlCMsyl4JRvjYgcd/T6VMqsacVKq7Ho4TA1p8vMmvSyXl5p6eZvXmoafoWpWOlaDBJe6dZyxmSSS5LxxNJnCEHJPB3ZzgZHpW/pukapqPiK5uNYa+he0kUWUsB8tDDvY7Rj6LyR0ry698VyTwS29np1lYQS7C8dsmwF0bcrcc5+uRViLx5rYuFe4n85QCNh+UH34xzXG8yw9tJfg/8jp/sjEuCUbJr5s9MS00mDxUlrrFldXGoTb7W3v75c73CmQeSMcYV8b1x93B5p2oz3vh3wbcz6rbm21SEC2st0gvGkB2hcsFyASDlSO3Ptw2g/EzVoPKtr6RLm3QNsllXMiMeVHHUduxx612Ol+I2vJZ557i5Fq8SKqxSfukfcSGwVDdwOp4ropVo1tYNNf1/Wx5NXLMXRlzTWn5/12XyLelHUZ71WvLbU7g3MsdrNbNCrW0RCA/ak3fdGcgqORuORmn6npb65penWWj+TF4fV2+0oQSrBQhQjnJJxtGCMbs9qgn8cXUNxNLcRKllYxkSXCOXeRmYLGgUgYyWGTyB61XvTd6G2jX0F1fyxSXKRXNnmNV+dSApH3dq/MflzngA9K1Slfa3Y45UZxbvp1t/X4XJfF0rz/FLwz9njlmgFpKp8vJWNgMkkk88bAR16Vz3jbULixubMaibQadJL8iZYyBkyQ24fdOTHgYPepfD3iR9Q8YaZ9osZZVtrqSHEUgCqxDKXIY9T0IHpXceMtFN9qmmtHPNFYyxsPLtkQZdSJCXLHPzKu0YHGWOeapfu5RjLsbSksLONKeqt/mcd4f1BLiGXWdal8m8EHk/aYE2+Sr9FLglTgsT8wAzg1cg1i01mFzHcudVsJFWK5WRUebGdvmGLP7tmHPQc9KkHhGZ9Qnu9AvTY3U8DOrgFWhBfjBBIPI6Yxgn6VieKNOvLW+WOxjgla9h2S5QR5kVtzAhGUZwT83Ppx3pKM5e6zX2dGUnZ/12en47Flri4uGM114O0VriQ75GS5TaWPJI56Zorzu98LWpvJzMbaOXzG3oDJ8pzyOOKK05V3/F/wCZusJFaaffL/I9x1a+1jw/HrV3aNfaqSWmVXKJDCg/hzgnAA/nmuctfF91qt5aagdOvLueFYzLZW966xRnIAwoXD7jjIJxwcVYudbGnzpot0YpBeQ71hs1WIW8oDeYuOSQTkndnkDIrlG17VRqI0TSrzUkE9xt2TYwMsFwjAZXAOQAOxIxWVOldarX7jnoYaLpuc4r1u1p8tfyPS08L2+opeab/aUsOjRLGRp0T7nsyUPBc5IIbJG0+oPHFRXek2Saiunw/Z7+0/stLaS0Zi804WQbXbvxjrkc9elcxpV9ceGvEdwniS3eSMRmO5ngVtkqklV3BiFwecnqSOprP8TatYXGpJFpAk0+z3CQLb3PlmfdhhuC4wMj+FucmhU5uVr6GVLB1JT5YO6t8vm9/wBfmd3eWNzZRRWa3CRXV5u8qzij/dBsfK8rDknaAM9yAOlch4ltbqzij03W2upb3yZZ4buORlSNizFYwB/CAR1GffFWAb/xi0Fv4hmgt7z9+1vdxWuEtx5ZGVJYbsllPP8Ad681nfY7LQn+zi8l1/U4EmdWwqY2pnYVUsQG6Dr9KqEbO0t/66m1BypT/e7rV2X6p/mmdF4f8WTaRpuPFkyRblBkiuGDGNQu1GXGchiPrjmr2keI9O1retqlvegM03lQxtIoXdhWIcegHsD0rB1LStL1DwZc3+pyXE6abhoxHMC0kbBSofIwXBJXcKsfDFodKuri5Mb2FhNaRTKztsRlYkIpZh80nBzyAARgc1EoRs5LdGVaFHklVSfNtbZX9PQsaBoutS2V/NePbSaXfnK28xKvbohO1VCjapHHGfrUvii9/srQra1uri5tbOYpDEYWVWIX721z936n863NY1KbSbSxm0azdPMn8n7AYggzISfNYqNygEMSR13VQ8ReKv7Nv/D2neINIgvLTVGZZ5FYyR27lgqL84wc7hkHHtnvHNKTvYxeJqX55xTV9ttv6Wpi6ZoiyaXpc9lpVtZW15hJoLo4dU3E7ep56nHXLGvPvG2i2MN+Y9KLMVHzIEfjABJyR05Feh+MFS18aNHqlverpmmWb6jBcWRwxcyDKEkADPTAPet7XPD1rqE0l1NdXcHmR7CiOBC+AeXQjBOO+egFKpGNWHLV1TPSweZPDOMr3T/rXvofNLoUYqwwaYfbrXUeONJistSKwOskRBZWQ8Eg4P6iuXwd4OTgDp2r43G4V4Wq4Xuuh9nCoqkVOOzEQsRlgAfTNR3c5WKVXL+X5ZO7GMEdDntUrKSeCRg9u9MnRjGQhCkeoyKwpVHTlzRdia0HKm4oLFLa3sor28MHlvGGbC/MJTwCoPTiug8EeIbiwntorOY6ndO7JG11NlonfAA7YBwP/rda5LzAE/cxxywuMY9AeoGO5JrU8H2T6DNFOFjuIo5FnZ5F+ZShyq/nznPavrsBi1iGopWtv/X5nz06c1JRhFONnd+bt96b69Nb+Xv+mfDu81CEXHiW8c3cgG6KNwFjJABIBzg47e9M8VaBdWkC6HpNrCti0TNLNKTghm+YAjndjNeoWrNcWkUhby3kjVyF7EjPQ1y3jZ5JNOs7iLfHGk/lmEL9/cOMnsBz0rqhWnKaTPnMNj69asoTenbon0/r7zxS/wBHuG0Jba+e4QwytEbjO5DJxtbJP3BgDPua4jX9NGn3rfaVjZYyiugUeXknIwB0IzmvV77U4m8Vx293FNcx7ViOwARIWI5KDj057Vy3xGtIo9Y8yxSONGhEisj7lkYAjHT+XpW+JTnTaPp4e/JQnHW1/wCl+hxVrdMhWPSGEdnMNryRqMoU6YJ9c4rWk1CRkKyuzqRgg9CK5W0vWj142U77iRgFFCqTjk1uHgd/p3r5WrjsRB25rHp5dKlVhJw6OzXRNdEunf57nQ/8JdqbQxwy3BmihZWjSQBtpU8HJ71WvvEmp3jlnuJgD1USEL0x93pisYgNjNAGGC55rCWZ4mSspHYsNSi7qK+4lnuruaKNJZ5DEgxHHu+VR6Adqr8jqD6VKUGeMZ9aeEXAxx+Oa5pqdV3k7+rNlC2widMYwacemaMYOABig5reOkSrdAVDg49OasWF/eadcC4sJ2gmB4ZRkH2I6EfXio4oyTgOACpPHaohzg+tdLg6cVJaGbSkuVq6PTNA+INnFotzaahp6CZm3K9vGoBJOeBxjBAwM+lSal4ivtd0ePUdLvTaX0CAXSRRbto4boVyR98Y57eteYWpG+VGX5uxz1HNT2skkYZYpHQnnOSfzr18PjNIuerZ488ppSm6kNHr/keya/qGmWdq19YzrZ6y0EW8tp7lJWcDqg6e/Jx371gSeLpnkZvsl0lg/neSqsC6OqbleJlPyIoxkckg4wa5dPE17PcW5uJcGKJoXIzhwRjcRkcj1BB966bRpYR4l0251KIxxSlty20xkt51xkiQP35z1P4dT6NGdOrG8dTyq2Anh42ldu2ny7foW9LmutQ0XSLy08RXdzc/aIp0sWjaKUygAzHLEecnzA4xgj0rq9G1S0tLzUdF0mxuDdKDKZdTaSVA6nDJlhwMKcAHGTxWrdQx+baJYTizcMjiFsOrQAFSqAnKq2ByPSsjU9IjbW7q300TWh/s9ru5f7OJlnxIP3W4kYPByMdGB7VCcZaP+vWx4UpQn/EWvp+du3zM9bzUZVEkujaN5jjc2LBzyevJxn8hRU1t8NvCmoW0V4sEqrcIJgrzHcNwzg89eaK056a/p/5mvtMKtGvzPWm0K/aGVf7Qs45XlDCWOwAby85KElznPrxS6T4aNmtwbq8F3LJIXjY26IIgTnAA5P1JJOKKK8r2krWPjni6tmr7+S/yKV54MIsUh0nUpLO4Zx9ouJIhO08e4sYzkjGcgZ9AK5m7+DWnXWqfbZr92fdvKtDkBioVivzcA4zjpzRRWkcTVjszenmmKp6xn+C/y+7t0NrQvAt5pejvp7a9LInnrJGyQeXsjUYEQG4/KABgDHTpVGb4Z3Jurm7g18RXkzECY2EcjKhPK/MTngAZ/wAaKKFiaid7/ggWaYpXtLffRf5GvZ+ANNtYpVRYWaRQpR4sxDBzwmfXHUn8KztZ+Fumax5Zv5i7oAoAQ+WqgnaFjLFVxnGcdABRRSWIqp3Uhf2lir8znr8izc+Bry88NXel3utiWeaMpHci1KmLOM8CTJXjpn8eKh0T4crp/haLRbjUzcormSSZYTGztvDcEMSMbVA5zx1ooo+sVLWv5g8yxLTjzaXvst/uNWfwtdiGC00/VUtLCHYFQ25llKrjKmR3OQcH+HOD1zzSX3g5bjVLO8h1G4txDxLGmSJ1ByFYE4xknPGenIooqfaz7mSxlZbP8EctrnwftdS0m0s4NSjtHgDZkSzHzFmLE4DDB5rmG/Z4BOR4mwPT+z//ALbRRWOIgsTb2utj06XEeZUY8kKtl6R/yD/hnjn/AJGf/wAp/wD9to/4Z49PE/P/AGD/AP7ZRRXN9Rofy/izT/WrNf8An7/5LH/IpXH7NRn3o/i39yxDBBpoypHofN/z61PYfs6S2VmYYvF7b85En9ndOfQy0UVvTpQpu8FY5v7ezBTdT2mu17LZ/L/huh7B4e8NDR9Fs9P+1tP9njCeYynLe/LE/rUmraA1/bCKO8aAhg24Ju6eozRRW/tJX5upwLF1ef2l9d9kcEnwaSO8nmTXGKTFsq9rkgMMYzv9eeQaqal8EpNTjxfeI1lkDBkk/s8Ap6hcOAM96KK2+t1n1/BHoviDMHvU/CP+Rz8/7NcbagbqHxOIyeoOnbjnnJB833qyv7PDCMK3iou3946f/wDbKKK4alGnUbcluOlxFmNJtwqWv5R/yFb9ngE8eJ8f9uH/ANspR+zzjn/hJ+f+vD/7bRRWf1Sje/Kbf605r/z9/wDJY/5Af2eRnnxN/wCU/wD+2Uo/Z7/6mf8A8kP/ALZRRQsHRWvL+Y/9a82/5+/+Sx/+RHD9nz/qZv8AyQ/+2Uf8M+/9TN/5If8A2yiirWHprSwf61Zr/wA/f/JY/wCQ5f2f9pJ/4SX/AMkP/tlIf2fc4/4qbp/04f8A2yiir5IrQT4pzV/8vf8AyWP+Qv8Awz/8+7/hJe//AD4f/bKB+z+Q+R4m/Ow/+20UU+RB/rTmv/P3/wAlj/kIv7Po8wsfExYHsbD/AO2VcsPgfcafOJrPxS0UmCuRY54P/bSiiqh7nwifE+aSVnV/8lj/AJGjpPwfktL2wmvNfF9HZgCJJbPDAglgd/mbuCenT27111z4TmuZYpZdSHmRuHXbCVA/J8/rRRWrrze7OGpm2LqS5pS19F/kc1N8F9Clmkka5vcuxY/6RL3/AOB0UUVf1qt/MR/aWK/n/I//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of acute osteomyelitis of the tibia shows many disconnected bony trabeculae in a sea of inflammatory cells (red arrow) and a single multinucleated giant cell (black arrow). The surfaces of the trabeculae (white arrows) have a few undifferentiated, spindle-shaped, connective tissue elements. There is little evidence of active bone formation or bone resorption.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jon Mader, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18468=[""].join("\n");
var outline_f18_2_18468=null;
var title_f18_2_18469="Diagnosis, treatment, and prevention of Bartonella infections in HIV-infected patients";
var content_f18_2_18469=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis, treatment, and prevention of Bartonella infections in HIV-infected patients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/2/18469/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/2/18469/contributors\">",
"     David H Spach, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/2/18469/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/2/18469/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/2/18469/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/2/18469/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/2/18469/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H28105014\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bartonella infections can cause serious morbidity and mortality in HIV-infected patients, particularly those with advanced immunosuppression.",
"   </p>",
"   <p>",
"    This topic will address the diagnosis, treatment, and prevention of Bartonella infections in HIV-infected patients. The epidemiology and clinical manifestations of disease are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28105021\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28105029\">",
"    <span class=\"h2\">",
"     General background",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of bartonellosis can be made through histopathologic examination of biopsy tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/1\">",
"     1",
"    </a>",
"    ]. Lesions are characterized by vascular proliferation; Warthin-Starry stain usually demonstrates numerous bacilli.",
"   </p>",
"   <p>",
"    Although isolation of this organism makes a definitive diagnosis, this is uncommonly accomplished due to the fastidious nature of this organism. Serologic testing is often used as supportive, but not definitive, evidence for infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28105036\">",
"    <span class=\"h2\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bartonella species are fastidious gram-negative bacteria that require specific laboratory conditions to enhance the yield. The likelihood of isolating of the organism increases if blood is cultured in pediatric or adult isolator tubes (Wampole, Cranbury, NJ) or in tubes containing EDTA. Bartonella species have occasionally been isolated from BACTEC (Becton Dickinson Diagnostic Instrument Systems, Sparks, MD) bottles.",
"   </p>",
"   <p>",
"    Plating samples onto either chocolate agar or heart infusion agar supplemented with 5 percent rabbit blood enhances the yield of isolating organisms in subcultures. Optimally, the microbiology lab should use fresh agar plates and incubate them in 5 percent CO2 at 35 to 37&ordm;C for a minimum of 21 days. Isolation of Bartonella from tissue samples remains very difficult, but some have successfully accomplished this by directly plating tissue homogenates onto agar and cocultivating with a bovine endothelial cell monolayer [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28105043\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard hematoxylin and eosin staining of BA lesions from any site characteristically shows lobular vascular proliferations composed of rounded vessels lined by variably protuberant plump endothelial cells (",
"    <a class=\"graphic graphic_picture graphicRef54383 \" href=\"UTD.htm?4/22/4454\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/3\">",
"     3",
"    </a>",
"    ]. In addition, clusters of neutrophils, neutrophilic debris, and lymphocytes are scattered throughout the lesions, especially around eosinophilic granular aggregates. Warthin-Starry silver staining of these aggregates reveals masses of small, dark-staining bacteria (",
"    <a class=\"graphic graphic_picture graphicRef62100 \" href=\"UTD.htm?27/35/28214\">",
"     picture 2",
"    </a>",
"    ). Electron microscopic examination, if performed, shows pleomorphic bacilli with a trilaminar wall (",
"    <a class=\"graphic graphic_picture graphicRef67623 \" href=\"UTD.htm?30/16/30980\">",
"     picture 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Histopathologic findings in peliosis hepatis and splenitis typically consist of cystic blood-filled spaces and fibromyxoid stroma that contains a mixture of inflammatory cells, dilated capillaries, and granular purple material. Warthin-Starry staining of these lesions demonstrates findings similar to BA. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26887?source=see_link\">",
"     \"Peliosis hepatis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28105050\">",
"    <span class=\"h2\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing is often used as supportive, but not definitive, evidence for infection.",
"   </p>",
"   <p>",
"    Two serologic methods, indirect fluorescence assay (IFA) and enzyme immunosorbent assay (EIA), have been tested for the diagnosis of B. henselae and B. quintana infections. Most of the data with these tests have come from studies involving patients with cat scratch disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. It is not clear whether HIV-infected patients develop antibodies to the Bartonella organisms in the same fashion as immunocompetent individuals. In one Bartonella serology study that involved injection drug users in Baltimore, HIV infection and low CD4 counts were associated with a decreased probability of seropositivity to Bartonella [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/7\">",
"     7",
"    </a>",
"    ]. Another study demonstrated that nearly one-fourth of HIV-infected patients with Bartonella infection documented by culture never developed serum antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Problems with the B. henselae IFA serology tests include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Significant cross reactivity occurs at the species level between B. henselae and B. quintana, especially for IgG assays.",
"     </li>",
"     <li>",
"      The sensitivity of the test does not appear to be optimal, especially with IgG assays.",
"     </li>",
"     <li>",
"      The prevalence of positive Bartonella serology in the general population is 4 to 6 percent, which creates difficulties with false positive tests.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the United States, a serologic test was originally developed at the CDC and is available at some state health laboratories. Several commercial laboratories offer serologic testing, but serologic validation data with HIV-infected patients are lacking. Although both the IFA and EIA serologic tests have undergone study, commercially available assays use the IFA test.",
"   </p>",
"   <p>",
"    In general, IFA IgG titers &lt;1:64 suggest the patient does not have a current Bartonella infection, but up to 25 percent of HIV-infected patients with advanced immunosuppression may never develop a positive serologic test [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/8\">",
"     8",
"    </a>",
"    ]. Titers &lt;1:64 could represent past infection. Titers &gt;1:64 but &lt;1:256 represents possible Bartonella infection and repeat testing in 10 to 14 days is generally recommended. Titers &gt;1:256 strongly suggest active or recent infection.",
"   </p>",
"   <p>",
"    Since data about Bartonella serologic testing in HIV-infected patients are sparse, these tests should not stand alone as a means to diagnose Bartonella infections. A positive serology can be used as supportive information in the appropriate clinical setting. However, a convincing diagnosis of Bartonella infection in HIV-infected patients generally requires a positive culture or histopathologic findings consistent with Bartonella infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28105057\">",
"    <span class=\"h2\">",
"     Polymerase chain reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of PCR-based tests has played an important role in studies and reports of Bartonella-associated infections because of the difficulty in isolating Bartonella species from tissue samples. The PCR test generally can distinguish among the different Bartonella species.",
"   </p>",
"   <p>",
"    The PCR test on tissue or blood is available commercially through Associated Regional University Pathologists, Focus Diagnostics, Mayo Medical Laboratories, and Specialty Laboratories, Inc. A rapid single-step PCR assay for Bartonella that amplifies the 16S-23S rRNA intergenic region has shown promise [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28105064\">",
"    <span class=\"h1\">",
"     THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;All HIV-infected individuals diagnosed with a Bartonella infection should receive antibiotic therapy. No randomized controlled trials have evaluated the optimal treatment regimen for Bartonella in HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/1\">",
"     1",
"    </a>",
"    ]. In a summary of data from approximately 50 patients at San Francisco General Hospital, patients generally responded well to prolonged courses of either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The United States Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents recommends",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    (500 mg four times daily) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    (100 mg twice daily) as first line agents to treat BA, peliosis hepatitis, bacteremia, and osteomyelitis; the recommended treatment duration is three months or longer [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/1\">",
"     1",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     Azithromycin",
"    </a>",
"    (500 mg once daily) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/57/10138?source=see_link\">",
"     clarithromycin",
"    </a>",
"    (500 mg twice daily) are recommended as alternative therapies. In addition, these guidelines recommend doxycycline, (100 mg twice daily) with or without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    (300 mg twice daily), as the treatment of choice for central nervous system involvement or other severe Bartonella infections [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/1\">",
"     1",
"    </a>",
"    ]. Some experts recommend a minimum of four months of treatment for patients with peliosis hepatis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26887?source=see_link\">",
"     \"Peliosis hepatis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recommendations published by an expert international panel in 2004 list oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    (500 mg four times daily for three months) as the antibiotic regimen of choice for patients with BA, and oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    (100 mg twice daily for three months) as an alternative [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/11\">",
"     11",
"    </a>",
"    ]. However, given the poor tolerance of oral erythromycin, the required four times daily dosing, and the multiple potential drug-drug interactions in HIV-infected patients, we recommend using oral doxycycline over erythromycin as first-line therapy. In addition, anecdotal reports suggest that the macrolides oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    (500 mg daily) and oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/57/10138?source=see_link\">",
"     clarithromycin",
"    </a>",
"    (500 mg twice daily) probably also have good activity and may be an option for patients who cannot tolerate erythromycin or doxycycline.",
"   </p>",
"   <p>",
"    The recommended treatment of Bartonella endocarditis in HIV-infected patients is the same as the general recommendations in HIV-seronegative patients, except that a longer duration of therapy may be required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/5/31830?source=see_link\">",
"     \"Endocarditis caused by Bartonella\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     Trimethoprim-sulfamethoxazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    , penicillins, and cephalosporins do not have reliable activity and thus are not recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28105071\">",
"    <span class=\"h1\">",
"     SUPPRESSIVE THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Relapse may necessitate lifelong suppressive therapy in some cases, particularly in those HIV-infected patients with severe immunosuppression. Long-term suppressive therapy with a macrolide or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    is recommended for patients with relapse or reinfection until the CD4 cell count has increased to 200",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/1\">",
"     1",
"    </a>",
"    ]. The patient can discontinue suppressive therapy if they have received at least three to four months of therapy and their CD4 count has remained greater than 200",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    for at least six months.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28105078\">",
"    <span class=\"h1\">",
"     IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;For severely immunosuppressed patients with Bartonella infection who start antiretroviral therapy, immune response inflammatory syndrome could theoretically occur, but there are no reports describing this complication in patients with Bartonellosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/35/23098?source=see_link\">",
"     \"Immune reconstitution inflammatory syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28105085\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary prophylaxis is not recommended for Bartonella [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since development of B. henselae infection is related to cat exposure, patients should be counseled to avoid cat scratches and to control cat flea infestation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, it is recommended that HIV-infected persons who desire a cat should acquire a healthy cat that is at least 1 year old [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Homeless, or marginally housed, HIV-infected persons should receive education regarding prevention of lice infestation and should receive treatment for local infection to minimize their risk of developing systemic B. quintana infection [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18469/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28105092\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of bartonellosis can be made through histopathologic examination of biopsy tissue. Lesions are characterized by vascular proliferation and Warthin-Starry staining usually demonstrates numerous bacilli. (See",
"      <a class=\"local\" href=\"#H28105021\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although isolation of this organism makes a definitive diagnosis, this is infrequently accomplished due to the fastidious nature of this organism. (See",
"      <a class=\"local\" href=\"#H28105036\">",
"       'Culture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Histopathologic findings in peliosis hepatis and splenitis typically consist of cystic blood-filled spaces and fibromyxoid stroma that contains a mixture of inflammatory cells and dilated capillaries. (See",
"      <a class=\"local\" href=\"#H28105043\">",
"       'Histopathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serologic testing is often used as supportive, but not definitive, evidence for infection. (See",
"      <a class=\"local\" href=\"#H28105050\">",
"       'Serology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Polymerase chain reaction testing plays an important role in the diagnosis of Bartonella because of the difficulty in isolating this organism from tissue samples. The PCR test generally can distinguish among the different Bartonella species. (See",
"      <a class=\"local\" href=\"#H28105057\">",
"       'Polymerase chain reaction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All HIV-infected individuals diagnosed with a Bartonella infection should receive antibiotic therapy. Although no randomized controlled trial data are available, observational studies suggest that patients generally respond well to prolonged courses of either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H28105064\">",
"       'Therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Long-term suppressive therapy with a macrolide or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      is recommended for patients with a history of relapse or reinfection until the CD4 cell count has increased to 200",
"      <span class=\"nowrap\">",
"       cells/microL.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H28105071\">",
"       'Suppressive therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18469/abstract/1\">",
"      Kaplan JE, Benson C, Holmes KH, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18469/abstract/2\">",
"      Koehler JE, Quinn FD, Berger TG, et al. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 1992; 327:1625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18469/abstract/3\">",
"      LeBoit PE, Berger TG, Egbert BM, et al. Bacillary angiomatosis. The histopathology and differential diagnosis of a pseudoneoplastic infection in patients with human immunodeficiency virus disease. Am J Surg Pathol 1989; 13:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18469/abstract/4\">",
"      LeBoit PE, Berger TG, Egbert BM, et al. Epithelioid haemangioma-like vascular proliferation in AIDS: manifestation of cat scratch disease bacillus infection? Lancet 1988; 1:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18469/abstract/5\">",
"      Regnery RL, Olson JG, Perkins BA, Bibb W. Serological response to \"Rochalimaea henselae\" antigen in suspected cat-scratch disease. Lancet 1992; 339:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18469/abstract/6\">",
"      Zangwill KM, Hamilton DH, Perkins BA, et al. Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med 1993; 329:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18469/abstract/7\">",
"      Comer JA, Flynn C, Regnery RL, et al. Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md. Arch Intern Med 1996; 156:2491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18469/abstract/8\">",
"      Koehler JE, Sanchez MA, Tye S, et al. Prevalence of Bartonella infection among human immunodeficiency virus-infected patients with fever. Clin Infect Dis 2003; 37:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18469/abstract/9\">",
"      Jensen WA, Fall MZ, Rooney J, et al. Rapid identification and differentiation of Bartonella species using a single-step PCR assay. J Clin Microbiol 2000; 38:1717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18469/abstract/10\">",
"      Koehler JE, Tappero JW. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus. Clin Infect Dis 1993; 17:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18469/abstract/11\">",
"      Rolain JM, Brouqui P, Koehler JE, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004; 48:1921.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16504 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-178.219.2.221-6D749065E6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18469=[""].join("\n");
var outline_f18_2_18469=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28105092\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28105014\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28105021\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28105029\">",
"      General background",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28105036\">",
"      Culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28105043\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28105050\">",
"      Serology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28105057\">",
"      Polymerase chain reaction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28105064\">",
"      THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28105071\">",
"      SUPPRESSIVE THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28105078\">",
"      IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28105085\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28105092\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/16504\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/16504|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/22/4454\" title=\"picture 1\">",
"      Light microscopy of Bartonella",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/35/28214\" title=\"picture 2\">",
"      Warthin Starry staining",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/16/30980\" title=\"picture 3\">",
"      Bacillary angiomatosis EM",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/5/31830?source=related_link\">",
"      Endocarditis caused by Bartonella",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=related_link\">",
"      Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/35/23098?source=related_link\">",
"      Immune reconstitution inflammatory syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26887?source=related_link\">",
"      Peliosis hepatis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_2_18470="Causes of gestational hyperandrogenism";
var content_f18_2_18470=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Causes of gestational hyperandrogenism",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/2/18470/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/2/18470/contributors\">",
"     Howard D McClamrock, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/2/18470/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/2/18470/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/2/18470/contributors\">",
"     William F Crowley, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/2/18470/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/2/18470/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/2/18470/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperandrogenism and virilization during pregnancy are nearly always the result of conditions arising during pregnancy. The reason for this is that hyperandrogenism in a nonpregnant woman usually results in anovulation and infertility, even if the androgen excess is not clinically evident as hirsutism or virilization.",
"   </p>",
"   <p>",
"    The incidence of hyperandrogenism during pregnancy is low, although the incidence of some of the ovarian diseases that can cause it is higher [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/1\">",
"     1",
"    </a>",
"    ]. The two most common causes of gestational hyperandrogenism are luteomas and theca-lutein cysts of the ovary. This topic will review these and other rarer causes of this problem (",
"    <a class=\"graphic graphic_table graphicRef59214 \" href=\"UTD.htm?8/50/9003\">",
"     table 1",
"    </a>",
"    ). The diagnosis and treatment of these conditions are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31236?source=see_link\">",
"     \"Diagnosis and management of gestational hyperandrogenism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An increase in androgen production in a pregnant woman can cause hirsutism in both the woman and her fetus. The extent of fetal virilization varies, depending on the time of onset of the increased maternal androgen production, its severity, and unknown factors. Fetal disorders causing virilization, such as congenital adrenal hyperplasia, are much more common than the maternal disorders discussed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LUTEOMAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ovarian luteomas are hyperplastic masses of large lutein cells, not true tumors, and they regress and disappear after delivery. The incidence of these lesions is probably greater than reported because most are unnoticed, either because they secrete little androgen or the effects of the androgen excess are minimal or not recognized. These subclinical luteomas may be discovered incidentally at the time of cesarean section or laparotomy for an unrelated indication such as uterine hemorrhage or postpartum tubal ligation. Direct diagnosis is made only when the luteomas are large and potentially obstructive or cause virilization. The first case of hydronephrosis due to pregnancy luteomas has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/2\">",
"     2",
"    </a>",
"    ]. The incidence may be greater in black than white women [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Luteomas are yellow or yellow-brown solid masses, often with dark red areas of hemorrhage, and are composed of masses of large lutein cells. They are usually from 6 to 10 cm in diameter (range 1 to 25 cm) and, while sharply circumscribed, are not encapsulated. Bilateral luteomas occur in approximately 45 to 50 percent of cases (",
"    <a class=\"graphic graphic_table graphicRef66532 \" href=\"UTD.htm?35/31/36347\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/1,4,5\">",
"     1,4,5",
"    </a>",
"    ]. The possible stimulatory role of human chorionic gonadotropin on hormone secretion by these masses is described below.",
"   </p>",
"   <p>",
"    As compared with normal pregnant women, those with luteomas have increased serum concentrations of testosterone, dihydrotestosterone, and androstenedione, and increased urinary 17-ketosteroid excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/1,4,6-8\">",
"     1,4,6-8",
"    </a>",
"    ]. Studies of tumor tissue have revealed substantial quantities of testosterone, dihydrotestosterone, and androstenedione.",
"   </p>",
"   <p>",
"    Maternal hirsutism or virilization was present in approximately 30 to 35 percent of reported cases of pregnancy luteoma (35 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/1,3\">",
"     1,3",
"    </a>",
"    ], indicating either that serum androgen concentrations are often not much elevated or that androgen action is blunted. The latter could occur because the increase in serum free testosterone is blunted by the increase in serum sex hormone-binding globulin concentrations that occur during pregnancy, so that less testosterone is available to peripheral tissues, or because the tissue effects of testosterone are blunted by the actions of estrogen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/61/35798?source=see_link\">",
"     \"Androgen production and metabolism in normal pregnancy\"",
"    </a>",
"    .) As examples of the degree of resistance to androgen that may be present, two women with luteomas of pregnancy who had very high serum testosterone concentrations (2650",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    [92",
"    <span class=\"nowrap\">",
"     nmol/L]",
"    </span>",
"    and 2830",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    [98",
"    <span class=\"nowrap\">",
"     nmol/L];",
"    </span>",
"    normal gestational concentrations are 50 to 120",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    [1.7 to 4.2",
"    <span class=\"nowrap\">",
"     nmol/L])",
"    </span>",
"    were not virilized [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among women with luteomas, about 80 percent of female infants born to virilized mothers are virilized, whereas the fetuses are not virilized if the mother is not. When estimating the risk of virilization of a fetus in utero, several factors merit consideration, including the sex of the fetus, the duration of exposure to androgens, and most importantly the stage of pregnancy during which the exposure took place [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cord serum androgen concentrations have been measured in only a few infants whose mothers had marked hyperandrogenism due to luteomas of pregnancy. Three infants, a male and two non-virilized females, had normal cord serum androgen concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/7,11\">",
"     7,11",
"    </a>",
"    ]. Two other infants had high cord serum testosterone concentrations: one was a virilized female infant [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/9\">",
"     9",
"    </a>",
"    ] and the other was a premature non-virilized male infant [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/12\">",
"     12",
"    </a>",
"    ]. Based upon these very limited data, the risk of virilization of a female infant appears to be correlated with serum testosterone concentrations in the fetus, but not the mother. Maternal hyperandrogenemia is therefore a necessary, but not sufficient, cause of virilization of a female infant, indicating that other factors, such as placental androgen degradation, must be important.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     THECA-LUTEIN CYSTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of gestational theca-lutein cysts is increased in women with multiple or isoimmunized gestations, molar pregnancies or trophoblastic disease, or diabetes mellitus. The incidence is highest (10 to 22 percent) in women with trophoblastic disease. These figures refer to women who had multicystic ovaries that were easily palpable at pelvic examination or were seen at laparotomy. However, the true incidence is probably higher; it has been suggested that similar cysts can found on pathologic examination of the ovaries in most women with trophoblastic disease. Mothers with pre-existing hirsutism such as those with polycystic ovary syndrome are more likely to have hyperreactio-luteinalis as the source of their androgen excess [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The size of ovaries containing theca-lutein cysts in pregnant women has ranged from normal to 10 to 15 cm; large cysts can cause troublesome pressure symptoms. The ovarian cortex is usually focally hyalinized, with multiple cysts below the surface and stromal congestion and edema. The cyst fluid ranges from clear to amber to blood-tinged, and the cysts have thin smooth yellow-tinged walls.",
"   </p>",
"   <p>",
"    About 30 percent of pregnant women with theca-lutein cysts have hirsutism or are virilized (",
"    <a class=\"graphic graphic_table graphicRef66532 \" href=\"UTD.htm?35/31/36347\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/1,14-16\">",
"     1,14-16",
"    </a>",
"    ]. Many if not all virilized women have high serum testosterone and androstenedione concentrations, and cord serum testosterone concentrations in infants of virilized mothers are either normal or high [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/14,15,17,18\">",
"     14,15,17,18",
"    </a>",
"    ]. Despite the presence of maternal virilization, and in some cases elevated cord serum testosterone concentrations,",
"    <strong>",
"     none",
"    </strong>",
"    of the 11 female infants reported have been virilized [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/1\">",
"     1",
"    </a>",
"    ]. Thus, maternal virilization and even fetal hyperandrogenemia seem to have no relationship to fetal virilization in this disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ADMINISTRATION OF PROGESTINS AND ANDROGENS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The administration of progestin, androgen, and even diethylstilbestrol to pregnant women can cause signs of androgen excess in the woman and masculinization of female fetuses [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. A similar effect occurs with placental aromatase deficiency, which leads to androgen accumulation by reducing the conversion of androgen to estrogen [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most affected mothers were treated with progestin because of threatened or habitual abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/19\">",
"     19",
"    </a>",
"    ]. In one study of 18 virilized female infants of mothers who had received a progestin, labial fusion occurred if the progestin was given before the 13",
"    <sup>",
"     th",
"    </sup>",
"    week of gestation, and six of the mothers were virilized [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/21\">",
"     21",
"    </a>",
"    ]. However, virilization of female infants has not been reported in women who continued oral contraceptive pills after conception [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/25\">",
"     25",
"    </a>",
"    ]. Female external genital development occurs between",
"    <strong>",
"     7 and 12 weeks",
"    </strong>",
"    of gestation; androgen exposure during this period may result in partial or complete labial fusion and clitoral hypertrophy. After the 12",
"    <sup>",
"     th",
"    </sup>",
"    week of gestation, clitoral hypertrophy remains a risk, but labial fusion does not occur. Male fetuses are not affected.",
"   </p>",
"   <p>",
"    Among progestins, those with a 19-nor structure are the most androgenic. Androgen administration can also cause virilization of female fetuses, but surprisingly does not always do so.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     OTHER OVARIAN TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Virilizing tumors are associated with hyperandrogenism in pregnancy (",
"    <a class=\"graphic graphic_table graphicRef59214 \" href=\"UTD.htm?8/50/9003\">",
"     table 1",
"    </a>",
"    ). Tumors that have been reported in a few pregnant women include Sertoli-Leydig cell tumors, Krukenberg tumors (ovarian metastases of gastrointestinal, particularly gastric, carcinomas), mucinous and serous cystadenocarcinomas, Brenner tumors, lipoid cell tumors of the ovary, sclerosing stromal-cell tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/1,26-30\">",
"     1,26-30",
"    </a>",
"    ], and adrenal tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Sertoli-Leydig cell tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sertoli-Leydig cell tumors (arrhenoblastomas) have been reported in 18 pregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. The rarity of these slow-growing tumors in pregnancy is a reflection of the effects of hyperandrogenism in nonpregnant women, although in a few cases the tumor was thought to have been present at the time of conception.",
"   </p>",
"   <p>",
"    These tumors are composed of seminiferous tubules and rete testis-like structures. Although the majority are benign, the proportion that is malignant is higher than in nonpregnant women (40 to 50 versus 12 to 22 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/32\">",
"     32",
"    </a>",
"    ]. Like nonpregnant women, most pregnant women (69 to 87 percent) with these tumors are virilized [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/32\">",
"     32",
"    </a>",
"    ]. These tumors are also associated with substantial maternal and perinatal mortality (31 and 50 percent, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Krukenberg tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Krukenberg tumors are ovarian metastases of primary tumors of the gastrointestinal tract that in some way activate the surrounding stroma. They are solid tumors and 80 percent are bilateral. Most of the handful of pregnant women with these tumors reported in the literature had hirsutism or virilization, and half delivered virilized infants (",
"    <a class=\"graphic graphic_table graphicRef66532 \" href=\"UTD.htm?35/31/36347\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/1,35\">",
"     1,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Polycystic ovary syndrome (PCOS)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The polycystic ovary syndrome has been associated with maternal virilization in a few pregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/13\">",
"     13",
"    </a>",
"    ], but fetal virilization has not been described. In one report of 20 pregnant women with PCOS and 26 pregnant women without PCOS, serum concentrations of androstenedione, testosterone, DHEAS, and free androgen index tended to be higher in the PCOS patients at gestational age 10 to 16 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/36\">",
"     36",
"    </a>",
"    ]. These differences became significant at 22 to 28 weeks. In contrast, serum concentrations of estradiol and progesterone were similar in the two groups, suggesting that the function of the fetal-placental unit was normal. Although it is likely that the maternal ovary was the source of the higher androgen concentrations, placental source of androgens was not ruled out. In addition, two-hour serum insulin concentrations on an oral glucose tolerance test were also higher in the PCOS subjects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=see_link\">",
"     \"Clinical manifestations of polycystic ovary syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/0/12?source=see_link\">",
"     \"Steroid hormone metabolism in polycystic ovary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cushing's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been numerous reports of Cushing&rsquo;s syndrome in pregnancy but there has been no mention of fetal masculinization or virilization [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4725?source=see_link\">",
"     \"Cushing's syndrome in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ROLE OF HUMAN CHORIONIC GONADOTROPIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human chorionic gonadotropin can contribute to the pathogenesis of and hormone secretion by luteomas and theca-lutein cysts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Luteomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human chorionic gonadotropin may either initiate or perpetuate hormone production by luteoma cells [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/7\">",
"     7",
"    </a>",
"    ]. This concept is supported by the regression of tumor mass and prompt decline in urinary 17-ketosteroid excretion to normal after delivery. However, most luteomas are diagnosed late in pregnancy, considerably later than the time of peak chorionic gonadotropin production, which occurs after 60 to 90 days of gestation; furthermore, theca-lutein cysts, not luteomas, are the characteristic ovarian lesion among women who produce excessive amounts of this hormone, such as those with trophoblastic disease. Thus, some chorionic gonadotropin may be necessary for hormone production by luteomas, but there must be another factor(s) causing growth and androgen production in late gestation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Theca-lutein cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Those women likely to have theca-lutein cysts (diabetic or isoimmunized pregnant women or women with multiple gestation or trophoblastic disease) tend to have increased chorionic gonadotropin production [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/38\">",
"     38",
"    </a>",
"    ]. However, its administration alone does not cause these cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/39\">",
"     39",
"    </a>",
"    ], not all women with massive elevations in serum concentrations have them, and the cysts may persist for several months after evacuation of molar pregnancies (which is followed by a rapid fall in serum concentrations) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18470/abstract/38,40,41\">",
"     38,40,41",
"    </a>",
"    ]. Therefore, chorionic gonadotropin is not the only factor involved in the pathogenesis of these cysts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gestational hyperandrogenism is rare and usually results from conditions arising outside of pregnancy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common causes are luteoma of pregnancy and theca-lutein cysts.",
"     </li>",
"     <li>",
"      Luteoma may be unilateral or bilateral, and the risk of virilization of a female fetus is high if the mother is virilized.",
"     </li>",
"     <li>",
"      It appears that maternal hyperandrogenemia is necessary but not sufficient for fetal virilization.",
"     </li>",
"     <li>",
"      Limited data suggest that cord blood androgen levels are more directly related to virilization of a female fetus.",
"     </li>",
"     <li>",
"      Theca-lutein cysts are not associated with fetal virilization, even when cord androgen levels are elevated.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/1\">",
"      McClamrock HD, Adashi EY. Gestational hyperandrogenism. Fertil Steril 1992; 57:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/2\">",
"      Wang YC, Su HY, Liu JY, et al. Maternal and female fetal virilization caused by pregnancy luteomas. Fertil Steril 2005; 84:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/3\">",
"      Joshi R, Dunaif A. Ovarian disorders of pregnancy. Endocrinol Metab Clin North Am 1995; 24:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/4\">",
"      Garcia-Bunuel R, Berek JS, Woodruff JD. Luteomas of pregnancy. Obstet Gynecol 1975; 45:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/5\">",
"      Shortle BE, Warren MP, Tsin D. Recurrent androgenicity in pregnancy: a case report and literature review. Obstet Gynecol 1987; 70:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/6\">",
"      Wolff E, Glasser M, Gordon GG, et al. Virilizing luteoma of pregnancy. Report of a case with measurements of testosterone and testosterone binding in plasma. Am J Med 1973; 54:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/7\">",
"      Nagamani M, Gomez LG, Garza J. In vivo steroid studies in luteoma of pregnancy. Obstet Gynecol 1982; 59:105S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/8\">",
"      Spitzer RF, Wherrett D, Chitayat D, et al. Maternal luteoma of pregnancy presenting with virilization of the female infant. J Obstet Gynaecol Can 2007; 29:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/9\">",
"      Verkauf BS, Reiter EO, Hernandez L, Burns SA. Virilization of mother and fetus associated with luteoma of pregnancy: a case report with endocrinologic studies. Am J Obstet Gynecol 1977; 129:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/10\">",
"      GRUMBACH MM, DUCHARME JR. The effects of androgens on fetal sexual development: androgen-induced female pseudohermaphrodism. Fertil Steril 1960; 11:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/11\">",
"      Illingworth PJ, Johnstone FD, Steel J, Seth J. Luteoma of pregnancy: masculinisation of a female fetus prevented by placental aromatisation. Br J Obstet Gynaecol 1992; 99:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/12\">",
"      Baxi L, Holub D, Hembree W. Bilateral luteomas of pregnancy in a patient with diabetes. Am J Obstet Gynecol 1988; 159:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/13\">",
"      Ben-Chetrit A, Greenblatt EM. Recurrent maternal virilization during pregnancy associated with polycystic ovarian syndrome: a case report and review of the literature. Hum Reprod 1995; 10:3057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/14\">",
"      Bradshaw KD, Santos-Ramos R, Rawlins SC, et al. Endocrine studies in a pregnancy complicated by ovarian theca lutein cysts and hyperreactio luteinalis. Obstet Gynecol 1986; 67:66S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/15\">",
"      Muechler EK, Fichter J, Zongrone J. Human chorionic gonadotropin, estriol, and testosterone changes in two pregnancies with hyperreactio luteinalis. Am J Obstet Gynecol 1987; 157:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/16\">",
"      Wajda KJ, Lucas JG, Marsh WL Jr. Hyperreactio luteinalis. Benign disorder masquerading as an ovarian neoplasm. Arch Pathol Lab Med 1989; 113:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/17\">",
"      Berger NG, Repke JT, Woodruff JD. Markedly elevated serum testosterone in pregnancy without fetal virilization. Obstet Gynecol 1984; 63:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/18\">",
"      Hensleigh PA, Carter RP, Grotjan HE Jr. Fetal protection against masculinization with hyperreactio luteinalis and virilization. J Clin Endocrinol Metab 1975; 40:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/19\">",
"      WILKINS L, JONES HW Jr, HOLMAN GH, STEMPFEL RS Jr. Masculinization of the female fetus associated with administration of oral and intramuscular progestins during gestation: non-adrenal female pseudohermaphrodism. J Clin Endocrinol Metab 1958; 18:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/20\">",
"      Duck SC, Katayama KP. Danazol may cause female pseudohermaphroditism. Fertil Steril 1981; 35:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/21\">",
"      GRUMBACH MM, DUCHARME JR, MOLOSHOK RE. On the fetal masculinizing action of certain oral progestins. J Clin Endocrinol Metab 1959; 19:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/22\">",
"      Bongiovanni, AM, DiGeorge, AM, Grumbach, MM. Masculinization of the female infant associated with estrogenic therapy alone during gestation: four cases. J Clin Endocrinol Metab 1959; 19:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/23\">",
"      Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab 1991; 72:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/24\">",
"      Conte FA, Grumbach MM, Ito Y, et al. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 1994; 78:1287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/25\">",
"      Bracken MB. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Obstet Gynecol 1990; 76:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/26\">",
"      Verhoeven AT, Mastboom JL, van Leusden HA, van der Velden WH. Virilization in pregnancy coexisting with an (ovarian) mucinous cystadenoma: A case report and review of virilizing ovarian tumors in pregnancy. Obstet Gynecol Surv 1973; 28:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/27\">",
"      Silva PD, Porto M, Moyer DL, Lobo RA. Clinical and ultrastructural findings of an androgenizing Krukenberg tumor in pregnancy. Obstet Gynecol 1988; 71:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/28\">",
"      Novak DJ, Lauchlan SC, Mccawley JC, et al. Virilization during pregnancy. Case report and review of literature. Am J Med 1970; 49:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/29\">",
"      Fayez JA, Bunch TR, Miller GL. Virilization in pregnancy associated with an ovarian cystadenoma. Am J Obstet Gynecol 1974; 120:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/30\">",
"      Daska, LR, Flynn, C, Goodman, A. Masculinizing sclerosing stromal cell tumor in pregnancy: report of a case and review of the literature. Eur J Gynecol Oncol 1998; 19:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/31\">",
"      Kirk JM, Perry LA, Shand WS, et al. Female pseudohermaphroditism due to a maternal adrenocortical tumor. J Clin Endocrinol Metab 1990; 70:1280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/32\">",
"      Galle PC, McCool JA, Elsner CW. Arrhenoblastoma during pregnancy. Obstet Gynecol 1978; 51:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/33\">",
"      Barkan A, Cassorla F, Loriaux DL, Marshall JC. Pregnancy in a patient with virilizing arrhenoblastoma. Am J Obstet Gynecol 1984; 149:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/34\">",
"      Widschwendter M, Meduri G, Loosfelt H, et al. Fulminant recurrence of a Sertoli-Leydig cell tumour during pregnancy. Br J Obstet Gynaecol 1999; 106:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/35\">",
"      Ritter, DB, McGill, FM, Greston, WM. Krukenberg tumor part II: Identification during pregnancy. Female Patient 1999; 24:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/36\">",
"      Sir-Petermann T, Maliqueo M, Angel B, et al. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 2002; 17:2573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/37\">",
"      Buescher MA, McClamrock HD, Adashi EY. Cushing syndrome in pregnancy. Obstet Gynecol 1992; 79:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/38\">",
"      Hatjis CG. Nonimmunologic fetal hydrops associated with hyperreactio luteinalis. Obstet Gynecol 1985; 65:11S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/39\">",
"      Daane TA, Lurie AO, Barton RK. Ovarian lutein cysts associated with an otherwise normal pregnancy. Report of a case. Obstet Gynecol 1969; 34:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/40\">",
"      Caspi E, Schreyer P, Bukovsky J. Ovarian lutein cysts in pregnancy. Obstet Gynecol 1973; 42:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18470/abstract/41\">",
"      KLEIN J. Delayed appearance and rupture of lutein cysts with hydatidiform mole. Report of a case. Obstet Gynecol 1963; 21:30.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7448 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.111.122.2-E64CDCC3B7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18470=[""].join("\n");
var outline_f18_2_18470=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LUTEOMAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      THECA-LUTEIN CYSTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ADMINISTRATION OF PROGESTINS AND ANDROGENS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      OTHER OVARIAN TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Sertoli-Leydig cell tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Krukenberg tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Polycystic ovary syndrome (PCOS)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ROLE OF HUMAN CHORIONIC GONADOTROPIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Luteomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Theca-lutein cysts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7448\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7448|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/50/9003\" title=\"table 1\">",
"      Causes gestational hyperandrogenism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/31/36347\" title=\"table 2\">",
"      Feature gestational androgenism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/61/35798?source=related_link\">",
"      Androgen production and metabolism in normal pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=related_link\">",
"      Clinical manifestations of polycystic ovary syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4725?source=related_link\">",
"      Cushing's syndrome in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31236?source=related_link\">",
"      Diagnosis and management of gestational hyperandrogenism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/0/12?source=related_link\">",
"      Steroid hormone metabolism in polycystic ovary syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_2_18471="GEP dendrogram NSCLC";
var content_f18_2_18471=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F81774&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F81774&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 549px\">",
"   <div class=\"ttl\">",
"    Gene expression profiling in NSCLC: adenocarcinoma vs. squamous carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 529px; height: 510px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gene expression profiling, non-small cell lung cancer (NSCLC). This is an example of hierarchical agglomerative clustering analysis. The experiment began by spotting samples of resected untreated NSCLC onto a custom 5000 gene glass slide array. The analysis begins with dentifying a single gene pair with the most similar expression across patients or experiments. These genes are then \"fused\" (subsequently represented by the mean of their two expression levels); this value is then considered a single element in further analyses. The process of \"fusing\" is repeated until all elements are included in the analysis, and a dendrogram is assembled. This dendrogram resembles an evolutionary tree, where terminal branches depict closely related specimens. Within this single hierarchical tree, the intercluster distance (branch length of the dendrogram) directly correlates with dissimilarity in gene expression. Similarly expressed genes are then ordered next to each other, and visualized as color coded rows (red for overexpressed, green for underexpressed). In this case, the gene expression profiling has been used to separate tumors into adenocarcinoma versus squamous cell histology.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David Carbone, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18471=[""].join("\n");
var outline_f18_2_18471=null;
var title_f18_2_18472="Birth diagram";
var content_f18_2_18472=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F71178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F71178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Birth diagram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 540px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The cardinal movements (or mechanisms) of delivery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wolters Kluwer. Copyright &copy;2009.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18472=[""].join("\n");
var outline_f18_2_18472=null;
var title_f18_2_18473="Major side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers";
var content_f18_2_18473=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Major side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/2/18473/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/2/18473/contributors\">",
"     Norman M Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/2/18473/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/2/18473/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/2/18473/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/2/18473/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/2/18473/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are widely used in the treatment of hypertension, chronic kidney disease, and heart failure. In addition to efficacy, these agents have the additional advantage of being particularly well tolerated, since they produce few idiosyncratic side effects and do not have the adverse effects on lipid and glucose metabolism seen with higher doses of diuretics or beta blockers [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44659?source=see_link\">",
"     \"Antihypertensive drugs and lipids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The specific side effects that are observed with ACE inhibitors and ARBs will be reviewed here. The use of these drugs in disorders such as hypertension, heart failure, and proteinuric chronic kidney disease are discussed elsewhere.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ACE INHIBITORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although high dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    therapy was initially associated with a variety of presumed sulfhydryl group-related complications such as rash, neutropenia, taste abnormalities, and even the nephrotic syndrome, these problems have become uncommon since the maximum dose was reduced to 100 to 150",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    and particularly with the use of other ACE inhibitors.",
"   </p>",
"   <p>",
"    The side effects that do occur are primarily related directly or indirectly to reduced angiotensin II formation. These include hypotension, acute renal failure, hyperkalemia, and problems during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/1\">",
"     1",
"    </a>",
"    ]. There are other complications &mdash; cough, angioedema, and anaphylactoid reactions &mdash; that are thought to be related to increased kinins since ACE is also a kininase (see below). This is an important distinction clinically because the side effects related to reduced angiotensin II, but not those related to kinins, are also seen with the ARBs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/40/25224?source=see_link\">",
"     \"Renin-angiotensin system inhibition in the treatment of hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weakness, dizziness, or syncope may result from an excessive reduction in blood pressure. In the ONTARGET trial, hypotensive symptoms sufficient to discontinue the drug occurred in 1.7 percent of the 8576 patients who received",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"     ramipril",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/38/27239?source=see_link\">",
"     telmisartan",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"     3",
"    </a>",
"    ]. First dose hypotension, which can be marked in hypovolemic patients with high baseline renin levels, can be minimized by not beginning therapy if the patient is volume depleted and by discontinuing prior diuretic therapy for three to five days. Hypotension can also occur after the initiation of therapy in patients with congestive heart failure [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/4\">",
"     4",
"    </a>",
"    ]. The risk can be minimized by beginning with a very low dose, such as 2.5 mg BID of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/19/8505?source=see_link\">",
"     enalapril",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29031?source=see_link\">",
"     \"Treatment of hypertension in patients with heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Reduction in GFR",
"    </span>",
"    &nbsp;&mdash;&nbsp;A reduction in glomerular filtration rate (GFR), that is usually modest but may be severe, is observed in some patients treated with ACE inhibitors who have bilateral renal artery stenosis, hypertensive nephrosclerosis, heart failure, polycystic kidney disease, or chronic kidney disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. As an example, an elevation in serum creatinine sufficiently severe to warrant discontinuation of the drug occurred in 0.7 percent of the patients who received",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"     ramipril",
"    </a>",
"    in the ONTARGET trial of patients with vascular disease or high risk diabetes, and a doubling of the serum creatinine occurred in 1.9 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19398?source=see_link\">",
"     \"Renal effects of ACE inhibitors in hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10069?source=see_link\">",
"     \"Renal effects of ACE inhibitors in heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30582?source=see_link\">",
"     \"Hypertension in autosomal dominant polycystic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In each of these disorders, intrarenal perfusion pressure is already reduced, a setting in which maintenance of glomerular filtration rate is maintained in part by an angiotensin II-induced increase in resistance at the efferent (postglomerular) arteriole. Blocking this response with an ACE inhibitor will sequentially relax the efferent arteriole, lower intraglomerular pressure, and reduce the glomerular filtration rate [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/7\">",
"     7",
"    </a>",
"    ]. Patients with acute volume loss due to vomiting",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diarrhea may be particularly susceptible [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rise in the serum creatinine concentration generally begins a few days after the institution of therapy, since angiotensin II levels are rapidly reduced. Thus, renal function should be checked at three to five days when an ACE inhibitor is begun in a patient who has renal artery stenosis or who is at high risk for this problem (as in an older patient with severe hypertension and atherosclerotic vascular disease) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/17/31001?source=see_link\">",
"     \"Establishing the diagnosis of renovascular hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Even with optimal management, some patients are unable to tolerate the administration of ACE inhibitors. Termination of the ACE inhibitor should be considered if hyperkalemia cannot be controlled (see next section) or the serum creatinine concentration increases more than 30 percent above the baseline value within the first six to eight weeks when blood pressure is reduced. Such a decline in renal function is uncommon if the patient is not volume depleted, diuretics have been transiently withheld prior to initiation of therapy, and the patient does not have bilateral renovascular disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=see_link\">",
"     \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another rare cause of acute renal failure that is of unproven relation to ACE inhibitors is the development of renal artery thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/10\">",
"     10",
"    </a>",
"    ]. This complication appears to occur most often in patients with marked (&ge;95 percent) stenotic lesions who have an excessive reduction in blood pressure. It is therefore unclear if there is any specific predisposing effect of the ACE inhibitor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hyperkalemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiotensin II and an elevation in the plasma potassium concentration are the major factors that increase the release of aldosterone, which is the major hormonal stimulus to urinary potassium excretion. In addition to the direct effect of systemic angiotensin II, angiotensin II generated locally within the adrenal zona glomerulosa may mediate the potassium-induced stimulation of aldosterone [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/11\">",
"     11",
"    </a>",
"    ]. Blocking both of these actions with an ACE inhibitor will reduce aldosterone secretion, thereby impairing the efficiency of urinary potassium excretion.",
"   </p>",
"   <p>",
"    The overall incidence of hyperkalemia (defined as a serum potassium concentration above 5.5",
"    <span class=\"nowrap\">",
"     meq/L)",
"    </span>",
"    in patients treated with an ACE inhibitor or ARB is approximately 3.3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"     3",
"    </a>",
"    ]. However, there is a marked variability in risk. ACE inhibitors generally raise the serum potassium concentration by less than 0.5",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in patients with relatively normal renal function. More prominent hyperkalemia may be seen in patients with renal insufficiency, diabetes, concurrent use of a drug promoting potassium retention such as a potassium-sparing diuretic or a nonsteroidal antiinflammatory drug, or among the elderly [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/12-14\">",
"     12-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with moderately severe to severe heart failure represent a setting in which multiple factors can contribute to the development of hyperkalemia. These include decreased renal perfusion due to the fall in cardiac output and often combined therapy with an aldosterone antagonist (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5031?source=see_link\">",
"     eplerenone",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28521?source=see_link&amp;anchor=H8#H8\">",
"     \"Use of aldosterone antagonists in heart failure\", section on 'Risk of hyperkalemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is also an increased risk of hyperkalemia among chronic hemodialysis patients who are treated with an ACE inhibitor or ARB. This was shown in a prospective study of 251 hemodialysis patient in which there was an association between a predialysis serum potassium concentration of &ge;5.5",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    and the use of an ACE inhibitor or ARB [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/16\">",
"     16",
"    </a>",
"    ]. Use of these agents was associated with an increased risk of hyperkalemia (odds ratio of 2.2, 95% CI 1.4-3.4), which was observed in patients with and without residual renal function. Dietary measures were the only intervention required to manage the hyperkalemia. Anuria appears to be particularly associated with an increased risk [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?41/41/42640?source=see_link\">",
"     \"Patient information: Low potassium diet (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Only one study has assessed the effect on potassium levels of angiotensin blockade in peritoneal dialysis patients. In this report of 29 stable normokalemic peritoneal dialysis patients, the risk of hyperkalemia with either an ACE inhibitor or an ARB was principally observed among those undergoing inadequate dialysis",
"    <span class=\"nowrap\">",
"     (Kt/V",
"    </span>",
"    less than 2.0), or with low solute transport characteristics [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are multiple mechanisms by which angiotensin II inhibition can lead to hyperkalemia in patients with end-stage renal disease: decreased urinary potassium excretion in patients with residual renal function; decreased colonic excretion which accounts for a significant percentage of total potassium loss in such patients; and relatively decreased clearance of potassium in those with inadequate dialysis (and low solute transport with peritoneal dialysis) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among hemodialysis patients first receiving an ACE inhibitor or an ARB, measurement of the serum potassium concentration every week should be performed for one month [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/20\">",
"     20",
"    </a>",
"    ]. Once stable, monthly measurements are recommended.",
"   </p>",
"   <p>",
"    Among patients with chronic kidney disease who are not dialysis dependent, issues surrounding the use of ACE inhibitors and hyperkalemia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=see_link\">",
"     \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cough",
"    </span>",
"    &nbsp;&mdash;&nbsp;A dry, hacking cough has been described in 5 to 20 percent of patients treated with an ACE inhibitor [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/21\">",
"     21",
"    </a>",
"    ]. The best data come from a meta-analysis of 29 trials in which cough was noted in 9.9 percent of patients treated with ACE inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. In the ONTARGET trial, cough sufficiently severe to discontinue the drug was observed in 4.2 percent of the patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"     ramipril",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"     3",
"    </a>",
"    ]. Cough is much less common with ARBs. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Angiotensin II receptor blockers'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The cough has the following clinical features:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      It usually begins within one to two weeks of instituting therapy, but can be delayed up to six months",
"     </li>",
"     <li>",
"      Women are affected more frequently than men",
"     </li>",
"     <li>",
"      Chinese, at least in Hong Kong, have a high prevalence that approaches 50 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      It typically resolves within one to four days of discontinuing therapy, but can take up to four weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/25\">",
"       25",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      It generally recurs with rechallenge, either with the same or a different ACE inhibitor",
"     </li>",
"     <li>",
"      It does not occur more frequently in patients with asthma but it may be accompanied by bronchospasm [",
"      <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/26\">",
"       26",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The mechanism responsible for the ACE inhibitor-induced cough is not known, but increased local concentrations of kinins, substance P, prostaglandins, or thromboxane may be important:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Both kinins and substance P are metabolized by converting enzyme; thus, their levels are increased by converting enzyme inhibition [",
"      <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/21\">",
"       21",
"      </a>",
"      ]. Kinins, for example, may induce bronchial irritation and cough via enhanced production of prostaglandins, which may then stimulate afferent C-fibers in the airway.",
"     </li>",
"     <li>",
"      Activation of the arachidonic acid pathway with ACE inhibition may also lead to elevated levels of thromboxane, which can potentiate bronchoconstriction. The possible role of thromboxane in ACE inhibitor-induced cough was evaluated in a double-blind crossover study of nine patients who had developed cough while taking",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/19/8505?source=see_link\">",
"       enalapril",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/27\">",
"       27",
"      </a>",
"      ]. The patients were treated with placebo or picotamide (600 mg BID), an agent that inhibits thromboxane synthetase and antagonizes the thromboxane receptor. Active therapy resulted in a significant reduction in thromboxane levels and stopped the cough in eight of the nine patients within 72 hours. Inadequate absorption of picotamide occurred in the one nonresponder.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nonsteroidal antiinflammatory drugs and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    can reportedly improve the cough related to ACE inhibitor [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/28-32\">",
"     28-32",
"    </a>",
"    ]. However, these have not been studied in large trials, and some may increase the risk of hyperkalemia, in particular among individuals with decreased kidney function.",
"   </p>",
"   <p>",
"    It remains unclear why cough occurs only in some patients treated with ACE inhibitors. It has been suggested that genetic factors may be important. However, common genetic variants for angiotensin converting enzyme, the B2 bradykinin receptor, or chymase (another enzyme that can convert angiotensin I to angiotensin II) do not explain the variation in susceptibility to cough .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5361360\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the ACE inhibitor is discontinued, improvement often begins within four to seven days [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/21\">",
"     21",
"    </a>",
"    ]. Readministration of an ACE inhibitor is associated with a high rate of recurrent cough (67 percent in a randomized trial) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who have had a good antihypertensive response to the ACE inhibitor can be switched to an angiotensin II receptor blocker, since these drugs are associated with a much lower rate of cough than ACE inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Angioedema and anaphylactoid reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angioedema is a rare but potentially fatal complication of ACE inhibitors that, in the largest clinical trial (ONTARGET), occurred in 0.3 percent of the more than 8500 patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"     ramipril",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"     3",
"    </a>",
"    ]. Half of 111 patients with an initial episode of angioedema while taking an ACE inhibitor had recurrent angioedema after the drug was discontinued, suggesting an underlying mechanism unrelated to the ACE inhibitor [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/35\">",
"     35",
"    </a>",
"    ]. The pathogenesis of ACE inhibitor-induced angioedema and the treatment of this condition are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38391?source=see_link&amp;anchor=H11#H11\">",
"     \"An overview of angioedema: Pathogenesis and causes\", section on 'ACE inhibitors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15641?source=see_link&amp;anchor=H25#H25\">",
"     \"An overview of angioedema: Clinical features, diagnosis, and management\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anaphylactoid reactions are also seen when ACE inhibitors are used in patients treated with high-flux hemodialysis using polyacrylonitrile (PAN) dialyzers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4295?source=see_link&amp;anchor=H3#H3\">",
"     \"Reactions to the hemodialysis membrane\", section on 'Type A reactions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Contraindication in pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;ACE inhibitors are contraindicated in pregnancy, since they are associated with an increased incidence of fetal complications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/32/1543?source=see_link\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Overdose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Manifestations of ACE inhibitor overdosing are usually mild [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/36\">",
"     36",
"    </a>",
"    ]. If, however, severe hypotension occurs, intravenous fluids and inotropic support may be required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ANGIOTENSIN II RECEPTOR BLOCKERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ARBs are typically well tolerated [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/37\">",
"     37",
"    </a>",
"    ]. The side effect profile is generally similar to that seen with ACE inhibitors (eg, increased incidence of hyperkalemia and of acute renal failure in renovascular hypertension or states of effective volume depletion) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3,16,38,39\">",
"     3,16,38,39",
"    </a>",
"    ]. The rate of certain side effects (eg, renal dysfunction, syncope) appears to be similar with the two classes of drugs; however, ARBs have lower rates of cough and angioedema and perhaps a higher rate of hypotensive symptoms than ACE inhibitors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Incidence of cough with ARBs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of cough is lower in patients treated with ARBs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"     3",
"    </a>",
"    ]. The magnitude of this difference was illustrated in a 2008 meta-analysis of 29 trials that directly compared the rate of cough in ARBs and ACE inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/34\">",
"     34",
"    </a>",
"    ]. The respective rates of cough were 3.2 and 9.9 percent, although there was significant statistical heterogeneity among studies.",
"   </p>",
"   <p>",
"    Similar findings were noted in the ONTARGET trial [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"     3",
"    </a>",
"    ]. Cough severe enough to require permanent discontinuation was significantly less common with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/38/27239?source=see_link\">",
"     telmisartan",
"    </a>",
"    (1.1 versus 4.2 percent with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"     ramipril",
"    </a>",
"    , relative risk 0.26).",
"   </p>",
"   <p>",
"    This benefit of ARBs also applies to patients with a prior history of ACE inhibitor-induced cough. This was illustrated in a randomized trial in which 135 such patients were randomly assigned to repeat therapy with an ACE inhibitor (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/58/937?source=see_link\">",
"     lisinopril",
"    </a>",
"    ),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/4/31815?source=see_link\">",
"     valsartan",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/4/8263?source=see_link\">",
"     hydrochlorothiazide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/40\">",
"     40",
"    </a>",
"    ]. The rate of recurrent cough was much higher with readministration of an ACE inhibitor (67 versus 19 percent with the other drugs).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Angioedema",
"    </span>",
"    &nbsp;&mdash;&nbsp;The protection of ARBs against side effects thought to be mediated by kinins is not absolute. Angioedema, typically characterized by swelling of the mouth, tongue, pharynx, and eyelids, and occasionally laryngeal obstruction, has been reported with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"     losartan",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/4/31815?source=see_link\">",
"     valsartan",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of angioedema appears to be lower with ARBs than ACE inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"     3",
"    </a>",
"    ]. The best comparative data come from the ONTARGET trial cited above in which the risk of angioedema was significantly lower in the more than 8500 patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/38/27239?source=see_link\">",
"     telmisartan",
"    </a>",
"    compared to a similar number treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"     ramipril",
"    </a>",
"    (eg, 0.1 versus 0.3 percent, relative risk 0.4) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"     3",
"    </a>",
"    ]. The pathogenesis of angioedema with ARBs is unclear but an increase in tissue bradykinin levels, or nonkinin factors may be involved. The pathogenesis of ARB-induced angioedema and the treatment of this condition are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38391?source=see_link&amp;anchor=H12#H12\">",
"     \"An overview of angioedema: Pathogenesis and causes\", section on 'Angiotensin II receptor blockers'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15641?source=see_link&amp;anchor=H25#H25\">",
"     \"An overview of angioedema: Clinical features, diagnosis, and management\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ARBs appear be safe in patients with symptomatic asthma. In one report,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/48/38663?source=see_link\">",
"     candesartan",
"    </a>",
"    did not induce cough or worsen bronchial hyperreactivity in such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2021?source=see_link\">",
"     \"Treatment of hypertension in asthma and COPD\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypotension appears to be more common with ARBs than ACE inhibitors. The magnitude of this effect was illustrated in the ONTARGET trial cited above in which hypotensive symptoms severe enough to require permanent discontinuation occurred significantly more often with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/38/27239?source=see_link\">",
"     telmisartan",
"    </a>",
"    (2.7 versus 1.7 percent with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"     ramipril",
"    </a>",
"    , relative risk 1.54).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Avoid in pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;As are ACE inhibitors, ARBs are contraindicated in pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. An additional concern is that AT1 receptor blockade results in the disinhibition of renin release by angiotensin II and increased formation of all angiotensin peptides [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/37\">",
"     37",
"    </a>",
"    ]. These peptides could activate the AT2 receptor, which is highly expressed in the fetus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8990691\">",
"    <span class=\"h2\">",
"     Lack of cancer and myocardial infarction risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 2010 meta-analysis of five trials of almost 62,000 patients suggested that patients treated with ARBs had a significantly increased risk of new cancers compared with patients in control groups (7.2 versus 6.0 percent, risk ratio 1.08, 95% CI 1.01-1.15) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/46\">",
"     46",
"    </a>",
"    ]. However, two subsequent meta-analyses failed to confirm this finding [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. One of these studies included 15 trials of almost 140,000 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/48\">",
"     48",
"    </a>",
"    ]. The cancer incidence was similar in patients treated with ARBs and controls, some of whom were treated with ACE inhibitors (6.2 versus 6.3 percent, odds ratio 1.00, 95% CI 0.95-1.04).",
"   </p>",
"   <p>",
"    In June of 2011, the Food and Drug Administration in the United States reviewed the available data and concluded that the use of ARBs for the treatment of hypertension does",
"    <strong>",
"     not",
"    </strong>",
"    increase the risk of cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/49\">",
"     49",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    The issue of cancer risk in patients receiving combination therapy with ACE inhibitors and ARBs is discussed below. (See",
"    <a class=\"local\" href=\"#H140142902\">",
"     'Possible increased risk of cancer'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A 2004 report suggested an increased risk of myocardial infarction among users of ARBs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/50\">",
"     50",
"    </a>",
"    ]. However, a subsequent meta-analysis of data from 37 randomized controlled trials showed no increase in risk [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ACE INHIBITORS VERSUS ARBS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best comparative data regarding the incidence of side effects observed with ACE inhibitors and ARBs come from the randomized ONTARGET trial of over 25,000 patients at high risk for cardiovascular events (diabetes or vascular disease), which compared",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/38/27239?source=see_link\">",
"     telmisartan",
"    </a>",
"    to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"     ramipril",
"    </a>",
"    or both drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/47/20218?source=see_link&amp;anchor=H16#H16\">",
"     \"Choice of therapy in essential hypertension: Clinical trials\", section on 'ONTARGET trial'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In terms of side effects, ONTARGET primarily presented data related to adverse effects of sufficient severity to require permanent discontinuation of the drug. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"       Ramipril",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/38/27239?source=see_link\">",
"       telmisartan",
"      </a>",
"      had similar rates of hyperkalemia, defined as a serum potassium greater than 5.5",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      (3.3 and 3.4 percent), acute renal failure, defined as a doubling of the serum creatinine (1.9 and 2.0 percent), and syncope requiring drug discontinuation (0.2 percent with both drugs).",
"     </li>",
"     <li>",
"      The rate of drug discontinuation (including episodes that were not permanent) was modestly but significantly lower with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/38/27239?source=see_link\">",
"       telmisartan",
"      </a>",
"      than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"       ramipril",
"      </a>",
"      (23 versus 24.5 percent, relative risk 0.94) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"       Ramipril",
"      </a>",
"      was associated with significantly higher rates of cough (4.2 versus 1.1 percent) and angioedema (0.3 versus 0.1 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/38/27239?source=see_link\">",
"       Telmisartan",
"      </a>",
"      was associated with a significantly higher rate of symptomatic hypotension (2.6 versus 1.7 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     COMBINATION OF ACE INHIBITORS AND ARBS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have demonstrated that patients who are treated with both an ACE inhibitor and an ARB are at higher risk for adverse effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H140142945\">",
"    <span class=\"h2\">",
"     Increased adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The supportive data on increased adverse effects come from the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The ONTARGET trial described in the preceding section evaluated",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"       ramipril",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/38/27239?source=see_link\">",
"       telmisartan",
"      </a>",
"      , and combination therapy in over 25,000 patients at high risk for cardiovascular events (diabetes or vascular disease). Combined therapy compared to ramipril alone was associated with significant increases in the following adverse effects that were severe enough to require drug discontinuation: hypotensive symptoms (4.8 versus 1.7 percent), syncope (0.3 versus 0.2 percent), and renal dysfunction (1.1 versus 0.7 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/3,52\">",
"       3,52",
"      </a>",
"      ]. There was also a significant increase in hyperkalemia, defined as a serum potassium above 5.5",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      (5.7 versus 3.3 percent) and an almost significant increase in overall mortality (12.5 versus 11.8 percent with ramipril alone, risk ratio 1.07, 95% CI 0.98-1.16).",
"     </li>",
"     <li>",
"      An increased incidence of adverse events with combination therapy was also demonstrated in a meta-analysis of four randomized trials that compared 17,337 patients with chronic heart failure who received either an ACE inhibitor alone or the combination of an ACE inhibitor and an ARB [",
"      <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/14\">",
"       14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/45/16090?source=see_link\">",
"       \"ACE inhibitors in heart failure due to systolic dysfunction: Therapeutic use\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2680?source=see_link\">",
"       \"Angiotensin II receptor blockers in heart failure due to systolic dysfunction: Therapeutic use\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Compared with patients who received an ACE inhibitor alone, those treated with both agents had significantly higher rates of the following complications: increased medication discontinuation due to adverse effects (15 versus 11 percent); worsening renal function, defined as an increase in creatinine of 0.5",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (44.2",
"      <span class=\"nowrap\">",
"       micromol/L)",
"      </span>",
"      or more over baseline (3.3 versus 1.5 percent); hyperkalemia (3.5 versus 0.7 percent); and symptomatic hypotension (2.4 versus 1.5 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H140142902\">",
"    <span class=\"h3\">",
"     Possible increased risk of cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a meta-analysis of trials of antihypertensive drugs, combination therapy with ARBs and ACE inhibitors compared with ACE inhibitors alone was associated with a significant increase in cancer incidence among 28,168 patients from two trials (2.3 versus 2.0 percent; RR 1.14, 95% CI 1.02-1.28) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, a second meta-analysis that included these two trials as well as five others found similar rates of cancer incidence in patients treated with combination therapy compared with ACE inhibitors alone (5.33 versus 5.26 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/48\">",
"     48",
"    </a>",
"    ]. However, there was significant heterogeneity among the seven trials. The cancer incidence tended to be higher with combination therapy in three trials (at a mean follow-up of 48 months), and somewhat lower with combination therapy in the other four trials (at a mean follow-up of 32 months).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H140142921\">",
"    <span class=\"h2\">",
"     Conclusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon the clear evidence of possible harm, combined ACE",
"    <span class=\"nowrap\">",
"     inhibitor/ARB",
"    </span>",
"    therapy should",
"    <strong>",
"     not",
"    </strong>",
"    be considered unless there is compelling evidence of clinical benefit that cannot be attained with other regimens [",
"    <a class=\"abstract\" href=\"UTD.htm?18/2/18473/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/30/483?source=see_link\">",
"       \"Patient information: Dealing with side effects from medicines (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H939716\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Side effects that occur with ACE inhibitors are related to either reduced angiotensin II formation or increased kinins. Those related to reduced angiotensin II formation include hypotension, acute renal failure, hyperkalemia, and problems during pregnancy. Side effects thought to be related, at least in part, to increased kinins include cough, angioedema, and anaphylactoid reactions. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'ACE inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hyperkalemia and renal failure may require termination of the ACE inhibitor. Termination should be considered if hyperkalemia cannot be controlled or the serum creatinine concentration increases more than 30 percent above the baseline value within the first six to eight weeks when blood pressure is reduced. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Reduction in GFR'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Hyperkalemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      ARBs are associated with lower rates of cough and angioedema and a higher rate of hypotensive symptoms. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Angiotensin II receptor blockers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A dry cough occurs in 5 to 20 percent of patients treated with an ACE inhibitor and approximately one third as many patients treated with an angiotensin II receptor blocker (ARB). Treatment consists of lowering the dose or discontinuing the drug. Readministration of the drug is associated with a high rate of recurrent cough. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Cough'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Incidence of cough with ARBs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Angioedema is a rare but potentially fatal complication of ACE inhibitors. Angioedema may also occur with ARBs but the risk is lower. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Angioedema and anaphylactoid reactions'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Angioedema'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who are on both an ACE inhibitor and an ARB are at higher risk for adverse effects. Thus, combined therapy should",
"      <strong>",
"       not",
"      </strong>",
"      be considered in the treatment of hypertension or other disorders unless there is compelling evidence of benefit. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Combination of ACE inhibitors and ARBs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Angiotensin converting enzyme (ACE) inhibitors and ARBs are contraindicated in pregnancy. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Avoid in pregnancy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Izzo JL,Weir MR.Angiotensin-converting enzyme inhibitors.J Clin Hypertens 2011;13:667.",
"    </li>",
"    <li>",
"     Taylor AA,Siragy H,Nesbitt S.Angiotensin receptor blockers:pharmacology,efficacy,and safety.J Clin Hypertens.2011;13:677.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/3\">",
"      ONTARGET Investigators, Yusuf S, Teo KK, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358:1547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/4\">",
"      Kostis JB, Shelton B, Gosselin G, et al. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators. Am Heart J 1996; 131:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/5\">",
"      Toto RD, Mitchell HC, Lee HC, et al. Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis. Ann Intern Med 1991; 115:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/6\">",
"      Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 2000; 160:685.",
"     </a>",
"    </li>",
"    <li>",
"     Rose, BD, Post, TW, Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/8\">",
"      Stirling C, Houston J, Robertson S, et al. Diarrhoea, vomiting and ACE inhibitors:--an important cause of acute renal failure. J Hum Hypertens 2003; 17:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/9\">",
"      Choudhri AH, Cleland JG, Rowlands PC, et al. Unsuspected renal artery stenosis in peripheral vascular disease. BMJ 1990; 301:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/10\">",
"      Hannedouche T, Godin M, Fries D, Fillastre JP. Acute renal thrombosis induced by angiotensin-converting enzyme inhibitors in patients with renovascular hypertension. Nephron 1991; 57:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/11\">",
"      Kifor I, Moore TJ, Fallo F, et al. Potassium-stimulated angiotensin release from superfused adrenal capsules and enzymatically dispersed cells of the zona glomerulosa. Endocrinology 1991; 129:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/12\">",
"      Reardon LC, Macpherson DS. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? Arch Intern Med 1998; 158:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/13\">",
"      Desai AS, Swedberg K, McMurray JJ, et al. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program. J Am Coll Cardiol 2007; 50:1959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/14\">",
"      Phillips CO, Kashani A, Ko DK, et al. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials. Arch Intern Med 2007; 167:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/15\">",
"      Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004; 351:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/16\">",
"      Knoll GA, Sahgal A, Nair RC, et al. Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients. Am J Med 2002; 112:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/17\">",
"      Han SW, Won YW, Yi JH, Kim HJ. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients. Nephrol Dial Transplant 2007; 22:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/18\">",
"      Phakdeekitcharoen B, Leelasa-nguan P. Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients. Am J Kidney Dis 2004; 44:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/19\">",
"      Panese S, M&aacute;rtin RS, Virginillo M, et al. Mechanism of enhanced transcellular potassium-secretion in man with chronic renal failure. Kidney Int 1987; 31:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/20\">",
"      H&ouml;rl MP, H&ouml;rl WH. Drug therapy for hypertension in hemodialysis patients. Semin Dial 2004; 17:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/21\">",
"      Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992; 117:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/22\">",
"      Wood R. Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study. Br J Clin Pharmacol 1995; 39:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/23\">",
"      Bangalore S, Kumar S, Messerli FH. Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference. Am J Med 2010; 123:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/24\">",
"      Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol 1995; 40:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/25\">",
"      Yeo WW, Chadwick IG, Kraskiewicz M, et al. Resolution of ACE inhibitor cough: changes in subjective cough and responses to inhaled capsaicin, intradermal bradykinin and substance-P. Br J Clin Pharmacol 1995; 40:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/26\">",
"      Lunde H, Hedner T, Samuelsson O, et al. Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ 1994; 308:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/27\">",
"      Malini PL, Strocchi E, Zanardi M, et al. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. Lancet 1997; 350:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/28\">",
"      Gilchrist NL, Richards AM, March R, Nicholls MG. Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study. J Hum Hypertens 1989; 3:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/29\">",
"      Dicpinigaitis PV. Use of baclofen to suppress cough induced by angiotensin-converting enzyme inhibitors. Ann Pharmacother 1996; 30:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/30\">",
"      Tenenbaum A, Grossman E, Shemesh J, et al. Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough. Am J Hypertens 2000; 13:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/31\">",
"      Dykewicz MS. Cough and angioedema from angiotensin-converting enzyme inhibitors: new insights into mechanisms and management. Curr Opin Allergy Clin Immunol 2004; 4:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/32\">",
"      Fogari R, Zoppi A, Tettamanti F, et al. Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study. J Cardiovasc Pharmacol 1992; 19:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/33\">",
"      Goldberg AI, Dunlay MC, Sweet CS. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol 1995; 75:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/34\">",
"      Matchar DB, McCrory DC, Orlando LA, et al. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med 2008; 148:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/35\">",
"      Beltrami L, Zanichelli A, Zingale L, et al. Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema. J Hypertens 2011; 29:2273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/36\">",
"      Lip GY, Ferner RE. Poisoning with anti-hypertensive drugs: angiotensin converting enzyme inhibitors. J Hum Hypertens 1995; 9:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/37\">",
"      Burnier M, Brunner HR. Angiotensin II receptor antagonists. Lancet 2000; 355:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/38\">",
"      Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 2004; 351:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/39\">",
"      Lee HY, Kim CH. Acute oliguric renal failure associated with angiotensin II receptor antagonists. Am J Med 2001; 111:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/40\">",
"      Lacourci&egrave;re Y, Brunner H, Irwin R, et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group. J Hypertens 1994; 12:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/41\">",
"      van Rijnsoever EW, Kwee-Zuiderwijk WJ, Feenstra J. Angioneurotic edema attributed to the use of losartan. Arch Intern Med 1998; 158:2063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/42\">",
"      Irons BK, Kumar A. Valsartan-induced angioedema. Ann Pharmacother 2003; 37:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/43\">",
"      Tanaka H, Teramoto S, Oashi K, et al. Effects of candesartan on cough and bronchial hyperresponsiveness in mildly to moderately hypertensive patients with symptomatic asthma. Circulation 2001; 104:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/44\">",
"      Saji H, Yamanaka M, Hagiwara A, Ijiri R. Losartan and fetal toxic effects. Lancet 2001; 357:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/45\">",
"      Serreau R, Luton D, Macher MA, et al. Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases. BJOG 2005; 112:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/46\">",
"      Sipahi I, Debanne SM, Rowland DY, et al. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol 2010; 11:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/47\">",
"      Bangalore S, Kumar S, Kjeldsen SE, et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol 2011; 12:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/48\">",
"      ARB Trialists Collaboration. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals. J Hypertens 2011; 29:623.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm257670.htm (Accessed on June 15, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/50\">",
"      Verma S, Strauss M. Angiotensin receptor blockers and myocardial infarction. BMJ 2004; 329:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/51\">",
"      Bangalore S, Kumar S, Wetterslev J, Messerli FH. Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials. BMJ 2011; 342:d2234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/52\">",
"      Mann JF, Schmieder RE, McQueen M, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008; 372:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/2/18473/abstract/53\">",
"      Holdiness A, Monahan K, Minor D, de Shazo RD. Renin Angiotensin Aldosterone System Blockade: Little to No Rationale for ACE Inhibitor and ARB Combinations. Am J Med 2011; 124:15.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3816 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-5682FA82D5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18473=[""].join("\n");
var outline_f18_2_18473=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H939716\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ACE INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hypotension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Reduction in GFR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hyperkalemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cough",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5361360\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Angioedema and anaphylactoid reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Contraindication in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Overdose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ANGIOTENSIN II RECEPTOR BLOCKERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Incidence of cough with ARBs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Angioedema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Hypotension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Avoid in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8990691\">",
"      Lack of cancer and myocardial infarction risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ACE INHIBITORS VERSUS ARBS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      COMBINATION OF ACE INHIBITORS AND ARBS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H140142945\">",
"      Increased adverse effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H140142902\">",
"      - Possible increased risk of cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H140142921\">",
"      Conclusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H939716\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/45/16090?source=related_link\">",
"      ACE inhibitors in heart failure due to systolic dysfunction: Therapeutic use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15641?source=related_link\">",
"      An overview of angioedema: Clinical features, diagnosis, and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38391?source=related_link\">",
"      An overview of angioedema: Pathogenesis and causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2680?source=related_link\">",
"      Angiotensin II receptor blockers in heart failure due to systolic dysfunction: Therapeutic use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/32/1543?source=related_link\">",
"      Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44659?source=related_link\">",
"      Antihypertensive drugs and lipids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=related_link\">",
"      Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/47/20218?source=related_link\">",
"      Choice of therapy in essential hypertension: Clinical trials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/17/31001?source=related_link\">",
"      Establishing the diagnosis of renovascular hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30582?source=related_link\">",
"      Hypertension in autosomal dominant polycystic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/30/483?source=related_link\">",
"      Patient information: Dealing with side effects from medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/41/42640?source=related_link\">",
"      Patient information: Low potassium diet (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4295?source=related_link\">",
"      Reactions to the hemodialysis membrane",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10069?source=related_link\">",
"      Renal effects of ACE inhibitors in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19398?source=related_link\">",
"      Renal effects of ACE inhibitors in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/40/25224?source=related_link\">",
"      Renin-angiotensin system inhibition in the treatment of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2021?source=related_link\">",
"      Treatment of hypertension in asthma and COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29031?source=related_link\">",
"      Treatment of hypertension in patients with heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28521?source=related_link\">",
"      Use of aldosterone antagonists in heart failure",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_2_18474="Microcystic adnexal carcinoma tumor cells";
var content_f18_2_18474=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Microcystic adnexal carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nests and cords of tumor cells of microcystic adnexal carcinoma are present in the dermis. Note the lack of epidermal involvement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18474=[""].join("\n");
var outline_f18_2_18474=null;
var title_f18_2_18475="Frequency heparin thrombopenia";
var content_f18_2_18475=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F82161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F82161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Patient population, frequency of HIT-IgG antibodies, and clinical HIT",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Patient population",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Days of treatment",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Frequency of HIT antibodies",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Frequency of clinical HIT, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Activation assay, percent",
"       </td>",
"       <td class=\"subtitle2\">",
"        Antigen assay, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiac, UFH",
"       </td>",
"       <td>",
"        5.1 &plusmn; 2.2 (SD)",
"       </td>",
"       <td>",
"        20.0",
"       </td>",
"       <td>",
"        50.0",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Orthopedic, UFH",
"       </td>",
"       <td>",
"        9.2 &plusmn; 2.2",
"       </td>",
"       <td>",
"        9.3",
"       </td>",
"       <td>",
"        14.1",
"       </td>",
"       <td>",
"        4.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Orthopedic, LMWH",
"       </td>",
"       <td>",
"        9.5 &plusmn; 3.0",
"       </td>",
"       <td>",
"        3.2",
"       </td>",
"       <td>",
"        7.5",
"       </td>",
"       <td>",
"        0.9",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     UFH: unfractionated heparin; LMWH: low molecular weight heparin.",
"    </div>",
"    <div class=\"reference\">",
"     Modified after Warkentin, TE, et al. Blood 2000; 96:1703.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18475=[""].join("\n");
var outline_f18_2_18475=null;
var title_f18_2_18476="Prognostic factors in chronic intestinal pseudo-obstruction";
var content_f18_2_18476=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F86277&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F86277&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Prognostic factors in chronic intestinal pseudo-obstruction",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1\">",
"            Poor outcome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Myopathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Early/acute onset",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Urinary involvement",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Malrotation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Short bowel syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Surgery",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Total parenteral nutrition (TPN)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Findings on small intestinal manometry:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Hypomotility",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Absence of MMCs",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Intestinal phasic and tonic pressure \"bursts\"",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Inadequate intestinal response to a meal (fed pattern)",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1\">",
"            Good outcome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Gender (male)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            No vagal dysfunction or sympathetic dysfunction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Clinical response to cisapride",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Normal bowel diameter",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Findings on small intestinal manometry: presence of MMCs, motor response to octreotide",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MMCs: migrating motor complexes.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Stanghellini V, Cogliandro RF, De Giorgio R, et al. Natural history of intestinal failure induced by chronic idiopathic intestinal pseudo-obstruction. Transplant Proc 2010; 42:15.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18476=[""].join("\n");
var outline_f18_2_18476=null;
var title_f18_2_18477="Norm autoregulation cereb";
var content_f18_2_18477=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F67583&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F67583&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal autoregulation of cerebral blood flow",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 447px; height: 259px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18477=[""].join("\n");
var outline_f18_2_18477=null;
var title_f18_2_18478="Temperature pattern in relapsing fever";
var content_f18_2_18478=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64476&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64476&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Temperature pattern in two patients with relapsing fever",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 316px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18478=[""].join("\n");
var outline_f18_2_18478=null;
var title_f18_2_18479="Hyperacute rejection IF IgM";
var content_f18_2_18479=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F66537&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F66537&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Renal allograft biopsy showing hyperacute rejection with IgM by immunofluorescence microscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 236px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADsAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5joAJpKeo4FYoxY3FGKk46UqICaehPMRYoqR0C/dpnaiyGncTFLjOBQOtFOwx3lN6j86aykHmlBIzRu5OeaVhajcUEU8kEU2iwJiYope1FFhiYoxS0d6LBcTFGKXvS0WAbijFLR0NFguJil2n0opynmiwDdpyBTjEw54/OpFXcRyBSSN2FSTzMi2mkxTs04oeuKqxVyPHFGOKdjHajtRYY3FGKUUUWATFFLQaLAJijFL2oosAmKAM06kFFgEpcUU7rRYYzBowad3paLCGYowacaXFKwDMUYp1FOwxpopTRSYhKcPemU/+HFCJYA81KmAPWoh1pcnPJqmriaFc5NM/CpFAznPFG0FsA8etJOwk7EdLj8KcwAOAachUdadx3I9vWkqV8EHBqPGTihMExO9L609Y+eaGUdqLoLjMUUH0p8eD1oC5GKKc64NJRcdwoooPWgAoNBoFABQKKU0AKO1BX1pF4NOY5HpSBjR1FSvIOwqKihq4WTDOaQClpSOPagYKuelIVIFSxjjjrTGbJNF9Sb6jMUUpPWimMTFKBS4oxmgLjfrQKMUUyhKcKTtSikAd6KD70CgQUnOaKDSKF60oAJptL0piY1shqKG5oqWAlOHSm06miWIPWloHSkHWmA5SAaCfQ0n1FHvmgQD3pPrS0hplId19jSKcGjvT1G40iXoPQgnmnuARUTDawxShxn2qGuqIt2GspB5700cN7VYcqwGagxzwaadyk7gxyBSYxTwvGaafSmNMUDJFDKQcUKOae3vSuK5HijrSmjHNMY2lx3NKozQRigBOuKKXHNJQMUcDNIeRR75oA5oEFAHFKAcdKME8UBcAxAIpO1ABzVvTLCfULlYLdQXPOWOAPqamUlFXewpSUVd7DbTT7m8z9mieQj+6M1LPpV5ACZbaVFAySVNfRXw08OzaPo8cVzYQLO3JkD5LfpxXTa5pcMtoUmt0YMrKUZQMgjsfWvk6/FKp13TjC8e9z5qrn8oTfLC8V1ufIZQgZwaZXteofC3T9UjkHh68eK8T79tcDv8AWvMde8ManoVy0OpWrxFT16g/Q17uEzXDYp8sJe92ejPZwuY0MQvdevZmFSCnuu3vTK9JHeg7Uo4pKWgYvX60n8qOQKM0CEo604+1IOaRSAVL5ZC7iOKsfZQlqJ2OVz0qGeVSAFJJqVK+xlzcz90rv1opDzRTZoJT1Q8CmVadcR5PHHFK9iJMaUUA7qh78UZ780D+tUlYSQGjtzQOtFUUFB6UDmjvQAqjJp3IPFEQ3EAVaa1nCZCNt9ahySepEpJPUrODgUxeasH5UwRzUBHPFCYJi5yMZpMY+ope/NA6+lMYDPvSjHagDNOUZPvSYmwVeafJGR15q/pGmy3t+tumFJ5O41oaxoE9lciOEPcEjOUUnB9K55YiEZ8jephKvCM+RvU54Jml2c11Og+DNX1dpZXjNpZxDMtxOpVVHt6n2rs/C/wusdbuJo01sYjA+ZEHz59BmuTEZrhsPdzntvbX8jGpj6MJcjlr5ankeNo9qYRzkHmvoK7+CukQ2k8sN5eXMsY+WNSq5P1xXJf8K/tY2hkmjkSIybWjLbn61zUeIMHVu4N/cYvNaEHZ3PLEABBYZA7Z600jk4FfRV98IdFu7BhYJJaTNyju5Yg+49K8y8R/C/xDpE4SO1a8jbo8A3ce47VWEz7B4l8qlZ9np/wC8PmdCtre3rocGF4BFOAAwTXrfhP4XLDDHf8AiuRoYwQfsajkj/aI6fQV6Vp/gPwjPPBcWumW4CMGHJIJ9CCcVz4viTC4eVleXmtvvMamcUIz5Ie8/I+XQH2HCnB9quaVpF7qkpj0+0luHA5CLnFfWC6FplmZont4ZYHcsY5EUquew46Vbgn0Dw9ZBrOC2toj97KhQT615dTi26tSott7amCzhSumlFru7/glqfPnh74UatqLRtdyJaox+ZdpaRfqteoeFPhRY6FqQuDK91wCA4xj8K1Na8faFBMWhuojKDyI/wDGuM1D4uvbzOGgaTLYU87WXsc1xVMTm+YpqK5U+mxxSxGJxLlBpteSsmvnqeuTXKWjeVFErAjJY9QfrWffXUbXamSNtnG5h0FeLxfErUdQkMKLBECScldxxVK2+IWqf2usXmPIoOw9Cp/Cuenw7iVe9rpdzkqYDGVLxaSS1se8TWNvcTpPanZOOjr3+tLe6VHqsP2XVraKZf7xGax9E1m38uObzBCSBkOwAJ9q6SLVFmhZlAzjIxXi1VWpS06dTloSpN3qNxfboz5z+MngKPwtcw3en7jYTErg87G9PxrzDv7V9feN7Oy17Q5ra+bEbDIJGSrdiK+YvEnh6XTLyVIwZIkON6jpX6Dw7mrxNBUq799de59TlmYwq3pN6rbzRztLQRjqKP1r6Y9sKOhpy4zzTT1JoQgyaPpQaSkUTGZzFsYkj0qGlBpD14otYSVhD1ooPWikwEq04zEpJ/DvVWrDABBikyJEWM0D2oB5/wAacgyeKoQzHrR2pxGCaTtTuO4nFHvSjFFAzQ026gt8mSPc3Y1buNZDqwSPHGKxlI5pQPbisJUYOXMzCVGMpczHbt5y2aXbj6U0AA4pxyfarZYzGDSgDqaUClAp3C41eTxVuwsbi9uFhtYmkkboBWp4a8Lap4gnVNNtJJVyA0mMKv1NerReArXw80N9qkrSJDx5cXG4/wA68vG5pRwz9ne8n03PPxmYU8P7t7y7HOeGdDTQtQhn1aL7bKVDFI3JVPqR1Ne0WusaXb2tpLBb2sMUx2biu07vSuV0bXtGiup5r8pbxk4jR+OPpWTr/i7SYNZtp7OJbuKPlSxOFOeSBXyGLhWzCracHdL5enY+ZqTxGJnzWd/676I9P8SW0OseHntrb5JHBHJ7+v0rlfB/hVPCrySS3H2i7nGP3anCiqWneObh7oKbRGgblXjBOR6VY17VGgsF1UASXLrmG2kOFVc9SPWvPp4fE0YvDN2jL8TKrOs1yPRytt5EfiTxRqenapCSLa1sNwEn75Wdh7jtWjqGvaI0KXjXlpsGHDFstkc8Ac18+eJ9Wm1nWrm6kAjaRuY0+6uOOKylkZDjdx6V9LDhyEqcHJ8rS1sevHI1UhFzlZ9bH0naeNTqgMmlWN1dMvGeFUVS1HxN4is3VTHaQMVLhHBJwPfNeMReI7mzWJrMyWzBNjNGxG73pNS8U3V9E/m5aZ+spY5/AVnHh9KfuxXL56v/ACIjlNWM7x2/H8zttY+JV/qNo9qI4opTwzYrl9H8Z6tol2JLeVpYdxMq4yP/ANVcnEss84EeWdzgVoSadf6fPHuJiZhnIbt717EMuwtGLpKKs+h6awOHppwaWvf+rnrFj8QptTlHm2wTT9nzysDnd7Cs/wAba1aaxYRQ295tEXAjVT83r+tcdpupRROjXt004QZCgYH40zUvEMsl4ZbRIYo+gCIK4KeVwhWUqUbW+78UefDLYxrKVONrfd+KI7Kzlu7oxxgbcYLMfTvmobu0utNMiSxLKrAgYO4D3FQi8uAd8bMpPPFadnfpcRst2X84fx54Ir0pe0g77rsehL2kHfdGHpSTz3AiiAy3r2967XRfDzx3Fqzq0zB8+XDEecerVTstY0+1uZBbRKXUYWQqMGu80fxVDZackUNymSd7Bhkc9celcGYYmvb93Dc4cdia32IWuQeNJbFruKCDFuVjDMqjAB9DW14YvNtyk6M0kJjEOAeMjuBXAavcr4g1aeZ9sJXgLkfMexrrfAcH2V3t9QcneMxgjj868nE0FTwqjJ6pbHlYiiqeHV3quh6RNF5kO58bG4ANeYa0ltYaxNbahGpjuASHPQivTLa1Lgtlsfw5ORXmHxR025vQ7+WwMYwrg15eVOLrezlKyZyYJXqpS0UjyvxJplvFPO1oQVBOB7VzRFdZdWNza6cPPJ3qSCPY1zDAbm6Cv0fCTvC1726n3mEneNr3t1IunSk60vOaSuw6wNFFHU+1IoSg0UvemDGnrRQetFS9wEqTcSvWoxTqEiGKKepxUYoBNU1cVh7nJ4pnWjrQM0bAtBRQaBS+1AwXuamiTPXgVGvHWnoSD7VDIkSFMHrW7F4alu/Cr61ptwl19mYi+tVUiW1XOEkI/ijPTcOh4OMgnCznFdR8OodcbxNbSeHCVu1yGZhmMoRhlkB4KEZBB4IrKdSNKLnN2SM5TjBc0nocqFzjA616n8M/hncatHHq+uxNDpIOVRgQ0uP5CvWtH+GeiWtw2sWNrFG/+smtCN627dym7ny89O46E9CdLxN4mzYmwjeNWK7VQYAJr5HNc9qzaoYNaP7Xl5f59PU8XGZnHklGN1daPv8A5Lv1J7PUNL0jRmaCKO2sbZeNq4XivJ/F3xThkuJDptojyHgSSc7fcCsHxd441R9Mm0Z0iihJ2uVHJAPSvO2O8nLYxSyrh+CbrYnVt6a9PMzweAlXgnitUtkSahey3l280jEu5yee9LHLK+AM5qkw+bParumnAZzkqOoNfWSiox0Wx7coqEbJbHf/AAx8RWunXd3Hrry+VKFdDt3DcvqKpfEjxJb6vf4snkeIDALDbgemKwUmyheMAkDA9hWNO7SuW49K82lgKbxLxNtfwPPpYKnLEPEWsyPJ7cU6OJmBZuFFCjAJJFNMrcDsK9TXoeo79CxNIWAjdMEdOaZbxNPL5UaZkPQVXMjBwwJznqaltLh7e4WZMFkORnkUuVqPukuLSfKXLFVibzZSUCnt1Jpt5qEly5yWK9snmqTu0jsSeWO6uh8M+GL7XJd1vEVgUgNJjgZ/nWNV06SdWqzGo6dL95VZmRW7SoTkDHXJ6V0nhjwwbzUAkk0TxoFZgDnIP0o1jQIrKOWKC7hklhOJMHBBrI0XUrjSnkeNmAOM49K5Z1Z4ik3Qlqcs6k8RSboyNj4g29lpWufZtM2iMRruUcgH0rmWuSF9Cabqt0by+ebczFznLdahjj3kAkH+ldGHo+zpRjN3aWp0Yej7OlGM3dpajHlPLLkE02W7lMQTeQPanS4G4ADr1qIfK4JUGupJPodKSfQdbPctNGod8MwPWvUYNejt7a3iubhWkQ/Lt5wMdDXm7XrSBQVVdvTFTGRTZsQT5ueK4sXhliLc6tY4sVhliOXnVrH0/wCBfElvqdqbQFGnQAP/APWpnjK0kmtDGke4lsAEdK+YNA8Q6hoV8lxYTlHRs4PIP1r6k8Na3H4l8P2moKMPIo3r6Eda+KzXKZ5ZWVeGsH+Z4GZYKeFile6W3+X+RzPiPw7p8Xgu68yNRdRw7i+MHNfN0vDMOOvavpf4vT+R4PuEQ7XkIXryfavmlEILlj0r6HhiU50J1Ju92enkPN7OcpPqQHOaTPJp3LMaRgR2xX1B9CJQDzRQOtBQZooo96YmEgwFPrRSMc0VLBeY2nDgcU0U/HFCJYgPNApcc0neqEKKTvSjmg8UAA9uaAKUDnpSmlcLir15qbGO1RoDmp0Ql1GOT6VnJmciWytZby6jgto2klkYKqqMkmvp/wCF+gReGNDMF1EBfTjMzYyV9FrmfhT4WttLe31abTpllZMD7Qfu57gdq0/F3it7LUSlpteFDhyOpNfDZzjp5jU+p0F7q3fdnzGOzCVeahQ6PZ9f+AdFrfiBdAU3VtORcICEXGdw/ukdx615f4muINYsbnxDoW7yYf8AkIafnL2bE4Dju0RPRv4TwexMPifxXZzM+SJHaLB81cfMey46AV5zo+u32ia0mpabN5c6EjkbldSMMjKeGUjIIPBFejkmX8lJxqr+vI1ynBtwftVv/WhHrGoC9l3hccYzWYD82DkivoAfBSPxR4CufGGhpNY3V1ai7tdHUq6BgTvVWySVYDKA4Izg5614D87fIB36V9LGmqcVFbH0Cp+ziorYacsCuPepFDLCCp4zgjNNAKj36U6KKSaQIgJJOKGN+ZdYTx2iKWK7uw7j3qk6mMkN1PpzVl8WdyEu2Z8DnB6Ctm4tdIurCM2crrc4+43Sud1VTtdaPqkc/tfZ2utH1SOaJJ6U0FAfmY/hTr9fKk8sHkdap5/OuuK5lc6kuZXLSvExwWI/CnrHuUlCGx2FUqVJGjYMhII6Gm4dh8vYvRKzNwOnWu38NeJ7vSLF4rZ/kIPygc5I9a4m3ufNl/eYVz/EOhrRj1JI4/LeIEeq1w4ugq0eScbnFiqKrR5JxuQhZpLqa6mZgXJ+8eufWqZJDYJBA7U67mV5P3W/aP71LGFZehzXRFWV2bxVlqMuiI0VkOc9vSk3cZB69ammgPkiQcqT+VV92TjjinGzRSd0SBdyMxIwvWklKnAWnzRGNI8jG4Zz606C186C4k3AGMA4z1o5klcXMlqQwpvlVehZgPzrbe0/s3V5LSaPew+Qqw559qkWwifQ0ucCORE3Z7k5qjY3zx6mlxdM0kjMC5PO7tg1zSm6t+XpdW8znlN1E+XpdW8zO1e1+yXbIVxzkV7p8BNQkl0NrdxGI42IUKOfcmvH/F1xDc3cQgAwq4PGK7X4K3WowXcixxSPZ9DxwCfevPzmm8RlzctHo9TizO9TBKb3Vmdj8fAf+Eet5omwgmww/Cvntn+9nvXtPxh1CV9EMM8ThZJBsbHAx2+teNNCPK3559KfDkPZ4JKXdl5G74a8lu2RxtgdaY7ZbmlApDxX0CPZS1uJ3pO9KaB9KCxBQ3WgfWrCwFoWkYqqjjnvQ2luTKSW5XcYx70UP19RRSZSGVLHwRmohmng4INBLHygA5A4poHenjL8U9U4waV7EXsQYpf5U5hzSD2qrjuA60v86FH40vXikwJIgBXrPwU8LQahcy6zqEYkitm2wxsOGk9T64rzDTLR7y7jgiGWY19I/DjTo9O8MxW0ZJXzSzE9z6185xFjHRwzhB2cvyPDzrFujS5YvV/kbN7rE1pcRRyWjqMsGkJyrDGQBivGfF08j6lNIbfZLLyV5G0/Sva9alKPlYhsiHmFj7V4b4pvxqN9dXIk/eh8YHpXz2RxTnzKPQ8PLbus+yOVvt13hn6VnPEu9gh6djWrcRtJH8sgjRuPmbvWUnlRu3mZOOmK+2ovSyPq6L93Q6nwD8QvEfgW78zQb0i2Y7pbSYF4JPqvY+4wfes3xnqthrniO61XTLE6cl2fOltQwZI5T9/YePlJ+YDAxnHbJy7SXb5hCbl2ng1BBG00ypGCzMcADqa6OZ6p7HRzPZ7ImEEnl7yvy02C6eN9qEAdeldfB4duLVIWuN6+Z8uGXgetT6l4StdKcM11G8BUMX789cV5/wBfo35W732OF46k3yvW+xx88/2iUO8a7h3rV02eBY286PdgcY45rKuRH9pZYTlAcChpvLjIYHGOK6J01OKSN501OKSM+/fdcuRyM1VpznLE02u+KsrHZFWVi9c6Xf2mnWN/c2k0VjfeZ9mndCEm2Ha+098E4NUTXqerX3hvXPg74P06XxJDZazoMeoO9lJZzuZmlm3xorquwEhRyTgbhnGDXlhNMpgODx1q45yAfaqf0q5OpQqp7AVE90RLcW3USSqpOM960bOy3s4Zwqr3JrLTOKs/aNijy9y+ozWFRSfwsympPSLL17ZTWir5zKYW6Mpzmspmy5CL8oPGaszXHnKoyeO2asabHFIrI6jeTwaiLcI3luQm4RvIqxncVMhJUH17U+7UbzJACI8dakvLfyo8kY5xWppraVLozfbG23MLfKueJB6GpnU5UppX6EzqcqU0rkenXUt1pUtht4VSwOOtZY2GJnkchozwAOTW1a6zBbzR+RbLyu0/LnJqlqunTw3yLLayQxyneQ1Z05cs2mrX1/zMqcuWTTVr6/5mQ84uJssMMSAMV9E/Drwhd2fhm2N1dyJGzCYRjAAz6n+lcF8P/Bmk6lqQNyWkeJt7RM21VXsfevbJdUt7TT5X81Ps8YI4ORx2r5niHMvacuGw/wA9PuseLm2Pp1GqEU7fr0PHPj0ZVlsIRJmBUztA715JGx4DdOvNd18TvEkesalbiJsrEmDke9cVIwkXgAYHWvosnpTo4OEJqzPYyqnKlhYQmrEMjBmO0YHoKYRQeDSV6yR6iVgz3o70h5pc80FCHgDFLuJ47U33peaYWGmilbiipYDRUirmoxVqNRtyDSbsRJiwKN/qKexAJANM+6Dzg1GzHNTa7M7XF70wdTThzmkqygUU9RnFCitDSLGTUb6K3h+/I2Bms5zUU5PYmc1FOT2RufD+ynm8TWYCuImba7Bc4U8Zr3aSyfSbSGG2m3vvJCEdfp9BUel+EotA8LRnTE36kUG5mJy5FZ+leJ2vNeg0vUbbytRjYnKn5eOo/KvgcfjJZjUdSivdjv8ALr6HxWZV54yo5wXupfh3N/W5TDpLib94+0Z7bvWuX8P6Dp0tn59/ZedNOcqpHAXPBq/8R9Raz00KgHzjlvSud/4WBb20Nuv2TfcLGA53YUcdhXPhaGIlQvRT1fR22OTD0a7o3ord9PI4jxT4bv7XWZo47ZtkkpES56A9KxNb0iGwBVpnMwOCAvH516DfanH4laW5jXFysYXZu4x3xXD6xb3byCBIWK9eRyffNfV4LEVZcsKjs1ufTYKvVfLCo7NbmDtaNOGznjg11fw3t0l1wvMgKRjIPcn0FY0Wk3DeWJonSEn7xGM0/TNXn0wn7I3ljcVVu9d2JvXpSp03qztxF61KVOm9WepeMvF9jDbtpts/mSoweRscr7fWvLNf1ea+mwWPlDotUpJmeedmcsWOWbuaiieIuxnywxxj1rDBZdTwi0V2ZYPL6eFjorsSIjNOuCdv4c1Y0lYfNaSeLzQnzbCdoI96fdRpLM8kKbLcnhc5Kj0ruc0p2sdrmlOxhN+lNPXitK6sJIsBMuDzx2rPZSDyK6YTUtUbxmpaoSkpQPSpbeAyuM8Lnk020lqU3bcW3iJ2yMMID+dSu3mOzt37UrKzPtTJA6CoWfbkc5FRuRuxwNPkUhAACARkEjrVfzPapkOQCST9e1DVgaaGRFw+CK3Ivs9pawzpKZLkjdgDhD71lwxOzgKDzVx2+zxNGVByMEntWNX3mkjKr71kMvdQnvUVZQBtJ6CqcahpNrMAPWnbenNXrexQ2huDModSP3Z6ketO8acbLQLxpq2xcsdOZV80KcjG1vSuguJHlvYnvW80OgB56CuduPEk7Wwt4YxhflU45xXonwx8NyTAav4hxHarzGjjG8+p9q8fHVHQputW07Lq/Q8nGTdKPta2nbuX9A0C6t1a9CGaScFeCf3adl/lWL4yvYtL0mLToJd165LOAeldP4w+ItlpCz2elbJZwPvryBXhGoX1xdX0lzNITK5JzXFleEr4uft66st159vkceXYStiZ+2rKy3Xn2+RWn3eaxkJLe9RlvSnOzO2WOSepodQBkV9atj6paWGHrSGlPNJ0qigo70E0tIYYpKO3NGTmmAjUUGipe40NFWoziOqo61OeFAFJmUhXIZuKaM7valXBb3pSfmo20EGKB6UvUUKKQhQMV0fgZQ/iKzRmdVZwDsOCfYVz2K0NGu5bHU7W5t/9bHIGHuQawxMXOlKK3aZjXi505RW7R9YJqIOm2tusTRQx9d4y/wCJrjrrwtIvjC31e1m3RAgtu6/Suc1/xfqV1cx3FpEYUaIbkAz9c/jXong69OpaTC04ZGIwSR3r83lQrYCn7Vac101vufD1IYin70mtfd+XY86+I4uFk8hwzKWJL46A9hXnV2oLBIwSB3PU19DeL9MtJ7GU3blIkAZpAMkV45q9pC6SXNqf3akhCw5b617mT42MqSjbY9HLcRyx9m1Zo5zR717G9DkEoOCAetev6XcQjw7NerbxtOy5CSp933x6V43DAzXLSNgKpy2a6abxTdCxlt4jtVkCkjoBjGBXdmOFeIceTfqdeYYZ13Hk36lbXtVe+dY2mLKBhU6BcnnFc5f25sAsYQYf5s4/rVIyyCQ4c7c5xT572dwA7b1HGGr1aOG9klGOx6dLDOlZR2IwA5wq8nriiS3KqCxXpS27tuJQ7Q3BNaMFqjxFZG65wTW0p8hvOpyGXHGXYKp/GnyRDOFYlR3qD50lOwlecDFbGj2Euo3kdt50cJb+KU7VH1p1J8i5m9Cpz5FzN6FO2laJstk7fun0qx9ihdDLLgFuQexpZ7fyJXXKkocEq2aqzTnorcVn8bvAz1m7wBrWMgsowMdBVUsobb2FEjyEZzhfaoTk10Ri+rN4xa3ZJPKRK7RKACeAKqEM7k+tXbaETShWcIvqaLmNI5SsbbgO+KqMkny9Rxkk7FaGDcwDHirsscSKBHyaY4QxJ5YfeB85YjB+lRqee9J3lqPVu5pWabcZqS/sJVVJSn7t/unrmjTEeZwxjZol4OK7yHTftulwo1kYguW3Yxx657nrXm4jE+wmmzzcRifYTTZ5l5LCYJzvPatrTbSGWaG0uN/myttAXvVq1YHU5UgQSXB4jyPb+dekfDLw1Bp07ahrZV9QTmKN/wCAH+LHrWOPzBUKTlLe2i6t/wCRljMcqULy07f12Dw/8NtOs1jvr6NnKnKQvxuPbNYHxG8Qz2aPbAFZmyi7ThUT2Fdh4/8AG8On28ltFn7SQQSP4a8A1e9lvrp5Z5GdmOeTmvOyjDYjG1PrGK1XS5wZbhquMq+3ru8VtcqO7NJuJJJPOe9I5BxnrQGwORUbNk8V9ekfUpai5K80Mc+lMzS9qZdhw4PPpTTzR1NJTHYWgdKSlzSGFJ3o7Ud6AENFBopMAFWY4mbAUEk8VWWr0U7KyMCNykEVMm+hlNvoWrrSZ7S1SafChz8q55rPYcgV0+qava39hiSH/SQOGXoK5vYW5HWsMPOco3qKzOahOco3qKzGIMmpQvHNRcjgdaUMTzWzRsx2eKs2EnlXcMoOGRwwPuDVXr2qRDtYGpkrqwmrqx9W+DrfTPFekwXcUERllj2ugA+8Oo/OtL/hHrrTbqERKVhBJK4rwr4OeNP+EX8RR/a2ZtOnIWVT0Q9mFfXVtcW+pWiTW7LNC/IINflGeUq+V4jl3py2/wAvkePQyChiFKk5Wmndea9PLbQ8w8VWktzYTQxj5nXoR+leCSJqOnajcrIDs5BjcZ4+navqTU7RTduJeAMgYrz/AMXeHUuil5aWiyuGIkJOCRj9a6cmzKNFezmtGeQlLBVZwmrpv56Hi1+4+zJPIygsMhQMEkdM1zSyM8js75B9K7aewk1HWjZ2kajy9xCDkD6mszVPDsumOTdxeUzcgeo9RX22HxFOPut6voexh69OK5W9WcszDkYB560YyORxUt3btE/qDyMU+1dVRleMNn3r0uZWuj0ub3boigcRHGMqeee1WGvAEAK8DkY71FKAQdqhRUcIQk7+T7UmlLVicYy1aIyBJISWAHWkMjBs7iT+tSNCWJKK23OM4qKRdjkDtWiaZrGzLSr5ijJKydSSeDVV+pFSKzSqqc8etLsCsQRSWj1FHTcrncRgHj0pYoGc8Dn0qchd3A4p6OIX5YY9abk7aA5aaFeWF4zzkUQP5bhioYd8jirctxHITllPHXNbWhaTFeqZN8UsaHDAHke9ZVK6pwvMyqV1TheaKVjpq3cbSR3FskQxuD53flW9B4W09SXfVLQEjKxl+TWXLH9mimSFiGGRkLwfrR4R0a71nW0iiRtijLPt4QetcVWcnCVT2nLFHFVlJwlPn5Uj1r4f+E44okuQIXLH5V2huP5VqeOIha6YbeKEqJGJdlGQmB941a0G6svDkNvZee73E3QBTzT/ABxbyXeizu98ttAq5kXH3x6E18RKvUqYtTqP3W9Nz5aU1Vqqcm27/Kx5zoF9FpwCw6bHtU4a5xktj1J/pWRqPijOpS3MjybWOMA4zjpz6VQ1TxcotTYWsQNsDwe5Ncdd3TzOTI3J6AV9fhsu9pJ1KsbXPosNl/PJzqxtcu+IdWOpXJYk7c5xnvWPu65AAprvz0+lRFiete9SpRpxUY7HuUqShFRjsDHcaQUULWxsFLik96XtQxoTvQaXpSUALRSD3pQDSGApO9O246jmk7+gpiGmilbg0VLGIOashcCqw9a27MWslttmHltnG6s6kuVXMKkuVXKqsGQfKqkelJFxJgtx60siKrssLblzjNICqjJ+8D0qfQjoRPjfSlRjIP4UPjdkVHuq7XKJAD3pfbNNXnvxTz14FIB6SFeFr0XwP8T9U8N2i2g/f24Py7mIKD0HtXnGB1FKp5AJ4rkxWEo4uHs60boxq0IVlaX/AAT6a8NfFXTtduRbahItvK33Xc8E+mfWvQ7ZI5IiOCrDPsa+JmZopflP0Ir2r4UfENbS2Sw1iTCpxHcMc4H91v8AGvi844bVGHtcJt2/yPKxGGdBqp8Uet9X/wAE7zUPC1p9vlnss2dy3BdFBHXPSvPfEWl3cd3NBeJJO56TNk8e1euy31tekS2kglLgcqwIp4gifCzojDsSM15GGzCrQd56/meBGo41XyO/9aHif/CF/a4IpW2qmMfP8oJrfs/h1pFxBBm6zhedmMk/Wuv8U+Hp9QtR9mfygnGK5nwt4b1Wy1GW6uJVVEHyoQW3H19q9P8AtGpWpOaq8rXQuWJr8rcp2a6dzhfEvheHw/v+2YMbk7Cp5x9PeuVisI7hGeAlkHBBXkE16Fr1tea1qstxe2l28KSBFQIduBWnZ20G/wAsWQV3+TAQ4wPWvYp5hOlSTm7y69jvhj5UqacneXU82/sW8FsXVGEa84rCmtiJmUjBzXuuvBLPw+YZFSCRgSNynOPQY9a8jgMZ1i3NzDM8RkG9UUnjPNdmAx868ZTa2OzA46daMpNbFaDS5IFjMqkGQZUEU7VdMns8koQ23OOpxXsWreHEu3tzp9k5cYbe442joPSqyeA/Pkb7ZfrbuxxsiO5j7ZNckc8p6Tm7eX/DHNHN4ytOWhxGheDobyxW5luBvx+8QnhDXKeJtOt7O62QSkpuwARzj1r3vS/D2kabZTxSJLGY+We7k+9x1Ncvpvibwjaajc2tzaWkkqygRzxwl9/vlqjDZtVlUnOEZTS6JE4fMqrqSnFOSXT+rnlWn+FNW1GLzNPtHnXggAcketdBaeENb02NXujHaYO/HmAkfgK9b8Ra7ANNvrS2tJPtEaKU2Jw2fcVheFNb8OpBJd3wEN3jDmX5s/SiWcYqtTc/Z6drXf8AXyCeaYmrByUNPS7/AK+RDo8/hj/RrPUZXnvHQ73KnYx9K6aO+8P6GzOstpBEw4VDzkdfrXlfjHxFpw1+SfTUGw4bIGOfb0rjLnVWnleRly7ZOSc04ZNPFJTlKST3T/rQUcpniUpNtJ9Gemal48s4NVa8tJlmk5Cr5Wcfia4rxV4u1bW/3F7ORbg5WJeB/wDXrmjMWk5x+ApsjgZ5zXt4fK6FCSko3a6s9nD5bQoNSSu13GklTn171C7ZJ5pzMXHTiom4716sUejFDmGVyRim9aM570YwKosQ09U+XJ6UsIBYA4pH4Y4PFJvoDethuMe9ONMp3amUJ60gpwHPNAxmgVxOop6EA5PSjCjnrSk5HApA3cGbc2RTANzUvSm9DQFuwN1xRSHJPNFJ7jEH0q9LC6cHg1RU4PatJ5yxDnPAxzUSvfQyne4xEOQWPFSyxrsLggDIxnqaiJVjw36U2TIA3Nn0FTZtkWuxnHOKjWl6tUqbQvOTV3sVsNB4Bp+ffNBC9VIxSHpzUgKp55FP4LcDFNVlP1qfcq7QV/GpZLGuuCuOferNndNbhgmMHg5p6r5yrgAD2qndJsfA6VnpP3WZpqfus6XSPEd7puVtJ2QMQwINegaT8VZYAiahAZx0Z1wD/hXjNrI3mBckg1oqC+4ltiY79687F5Zh67/eRODE4CjN3kj6I0Hx7omqOI/tn2eQ/wAM/wAv4Z6V2CXlmY1QTwFW6OrDrXyEtzFGdoYnnqKvrey/Zt0M8qgH14BrwsTwvCTvTm0vNXOF5V7N+49H31PpfWpbeCNlmmCFvutnk1labqcCz/ZLeFvkXeSBnJr57/4STUCAs11LIAMLucnFJB4k1C3uhc215cRXC8B0bmnDhqooOLlc5v8AV+o73kfRGopFfhDcyokKHcUYgcVzHiLXdE/s+eDSrmCG+Awkpjyox9K8f1HxLqV6C13dySORgkms+1vir7WOQeprpw/D8oWdSW3Rbf8ABNaGQyiuapLboj0EfEDV4ohbXUpvYwOTCChbHv2qp4W/t/XG1FrffsPzLHu5GT2Jrirq68uVTAxBFRvq12QQtxKg64RyB+leostioNUYpN+X6Hp/2fHlfs4pN23X6HbXSa/p18YdbndUcHasjbiR/Sse90m1OZlkCOx4XeMn8OorHttUn8wG5d5lxj52JP5mmSyyNcbk4BrWnhqkHuk/JWTNIYepB7peisjs73xtrNtYrapdBYFTy1GwbgMY61w01w0rkhmLN13Gr00ZaLPDeu41TRFjcllBGOK0w1ClRT5IpPyLw1ClST5ErlUq+ctmoyQpOKmuZ94IAA5zxVXJxmu+Kb3O5LTUcXP0pmeOtJ/Oj1zVpFWFZuMA8UztSnjFA5zTGhB7U9RuOKQkAYFIDigCWaIwkK3DYzjOcVEoyauLCjRBj8xPUg9Kk06zS5u0ieTYHYL6/jWftFFNsh1Ek2ygwwODSqua9Sh+Fm9UkF47QtxwoB+tGq+EtG8O2gF9K08+chlOMD3rzf7Zw0mo025Psked/bGHbUYNt+SPMNpzxTCh3HFb+qXemCQC0iYnGCSOM1kTx4AkRgQ3b0r0KdRyV2rHfTqOSu1YrZ7GnA0hOTSVsbAaSnLjHvSUANPWilPWipe5SGg4HFWxKSoHYVTqZThcGk1cykiwjAsM/jSuvzkLkjPGabb/AOsG44GepqaRirMwwyn0rPZmb3Idq4759aUR7iB2PrS79zBQBjNOuEaCVo26rTv0C/QYUCH6U0lSAe9WTHmESkHb0P1qCOIyK20dPehPqwTRJboJGwozj9Kklh8iQFmVwelVlBXIViPWrEDAzASEEdOamSadxSunfoXLR1GVJAB98CopxlmLEEVqW9lDcIBHJGpHXd1rN1Zjb3DQgKdvcciuaElKdluc0JqU/dCyt0b5y20g9D3rQkktlsmU5D844rFW5KqByMelOBeRMnJX1q50nJ3bLlScndsq5waf5rbduTtodfmAFLtycD1rodjpIjyafGhckDP4Cjbg4FX4NTktrKW2gCIspy5wNx9s+lKTdvdRMuZL3UUZEIwD2oUMMnHAp3zMpc9PXNAj3fdPXtTuUN3DocUzGGyasSxrEwCsH4zkU1w7bd3TtQn2GnfYdGocgDrU1srC6Uc4Jx61CrRRcurMewzxUK3DISV4PXips5bENOV0dDe2pXBMbKNvp3rEnJ9SSPyqa71u+u7dIJ52eNBhR6CqkLqzANWdGnOK98zpQlBe8RbHY8KTmpGgEa4dsN6VdUhMqibie+elV5sxgiVc1qpts1Um2UnXDYyDTe1PZgW46UK2McCtjS40IcZxgU0n2rpLRrK5sREYxFKeCx6NWHc2/lSOoYHH61lTq8zaatYzp1eZtNWK1ApSpHUUqIznCgmtrm1x6M7DYvNWrWGVHEiE7l5z6VNpem3FwWEY46bverN9ZvppNvK2W4JFc06sb8iepzzqxcuRPU6jQ/iNd6cnkyjzQBgZ5pmp2mpeKgb6UiOAHhc9foK4mGHzrsCLhc969NtdUW40aK2aJEMA+dozjIxXk4qhDCSVXDxSk932PKxNGGFkqlCNpPd9jzq60qWC6WGPMjMcAkVrJpMH2d47qUKRg7vQ/wCFVr7X3juP9DjVUVsgtyTWRcX884YO3BOTXoqFeold2O9Rr1Eruw+9gWA7VKsvOHHOap/SnNIzqAzEheme1MzXXFNKzO2EWlqA6UpNJSd6sqwHrRQetFSxiCpkBOKh7VNHwoIpPYzkOVSTxSMCGAzzU2eRwKjY/vDSTITJnQgDbjjqRU9yqNHG8jEzkc5qmpIPBp90SrDB6gGoad0TbVDmmcQ+UWwnXAoiAKjZnOfzquvzdanHCAjrVNWG0kTmPL/NjJ7CmSRmOQfKy/WtXRrSOcoX3ZOeQaqawzfaQjMWC5xuNYRqXnyGKnefIX9Cs5NQvEjiOSe2a6q48CXoiaSW3LKOp71yXgueSHxLZtExU+YOnevpvUm2aTPIACRETyPavnc5x9bBVoxhszws1xdXC1lGGzR8q6jaJBdPGCV2nkNUkBMKbRt2sOcjpUWqTvJfzlsZLntRCMrjnFfRJNwXMe6k3BXK8iNv5PftQfl6GnuxBIB4FQvw1arU2RJ5bsoODgjOcVE3TpUwlfy9uflHaomY01fqNXG88c8VZTBj5IBxwKqk81JDy65705LQbV0W44AVDORyeBUVypiOCPcVecbIsr64qDVgDBbvj5mBzWMZNySfUwjNuVmZjtuPNN7ZqVEBXNMcAHA6V0eR0IYeoqe22h1LDIFQ0sTHd2ptaAb1u6Ochdv4Vo33h7faLcGXcWGcVzlrcylwA+BntW9Zavdwuio4wvqM5+tebXjUg1KmzgrxnTalBnP6hYSWdyYnHzAA8VSKleoOfeup8WarPqeoxvOkKlQAPLTbWVdIklqHKAP6iunD15ThGU1qzehWlOEZSWrKUU4RMHr60sTCSTLdDUG0bquW8Skgc1vJJamzSQ+8jjaMFOKo7yuVU4HtTrtj5xXPyjpUSjIJpwjaOo4Ky1JobuaEkxSMp9ae1405Zrl5HbHBBqp3oFPkjvbUpwjvYu6VdCC6UyglDwfWte61D7Osghf5JFwAP61zecHinZJ6ms6lCM5czM50IzlzMGOWJ9aSg8UlbG+wtHejPNKBmkMbjmlNKvWlb+dMTZH3ooP3qKl7jP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immunofluorescence microscopy in hyperacute rejection showing the almost pathognomonic deposition of IgM around the wall of a small artery. The lumen (L) is markedly narrowed by intraluminal fibrin deposition (arrow) which comprises most of the space between the remaining lumen and the immunoglobulin positive vascular wall.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_2_18479=[""].join("\n");
var outline_f18_2_18479=null;
